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Abstract 
Transition metal-catalysed cross coupling chemistry is a valuable tool for synthetic 
organic chemistry, enabling the preparation of compounds of great interest. The 
catalytic metal of choice is usually palladium, which generally offer better 
performances in term of catalytic activity and easy handling. On the other hand, the 
use of nickel in this class of reactions is gaining attention, as it would provide more 
economically and environmentally sustainable processes. 
Deprotonative cross couplings are a subgroup of these reactions, in which the 
nucleophile is generated in situ by direct deprotonation of a (relatively) acidic C–H 
bond, for example those of an enolizable ketone or an imine. The reaction products 
often represent intermediates towards more complex molecular architectures, by virtue 
of the well-known carbonyl chemistry. 
The development of a Pd-catalysed methodology for the prototypical deprotonative 
coupling, the α-arylation of ketones, is reported in this thesis. It requires significantly 
lower catalyst loadings compared to previous reports, and displays good tolerance 
towards functionalised substrates. A related protocol for the intramolecular α-arylation 
of imines towards indoles was subsequently disclosed: as it requires low catalyst 
loadings and displays good scalability and simple setup, this methodology is a 
promising hit for industrial applications. 
The parallel development of nickel-catalysed protocols afforded an efficient method for 
the α-arylation of ketones, using chloroarenes as electrophile for the first time in the 
literature. The method was further optimised for the synthesis of an intermediate 
towards a commercial medicinally active compound. Building up on these findings, 
the first nickel-catalysed protocol for the deprotonative arylation of benzylamine-
derived imines was also developed. 
Last, the first aqueous palladium-catalysed protocol for the α-arylation of ketones was 
investigated. The method proved flexible, showing excellent functional group 
tolerance: compounds containing base-sensitive functional groups, halogenated small-
molecule drugs, and Boc-protected amino acids were all suitable substrates. 
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1 Introduction 
1.1 Modern cross-coupling chemistry and deprotonative cross 
couplings 
1.1.1 Historical perspective 
Metal-catalysed cross-coupling (CC) chemistry undoubtedly represents a milestone 
achievement for modern synthetic organic chemists, as it allows the straightforward 
synthesis of a wide range of compounds whose preparation would otherwise be 
difficult, or even impossible, to accomplish.1 The access to moieties like 3-arylacrylates 
3, arylalkynes 5 and (poly)arylamines 7 has been made straightforward by the rise of 
the Pd-catalysed Mizoroki-Heck, 2  Sonogashira 3  and Buchwald-Hartwig 4  reactions, 
respectively (see Scheme 1). 
 
 
Scheme 1. Examples of Pd-catalysed CCs. 
Palladium catalysis also provided access to the biaryl motif 9, which can today be 
prepared via CC reacting a haloarene with various organometallic reagents. These 
reactions are now well-known, named after their inventors: Kumada-Tamao-Corriu,5 
Negishi, 6  Stille-Migita, 7  Suzuki-Miyaura, 8  and the coupling of organolithium 
compounds reported by Feringa in 2013.9 All these protocols made the diaryl scaffold 
easily accessible, thus paving the way for the development of many materials and 
bioactive compounds which contain such motif (see Scheme 2).10 
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Scheme 2. Synthesis of biaryls using CC chemistry. 
Formally, CCs can be considered as reactions between an organic (pseudo)halide 
electrophile, and a carbon or heteroatom nucleophile, such as organometallic 
compounds, amines and thiols. A general mechanism for Pd-catalysed cross coupling 
protocols can be summarised in three key steps:11  
1) the Pd0 species 10, often formed in situ by activation of a PdII source, undergoes an 
oxidative addition step, activating the C–X bond in the electrophile 1 and thus 
producing the PdII species 11;  
2) the nucleophile 12 then coordinates the Pd center in an associative substitution 
reaction, leading to the dissociation of the halide or pseudo-halide (most commonly, a 
tosylate or triflate);  
3) once both the electrophilic and nucleophilic counterparts are bound to the Pd center 
in intermediate 13, a reductive elimination step gives the desired coupled product 14, 
regenerating the catalytic Pd0 species, ready to undergo a new catalytic cycle (see 
Scheme 3). 
 
Scheme 3. Minimal mechanism for Pd-catalysed cross couplings. 
It has to be noted that the mechanism of a specific Pd-catalysed CC can involve more 
steps, depending on the nature of the catalyst and the coupling partners.1 More 
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importantly, other catalytic metals can couple these starting materials, through a 
sometimes intrinsically different mechanism. One paradigmatic example of this 
difference is the involvement of SET, which has been proved when other metals, 
especially Fe or Ni are used as catalysts.12 
The key importance of metal catalysed CC chemistry made it a testing field for 
organometallic chemists.13 During the past decades, the efforts have been focused on 
the understanding of the mechanism of CC reactions, with the following aims:  
1) the development of new Pd-catalysed protocols, for example the Buchwald-Hartwig 
amination, reported in the mid-1990s;14  
2) the improvement of existing reactions, to such an extent that, for example, the scope 
of the Suzuki-Miyaura coupling is nowadays remarkably wide, including virtually any 
kind of functional group;15  
3) the replacement of Pd catalysts with more earth-abundant and cheaper metals, such 
as Ni and Cu.16  
One of the major threads of the research in this area, which enabled many of the 
aforementioned aims, is the use of ancillary ligands to boost the performance of the 
catalytic metal(s).17 Early examples of metal-catalysed CC chemistry relied on the use 
of ligand-free protocols, often using simple metal sources such as PdCl2, Pd(OAc)2 and 
[Ni(COD)2], often with the addition of simple ligands such as PPh3. Such systems allow 
the conversion of simple coupling partners, but display important limitations when 
more challenging reactions are performed. Sterically hindered and/or unactivated 
substrates, such as chloroarenes or electron-rich bromoarenes, are unsuitable substrates 
when ligand-free or simpler catalytic systems (e.g. triphenylphosphine-supported 
catalysts) are used. Moreover, the catalytic activity of such systems is usually low, and 
relatively high catalyst loadings (5 or 10%) are often required.18 The design of better 
performing catalysts has led to the study of more sophisticated ancillary ligands, 
capable of maximising the synthetic potential of metal-catalysed CC chemistry.17 The 
following section of this introduction will focus on the development of the class of CC 
protocols described in this thesis, and will outline the main characteristics that 
ancillary ligands must display to enable deprotonative cross coupling chemistry.  
 14 
1.1.2 Deprotonative Cross Coupling reactions 
As mentioned above, the study of ancillary ligands enabled the disclosure of novel 
reactivities, e.g. the Buchwald-Hartwig amination. Buchwald and Hartwig also 
contributed, together with Miura, to the development of the Pd-catalysed α-arylation 
of ketones.19 This reaction is the first catalytic Deprotonative Cross Coupling (DCC) 
reported and the basis for the work presented in this thesis. The concept of DCC was 
introduced by Walsh in 2012.20 
 
Scheme 4. The general equation for deprotonative cross coupling processes. 
DCC reactions are characterised by the formation of a nucleophilic coupling partner in 
situ, by reaction of a relatively acidic C(sp3)–H bond and a base. The acidity of the C–H 
bond is usually due to an electron withdrawing functional group. While carbonyl 
derivatives (ketones in primis) are by far the most studied pro-nucleophiles, arylation α 
to other electron-withdrawing moieties has been achieved: nitro-, nitrile- and sulphone 
functional groups all proved to be active in the Pd-catalysed α-arylation reaction. 
Scheme 5 shows the typical reaction mechanism of the now well-known α-arylation of 
ketones as a prototypical example of this kind of processes. The elementary path of a 
Pd-catalysed cross coupling is followed: the catalytic Pd0 species activates the C–X 
bond of the electrophile 1; the [PdII(Ar)(X)] 18 complex formed (analogous to complex 
11 in Scheme 3) can then undergo a transmetalation step with the anionic nucleophile, 
usually generated by deprotonation of the enolisable ketone pro-nucleophile. the 
[PdII(Ar)(enolate)] species 20 undergoes the reductive elimination step, forming the 
desired C–C bond and regenerating the Pd0 catalyst. 21 
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Scheme 5. Mechanism of the α-arylation of ketones according to Hartwig.22 
Depending on the nature of the coupling partners, additional relevant steps can be 
added to the mechanism depicted in Scheme 3, leading to more complicated reaction 
pathways and/or the change in the kinetic behaviour, e.g. different rate limiting steps. 
In the case of the α-arylation of ketones showed in Scheme 5, for example, the 
equilibrium between the C–bound and the O–bound enolates 18 and 18’ is found to be 
rate-determining, as only 18 can undergo the key reductive elimination step (vide infra). 
Moreover, like in other cases of metal-catalyzed CC processes, this mechanism is not 
general, especially when using metals other than Pd. The very nature of the reaction 
pathway can indeed change dramatically: one striking example of this is the study 
reported in 2014 by Chetcuti and Ritleng on Ni-catalysed α-arylation of ketones (see 
Schemes 24 and 25 in this Chapter for further discussion). Nevertheless, some critical 
features that are common in most of the DCC processes reported so far can be 
summarised in 5 main points. 
1) The arylated product is generally more acidic than the starting material: this often 
leads to preferential deprotonation of the product, whose conjugate anion can compete 
with the starting material in the catalytic process, resulting either in formation of 
polyarylated products, or in slower reactions. The use of an excess of base (2 
equivalents or more) is often very beneficial, as it ensures the deprotonation of both 
substrate and product. This leads to more selective mono-functionalization of the 
former over the latter, because of its more favourable steric properties.22 The need for 
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an excess of base limits the development of asymmetric version of carbonyl arylation, 
because the newly formed stereocenter is labile to basic conditions, unless quaternary.23 
2) The selection of the base (more often of the base/solvent system) is crucial, as small 
differences, for example in solvent polarity or base countercation, can result in 
dramatic change of reactivity. In some cases, a mild, relatively weak inorganic base 
(typically Cs2CO3 or K3PO4) can be used (vide infra the monoarylation of acetone), while 
t-butoxides and metal amides are the most common choice for DCCs. 
3) The functionalization of a methyl moiety, e.g. in an acetophenone derivative, is 
complicated by the side reactions that it can undergo under the reaction conditions, 
most importantly self-aldolisation.22 Moreover, the monoarylated product is highly 
reactive towards subsequent arylation. The selective monoarylation of such substrates 
is hence difficult when using non-sterically encumbered, or unactivated aryl 
electrophiles, even if two equivalents of base are used.  
4) In some cases, pre-formation of the anionic nucleophile (e.g., a Zn enolate) or of a 
synthetic equivalent (e.g., a silylenol ether) is advantageous allowing superior control 
of the reaction outcome and improves functional group tolerance.24 
5) Although some examples of ligand-free protocols are known (including the early 
report by Miura), ancillary ligands play a pivotal role in DCC processes, an importance 
that has been confirmed by many subsequent studies.19c,25 
1.1.3 Ligand effect in DCC processes. 
Although a wide range of ligands have been tested and proved somehow successful in 
metal-catalyzed CC chemistry, the introduction of chelating diphosphines (e.g. BINAP-, 
Xantphos- and DPPF-type diphosphines) () has been a major breakthrough in this area 
during the ‘90s (see Scheme 6).26 The use of bidentate phosphines was introduced by 
Hartwig and Buchwald during the development of C–N bond forming catalytic 
reactions, and substantially improved on the previously reported triaryl-
monophosphine-based systems. 27  Bidentate phosphines also represent the “first 
generation” system for DCC reactions.28 Some of these systems proved very active: one 
notable example is the DtBPF ligand 22, initially reported by Hartwig, but 
subsequently developed by Colacot as one of the most robust ancillary ligand for Pd 
catalysed α-arylation of carbonyls. 29 
 17 
 
Scheme 6. Examples of bidentate ligands utilised in DCC reactions. 
The mechanistic studies on DtBPF/Pd catalysed α-arylation led Hartwig to the 
conclusion that only one of the P atoms of the ligand was bound to Pd through the 
whole catalytic cycle.29a This observation triggered the study of monophosphines as 
ligands for cross couplings.30 At the beginning of the 21st century, the development of 
specifically designed bulky monophosphines, and amine-phosphine bidentate ligands 
led to significant improvement in CC chemistry (see Scheme 7), 31  and in DCC 
chemistry especially.28 
 
Scheme 7. Selected examples of monodentate phosphines utilised in DCC processes. 
Concurrently with these developments, the introduction of N-Heterocyclic Carbenes 
(NHCs) as ancillary ligands has also provided very efficient methods for the α-
arylation of carbonyls and related reactions.17a NHCs32 are carbon-based ligands, whose 
sterics and electronics are easily tuned by varying the N-substituents and backbone 
(see Scheme 8).33 Although they have been considered for some time as phosphine 
mimics, studies on their characteristics and behaviour proved that they rather represent 
an alternative to phosphorus-base ancillary ligands, and the applicability of these two 
classes of ligands sometimes proved complementary.34 
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Scheme 8. Monodentate NHC ligands utilised in DCC processes. 
Common traits can be individuated in ligands that promote cross coupling chemistry 
in efficient way: 
1) as mono-ligated Pd species are proved to be the most active in CC chemistry of 
challenging substrates (e.g. chloroarenes), monodentate ligands generally provide 
superior catalytic activity,35 with few exceptions,29,36 because of the high reactivity of 
the derived, 12-electron species unsaturated [Pd0(L)] catalytic complex; 
2) the electronic properties of the donor group is crucial, as strong σ-donors (namely, 
electron-rich) ligands usually give superior activity towards unactivated electrophiles, 
as they favour higher oxidation state at the Pd center. Moreover, the σ-donor/π-
acceptor properties of these ligands also guarantee stronger ligand–metal bond, which 
limits the catalyst degradation;37 
3) the steric properties also play an important role, as a crowded environment 
“protects” the catalytic species (especially in the cases of Pd and Ni catalysed 
protocols), slowing down the bimolecular decomposition pathway and accelerating the 
reductive elimination step. The concept of “flexible steric bulk” has been coined, 38 
following the observation that rigid bulky substituents around the metal hamper the 
reactivity, while a more flexible substituent enhances the reactivity; 
4) the tunability of the steric and electronic properties allow the design of optimal 
catalysts in terms of activity and selectivity.39 
Together with the key importance of the ligand employed, the assembly of the 
catalytically active complex can also be crucial.40 The initial results, based on the use of 
multicomponent catalytic systems, meaning a metal source and a ligand (or a ligand 
precursor), were subsequently shadowed by the performances displayed by well-
defined PdII pre-catalysts, which often have the additional advantage of being air stable 
(at least in the case of Pd complexes), and therefore easier to handle. The higher 
activity has usually been explained by the selective formation of the (putative) active 
species, avoiding the presence of “unactive” complexes in the reaction mixture.41 
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Studies in this area provided a number of precatalytic architectures in the past 15 years, 
as outlined in Scheme 9.40 
 
Scheme 9. Typical architectures of Pd pre-catalysts. 
The activation of these well-defined complexes depends on the nature of their 
structure. The generation of the active Pd0 species is driven by the reactivity of the so-
called “sacrificial” or “throw-away” ligands, usually designed to easily release the 
catalytic species under the reaction conditions. The mechanism of the activation step is 
not always unambiguously understood, 42  and different modes of activation are 
observed for the same pre-catalyst under different conditions.43 In most cases, however, 
such step is proven, or at least supposed, to occur by nucleophilic attack on a PdII 
centre, followed by reductive elimination generating a [Pd0(L)n] species. Complexes 41 
(and derivatives), for example, are activated by attack of a t-butoxide anion followed 
by reductive elimination of a product 44, as shown in Scheme 10, equation 1.43a In the 
cases of complexes 40, the activation proceeds through deprotonation of the amine, 
followed by reductive elimination to give indoline 47 (Scheme 10, equation 2).44 
 
Scheme 10. Modes of activation of selected pre-catalyst architecture (“throw-away” ligands).43,44 
The crucial reports about carbonyl α-arylation reactions of ketones will be summarised 
in Section 2 of this introduction, while Section 3 will focus on the functionalization at 
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benzylic C–H positions. The application of deprotonative cross couplings to the 
synthesis of heterocycles will be covered in Section 4. It has to be noted that most of 
these protocols rely on the use of Pd as catalytic metal; nevertheless, important 
examples of DCCs are reported with other catalysts, especially the cheaper and more 
widely available first-row transition metals Cu and Ni. Such methodologies will be 
mentioned in the respective relevant paragraphs, in order to give a most 
comprehensive overview of all the options available in the synthetic chemist’s arsenal.  
1.2 α-arylation of ketones 
1.2.1 Main examples of α-arylation of ketones 
α-aryl carbonyls represent a widespread motif in many bioactive compounds and/or 
intermediates towards their synthesis. During the past decades, classic organic 
synthesis has provided a variety of stoichiometric methods for their preparation.45 
Despite their utility, these protocols display many crucial drawbacks, hampering not 
only their applicability on large scale, but also their generali and easy application on 
laboratory scale. Indeed, the need for a methodology that easily delivers such scaffolds, 
led to the first example of metal-mediated α-arylation of a ketone, reported in 1973. 
Semmelhack used quasi-stoichiometric amounts of Ni for the intramolecular coupling 
between the enone moiety and the aryl iodide group in compound 49, leading to the 
core of the natural product Cephalotaxinone 50 (see Scheme 11).46 
 
Scheme 11. First example of α-arylation of ketones: the synthesis of Cephalotaxinone according to 
Semmelhack.46 
The first Pd-catalysed versions of α-arylation of ketones were reported concurrently 
by Miura, Buchwald and Hartwig (see Scheme 12).19 The use of a bidentate ancillary 
ligand (DTPF (Scheme 12, equation 1) by Hartwig, Tol-BINAP (Scheme 12, equation 2) 
by Buchwald), together with a Pd source, gave good performances for a range of 
coupling partners. These initial findings mainly focused on the use of activated iodo- 
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and bromoarenes. It is noteworthy that these early reports contain examples of 
acetophenone derivatives as pro-nucleophiles, later found to be challenging substrates. 
 
Scheme 12. First general examples of arylation of ketones and selected examples of the scope. 1) 
Conditions: 7.5 mol% [Pd(dba)2], 9 mol% DTPF, refluxing THF, 2h; b) Conditions: 2.5 mol% [Pd2(dba)3], 6.0 
mol% tol-BINAP, 70 °C in THF, until completion. X=Br or I. 19 
Hartwig proved that DtBPF ligand gives superior results when compared to other 
bidentate ligand.29a Further studies suggested that such an improved performance 
could be due to the de-coordination of one of the P donors during the catalytic cycle, 
because of the large steric bulk and of the electronic properties of this ligand (see 
Scheme 13).  
 
Scheme 13. The mechanism of the reductive elimination from Pd-diphosphine complexes confirms only 
one P-donor is necessary.29a 
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The above-mentioned studies were crucial to shed light on the mechanism of the 
reaction (which is shown in Scheme 5). Such findings triggered the study of 
monodentate phosphines to perform this transformation: early studies by Hartwig 
proved that PCy3 and PtBu3 were suitable for such transformation, and led to the 
development of monodentate ligands for CC chemistry.29a Other studies involving 
monodentate phosphines were carried out by Beller and Hartwig, showing the 
catalytic potential of this class of ligands.47 Buchwald subsequently proved that very 
bulky monodentate phosphines, such as XPhos, provide excellent selectivity even 
when acetophenone derivatives were used.48 These results confirmed the hypothesis, 
previously reported by Buchwald, that increased steric bulk can significantly improve 
the performance of CC catalysts (see Scheme 14).49 
 
Scheme 14. α-arylation of arylmethylketones using an XPhos-based pre-catalyst according to Buchwald 
(selected examples, total scope 12 entries).49 
Despite these exceptional results obtained with monodentate phosphines, it has to be 
noted that some bidentate ligands, like the aforementioned DtBPF 21 and NiXantphos 
24, provided catalytic activities comparable with those achieved with monodentate 
ligands, and are still used in this (and others) CC reaction. Specifically designed 
ligands like XPhos are often the most successful ones in α-arylation of ketones, 
although the use of simpler phosphines is still a field in development, as demonstrated 
by the protocol reported by Shaughnessy in 2014 (see Scheme 15).50 
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Scheme 15. α-arylation of ketones using DTBNpP ligand according to Shaughnessy (selected examples, 
total scope 25 entries). Conditions A: X=Br, T= 50 °C, [Pd] = [DTBnPP] = 0.25 mol%. Conditions B: X=Cl, T = 
80 °C, [Pd] = [DTBnPP] = 0.50 mol%.50 
The success of monodentate phosphines in the α-arylation of ketones prompted the 
study of other classes of ligands. The application of NHCs in CC chemistry has been 
pioneered by Nolan, who proved the suitability of their NHC-bearing, Pd-based well-
defined pre-catalysts in the α-arylation of ketones.51 Subsequently, the same group, 
and others, reported on the use of various classes of well-defined, NHC-containing 
pre-catalysts for this reaction. Scheme 16 shows the results reported by the same group 
2006. The use of the NHC-based pre-catalyst 89 resulted in high yields of coupled 
products even at relatively low (0.25 mol%) catalyst loading.52 
 
Scheme 16. α-arylation of ketones at low catalyst loading using an NHC-based pre-catalyst according to 
Nolan (selected examples, total scope 16 entries).52 
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An interesting field that has emerged in this area since 2011 is the selective mono-
arylation of acetone. Such a transformation is challenging because of the high reactivity 
of the mono-arylated products, that hampers the selective monoarylation and the poor 
reaction rates showed by small ketones, because of the slow reductive elimination 
step. 53  In 2011, Stradiotto reported the first mono-selective catalyst for acetone 
arylation, using the P–N ligand Mor-DalPhos 97 (see Scheme 17).54 The protocol shows 
an impressive scope of chloro- and bromoarenes at catalyst loadings as low as 1 mol%. 
The same catalytic system has also been successfully applied to α-arylation of more 
common substrates (aryl- and cyclic ketones),55 and to carbonylative α -arylation 
processes.56 
 
Scheme 17. α-arylation of acetone, according to Stradiotto (selected examples, total scope 21). Catalyst 
loadings shown in parenthesis.54 
After the first disclosure, a number of protocols for the α-arylation of acetone were 
disclosed (see Scheme 19), using a wide variety of catalytic systems and aryl 
electrophiles.57 
 
Scheme 18. Other ligands for the α-arylation of acetone. 
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A recent report by Kwong proved that the specifically designed indolylphosphine 106 
provides superior performances in this transformation: the desired mono-arylated 
products were obtained in good yields with catalyst loading as low as 0.1 mol% in 
some cases (see Scheme 19).58 
 
Scheme 19. Specifically designed, high-performance indolylphosphine for the the α-arylation of acetone. 
(selected examples, total scope 25 entries).58 
In 2014, the α-arylation of α,α-difluoromethylketones (see Scheme 20) was disclosed 
by Hartwig,59 who used the well defined phosphine-containing palladacycle 114 as pre-
catalyst to accomplish the coupling of these pro-nucleophiles. The reactivity of 
difluoroketones in cross coupling reactions is limited by their electronic properties, that 
make the reductive elimination step sluggish. Their utility in the one-pot, two steps 
synthesis of difluoromethylarenes, which are difficult to obtain by other means, was 
demonstrated for a wide scope (31 entries), was proven. This methodology highlights 
the extreme versatility of the α-arylation of ketone in the context of synthetic organic 
chemistry.  
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Scheme 20. α-arylation of difluoromethylarylketones according to Hartwig (selected examples, total 
scope 31 entries).59 
In 2016, Feringa reported a protocol for the generation of lithium enolates by reacting 
benzamide derivatives and organolithium reagent. The subsequent α-arylation of the 
enolates were then achieved one pot, without the use of additional bases. Although the 
yields ranged from modest to good, this strategy potentially represents an entrance to 
variously functionalised α-arylketones (see Scheme 21).60 
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Scheme 21. One pot α-arylation of enolates generated by nucleophilic attack of an organolithium reagent 
on amides, according to Feringa (selected examples, total scope 22 entries).60 
As previously mentioned, other metals were used for this transformation. In 2007, the 
first example of Ni-catalysed α-arylation of ketones was reported by Matsubara using 
the mixed NHC/phosphine well defined Ni pre-catalyst 140 (see Scheme 22).61 Despite 
the many drawbacks this method suffered (unsuitability for methyl ketones and 
unactivated chloroarenes, high catalyst loading, moderate yields), it represented an 
important milestone for Ni-catalysed cross coupling, which was until then limited to 
the stereoselective arylation of tertiary, cyclic ketones.62 
 
Scheme 22. Ni-catalysed α-arylation of propiophenone derivatives according to Matsubara (selected 
examples, total scope 11 entries). X= Br unless otherwise specified. [a] X= Br; When X = Cl, 58% yield was 
obtained. [b] X=Br; when X=Cl, 39% yield (NMR) was obtained. [c] 5 mol% [Ni].62 
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In 2014 Chetcuti and Ritleng reported on the [Ni(NHC)(Cp)Cl]-catalysed α-arylation 
of ketones (Cp = cyclopentadienyl).63 When the NHC ligand is IPr (see Scheme 23), this 
system showed improved activity with respect of Matsubara’s, allowing the conversion 
of a range of bromo- and iodoarenes at 3 mol% catalyst loading, obtaining moderate to 
good yields. However, the use of more challenging substrates, namely methyl ketones 
and chloroarenes, led to poor or no conversion. 
 
Scheme 23. Ni-catalysed α-arylation of ketones according to Chetcuti, Ritleng (selected examples, total 
scope 23 entries). Unless otherwise noted, X= Br and t= 24 h. [a] X= I. [b] t= 48 h.63 
Complexes 152 and 153 were synthesised starting from [Ni(IMes)(Cp)Cl] 151, with the 
aim of probing their involvement as catalytic intermediates in the CC reaction (see 
Scheme 24). Complex 151 is a competent catalyst for the reaction, although less 
efficient than its IPr congener 145; the synthesis of possible Ni-enolate and Ni-aryl 
intermediates of this complexes was reported to be difficult, because of the instability 
of such derivatives. 
 
Scheme 24. Generation of putative reaction intermediates from pre-catalyst 151, according to Chetcuti and 
Ritleng.63 
These studies showed that this process does not involve under a Ni0-NiII cycle, 
probably because of the strong ligation of the Cp moiety to the Ni center (see Scheme 
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25). Complexes 154 and 153 failed to provide significant amount of coupled products; a 
radical mechanism was therefore proposed by the authors. This result proves that the 
ancillary ligand plays a crucial role in DCCs also in cases when the mechanism is not 
the “common” one. 
 
Scheme 25. Mechanistic studies on the [Ni(NHC)(Cp)Cl] class of pre-catalysts according to Chetcuti and 
Ritleng.63 
In the same year, Itami and Yamaguchi reported on a Ni-catalysed aryl-pivalate C–O 
activation/α-arylation of ketones).64 Despite the high temperature required (150 °C in 
toluene), this methodology shows a spectacular functional group tolerance, allowing 
the coupling of a large array of heterocycles and functional groups, including 
enantiopure aminoacid derivatives. Methyl ketones were tolerated when naphthalene-
derived aryl pivalates were used, although moderate yield were observed when less 
sterically hindered aryl pivalates were used (see Scheme 26).  
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Scheme 26. Ni-catalysed α-arylation of ketones using pivalates as electrophiles according to Itami, 
Yamaguchi (selected examples, total scope 29 entries).64 
The authors also isolated the intermediate 167 derived from the oxidative addition of 
the aryl pivalate 166 to the L/Ni0 complex; this complex was active as a catalyst in the 
transformation (see Scheme 27). This result indicates that a Ni0-NiII mechanism is 
active in this case. 
 
Scheme 27. Mechanistic studies on the mechanism of the Ni-catalysed ketone arylation of ketones 
according to Itami and Yamaguchi.64 
Another first row transition metal that proved to be active in the α-arylation is Cu. 
Copper is commonly used in cross coupling catalysis, especially for arylation of amines 
and amides. Taillefer reported in 2012 the first example of Cu-catalysed α-arylation of 
ketones, using ligands 171-173 in junction with CuI as catalyst (see Scheme 28).65 This 
system is limited to aryl-benzyl ketone derivatives, and shows a limited functional 
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group tolerance. Nevertheless, its synthetic utility has been proven by employing it in a 
concise synthesis of Tamoxifen. 
 
Scheme 28. Cu-catalysed α-arylation of deoxybenzoin (arylbenzylketones) according to Taillefer (selected 
examples, total scope 18 entries).65 
1.3 Deprotonative Cross-Couplings at α-benzylic position 
Benzylic C–H bonds notoriously display peculiar reactivity, dictated by the close 
position of aromatic rings, that increase their acidity and lower their nucleophilicity.66 
Polyarylated benzylic derivatives, such as triarylmethanes and (diarylmethyl)amines 
have showed interesting properties in many areas, particularly for optoelectronic 
materials, 67  and in medicinal chemistry (for more information about the 
(diarylmethyl)amine moiety, see Chapter 5). The development of CC protocols 
towards these motifs potentially provides a simple and general pathway toward these 
classes of compound. 
1.3.1 Arylation of (poly)arylmethanes. 
The development of Pd-catalysed DCC chemistry towards the synthesis of 
polyarylmethanes was pioneered by Miura, who reported the first transition metal-
catalysed arylation at the benzylic position of p-nitrotoluene derivatives in 1998.68 The 
reaction was either mono- or di-selective, depending on the steric properties of the 
coupling partner; moderate to good yields were observed (see Scheme 29). The need 
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for a strong electron-withdrawing group on the aromatic ring of the pro-nucleophile, 
together with the high temperature required, limited the scope of this transformation.  
 
Scheme 29. Arylation of electron-deficient toluene derivatives according to Miura (selected examples, total 
scope 11 entries).68 
The group of Yorimitsu and Oshima subsequently reported the first direct arylation of 
diarylmethanes under Pd catalysis, using [Pd(MeCN)2Cl2]/PCy3 as catalyst and 
CsOH•H2O as base (see Scheme 30).69 The reaction allows the synthesis of complex 
compounds, for example the polycoordinating architecture of compound 196, but the 
study covered only few haloarenes. The presence of a nitrogen-containing aromatic 
ring was necessary, but not sufficient, to achieve this transformation: entry 204 shows 
that a 3-benzylpyridine could not be used as pro-nucleophile. 
 
Scheme 30. Benzylic arylation according to Yorimitsu and Oshima (selected examples, total scope 16 
entries).69 
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In 2010, Morris and Burton reported the deprotonative Pd catalysed mono-arylation of 
nitrogen-containing methyl-heterocycles. 70  Their catalytic system was based on 
Xantphos, while different Pd sources, such as Pd(OAc)2, Pd2(dba)3 and (MeCN)2PdCl2 
could be used successfully. The authors observed that the best results were obtained 
when using the Fairlamb catalyst, a tetramethoxydibenzylideneacetone (208)-based 
version of Pd(dba)2 (see Scheme 31). A wide scope of naphthiridine, pyperazine, 
pyridine and quinoline derivatives was synthesised via arylation at their benzylic 
position. The system shows an impressive functional group tolerance, and is appealing 
for late stage functionalization of such heterocycles (see entry 217), although also in 
this case substrate specificity was observed. Bromo- and iodoarenes, as well as aryl 
triflates, were suitable electrophiles for this transformation, while the use of 
chloroarenes resulted in no reaction.  
 
Scheme 31. Benzylic arylation according to Morris and Burton (selected examples, total scope 29 entries).70 
A similar approach was reported by Li,71 using Pd(OAc)2/PCy3 and NaOtBu, for the 
arylation of (heteroaryl)-CH3 moieties. In this case, only diarylation products were 
observed, making the selective synthesis of differently substituted compounds 
impossible (see Scheme 32). 
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Scheme 32. Diarylation of methylheterocycles according to Li (selected examples, total scope 26 
examples).71 
To overcome the limitations encountered by the aforementioned groups, namely 
substrate specificity and lack of mono-arylation selectivity, Walsh reported the 
coupling of a series of Cr(CO)3-coordinated toluene and diarylmethane derivatives in 
with aryl bromides (see Scheme 33), using [Pd(PPh3)2Cl2] as catalyst.72 Chromium 
tricarbonyl is commonly used as a protecting group to de-activate electrophilic 
substitution on aromatic rings.73  
 
Scheme 33. Arylation of chromium tricarbonyl-activated diarylmethanes (selected examples, total scope 18 
entries).72 
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Walsh subsequently focused on the chromium-free version of the benzylic arylation of 
diarylmethanes, trying to expand the previous report by Yorimitsu and Oshima 
(summarised in Scheme 27). High yields of the desired triarylmethanes were obtained 
when NiXantphos 26 was used as ligand (see Scheme 34).74 
 
Scheme 34. Direct arylation of diarylmethanes according to Walsh (selected examples, total scope 34 
entries).74 
The authors achieved high efficiency of the protocols showed in Scheme 34 by careful 
study of the deprotonation of diphenylmethane: variety of base-solvent systems were 
tested, trapping the anion with benzyl chloride (see Scheme 35). A thorough study 
using HTS techniques, covering many different reaction conditions, led to the 
conclusion that this reaction is extremely base dependent, being KHMDS the one only 
base capable of efficiently promoting the deprotonation both at room temperature and 
at high temperature; CPME was found to be the optimal solvent. Subsequent studies 
demonstrated that other bases, such as LiHMDS and NaHMDS, also gave satisfying 
results when used in combination with crown ether or chelating amines additives;75 the 
effect of chelating additives has been explained by the change of nucleophilicity 
imposed on the main-group metal-anion species. 
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Scheme 35. Study of the deprotonation of diphenylmethane 256 performed by Walsh.74 
The protocols reported by Walsh rely on the use of the NiXantphos ligand 270.76 
Complexes containing this chelating diphosphine show high reactivity towards 
oxidative addition compared to other diphosphines displaying similar bite angle (see 
Scheme 36, equation 1). This behaviour is rationalised with the deprotonation of the 
free N–H bond under catalysis conditions, enhancing the electronic properties of the 
coordinating phosphorus atoms and therefore making NiXantphos-containing catalysts 
suitable for cross coupling on chloroarenes, a feature shared by few bidentate ligands 
(Scheme 36, equation 2).77 
 
Scheme 36. 1) Comparison between Xantphos-type ligands in the coupling diphenylmethane with a 
chloroarene; 2) study on the coordination chemistry of NiXantphos.77 
Wu reported on the Pd catalysed arylation of methylene-bridged polyarenes, in 
particular arylfluorenes: the use of Cs2CO3 in combination with PCy3 allowed the 
preparation of a range of 9-arylfluorenes.78 Such an approach proved valuable to the 
synthesis of extended π–bowls compounds as well as other polyconjugated organic 
materials (see Scheme 37). 
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Scheme 37. Arylation of fluorene derivatives according to Wu (Selected examples, total scope 22 entries).78 
The Walsh group subsequently reported on the functionalisation of allylarenes.79 The 
C–H bond is in this case activated both by the aryl ring and the vinyl moiety. The effect 
of the base in the deprotonation of these substrates was studied, in order to favour the 
deprotonative pathway over the Heck-type pathway that can take place under Pd 
catalysis in the presence of olefins. Different ligands afforded different selectivities 
between α-and γ-arylation: PCy3 was chosen as optimal ligand, as it provided high 
selectivity towards arylation in α position (see Scheme 38). 
 
Scheme 38. Arylation of allylarenes according to Walsh (selected examples, total scope 25 entries).79 
In 2016, DCC processes involving benzylic C–H bonds have been reported also under 
Ni catalysis. Walsh demonstrated the utility of the NiXantphos ligand for the 
deprotonative coupling of diarylmethanes, using [Ni(COD)2] as a catalyst (see Scheme 
39). 80  Comparison between the behaviour of NiXantphos and other Xantphos 
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derivatives showed that both the sterics and the electronics of the P atoms are relevant, 
as the more electron rich and bulkier tBu-Xantphos proved less effective than both 
Xantphos and NiXantphos, implying that steric hindrance might hamper the 
transmetalation step and therefore suppress the catalytic activity. 
 
Scheme 39. Ni-catalysed arylation of diarylmethanes according to Walsh (selected examples, total scope 20 
entries).80 
1.3.2 C–H arylation of benzylamine derivatives. 
The first strategy for the C–H arylation at the benzylic position of benzylamine 
derivatives was reported in 2008 by Yorimitsu and Oshima. A series of Xanthone-
derived benzylimines (299) were synthesised and treated with [Pd(allyl)Cl]2/PCy3 in 
the presence of CsOH•H2O and chloroarenes, leading to arylation at the benzylic 
position (see Scheme 40). 
 
Scheme 40. Isomerisation of the coupled product 309 to 310, as observed by Yorimitsu and Oshima. 
The synthetic utility of this methodology is hampered by the thermal isomerisation of 
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Xanthenamine-derived imine 310. The problem of isomerisation was solved using a 
reduction/hydrolisis approach, with the disadvantage of an overall more complicated 
protocol, but higher yields and simpler purification of the desired product were 
achieved. 81  Scheme 41 shows the products obtained using this strategy. A fair 
functional group tolerance was observed. 
 
Scheme 41. One pot, three steps Pd-catalysed C–H arylation, reduction and hydrolysis to products 311 
according to Yorimitsu and Oshima (complete scope).81 
In 2014, 82  Walsh reported the deprotonative arylation of benzophenone-derived 
benzylimines, adopting the strategy developed for the synthesis of triarylmethane: 
after finding the best deprotonation conditions through HTS of base/solvent systems, 
they found that Pd(OAc)2/NiXantphos was the best catalyst for this reaction using 
bromoarenes as electrophiles (see Scheme 42). The benzophenone-derived imines 313 
used as starting materials for this protocol have the advantage of being cheaper and 
more readily available than the Xanthone-derived imines used by Yorimitsu and 
Oshima (see Scheme 41). 
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Scheme 42. Arylation of benzophenone-derived benzylmines using bromoarenes as electrophile according 
to Walsh (selected examples, total scope 26 entries). Slow addition of the base (as a solution 0.2 ml/h) was 
necessary.82 
A similar catalytic system was subsequently found by Walsh to be active also for 
chloroarenes, only at slightly higher temperature (see Scheme 43). 83  The lower 
temperature employed for Walsh’s protocols suppresses the isomerisation of the 
desired product observed by Yorimitsu and Oshima (Scheme 41), resulting in much 
higher yields. The disadvantage, however, lie in the need for slow addition of the base 
to the reaction mixture, making the whole method less user-friendly. 
 
Scheme 43. Arylation of benzophenone-derived benzylimines using chloroarenes as electrophile according 
to Walsh (selected examples, total scope 29 entries). Slow addition of the base solution(0.2 ml/h) was 
necessary.83 
The use of imines was overcome by Walsh in 2015, when his group reported the use of 
a NiXantphos-based Pd catalyst for the arylation of Boc (Boc: tBu-carbamate) protected 
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amines.84 The protocol was applied only to methyl- and ethylamine derivatives, with 
the exception of the tetrahydroisoquinoline derivatives 345, a precursor of Solifenacin 
(see Scheme 44). 
 
Scheme 44. Arylation of Boc-protected benzylamines according to Walsh (selected examples, [a] 7 equiv 
base, 30 hours, 85 °C.84 
Walsh subsequently reported on the use of tertiary (azaarylmethyl)amines for the 
synthesis of (diarylmethyl)amine derivatives.85 This method was suitable only for 
heterocyclic derivatives, as the presence of a pyridine or quinoline moiety was 
necessary to observe reactivity (see Scheme 45). 
 
Scheme 45. Arylation of (azaryl)methylamines according to Walsh (selected examples, total scope 29 
entries).85 
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Walsh reported on the deprotonative arylation of β, γ -unsaturated imines in 2016.86 
Regioselective α- or γ-arylation was achieved by tuning the reaction conditions: when 
using KHMDS as base, [Pd(2-methylallyl)Cl]2 as metal source, and PtBu3 as ligand, 
high selectivity for α-arylation was observed (see Scheme 46). 
 
Scheme 46. Arylation of enimines at the α position according to Walsh (selected examples, total scope 18 
entries).86 
The use of a pre-catalyst based on the architecture 40, bearing NiXantphos as ancillary 
ligand, together with NaHMDS, led to high γ-selectivity (see Scheme 47). 
 
Scheme 47. Arylation of enimines at the γ position according to Walsh (selected examples, total scope 15 
entries).86 
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1.4 Applications to the synthesis of heterocycles 
Due to the well known chemistry of carbonyl compounds, α-arylation-type CCs have 
been involved in many synthetic protocols towards natural products87 and heterocyclic 
scaffolds.88 This section will focus on application of α-arylation of carbonyl derivatives 
for the synthesis of O- and N-containing heterocycles, mainly oxindoles, benzofurans, 
indoles and isoquinolines. 
1.4.1 Synthesis of oxindoles 
α-arylation protocols have been first applied to the synthesis of oxindole scaffolds. The 
employed strategy is straightforward, as it involves the intramolecular arylation of 2-
haloaniline derived amides, leading to the direct formation of the desired C–C bond. 
This strategy had been explored by Hartwig in the synthesis of a small range of 
substituted oxindoles (see Scheme 48). The authors used a first generation catalyst (a 
Pd source + a bidentate ligand, BINAP) for the intramolecular coupling of 2-
bromoaniline derived amides 376. 89  Noticeably, the synthesis of tetrasubstituted 
carbons at the 3 position afforded higher yields compared to the corresponding tertiary 
carbons, probably due to the side reactions arising from the subsequent deprotonation 
at that position, still enolizable when trisubstituted. This feature triggered the research 
about enantioselective synthesis of tetrasubstituted oxindoles with good success, 
achieveing high yields and enantiopurity over a broad range of target compounds.90 
 
 
Scheme 48. Synthesis of oxindoles according to Hartwig (complete scope).89 
Marsden subsequently reported on a much more efficient method to perform this 
reaction.91 Using an NHC ligand, they were able to synthesise similar compounds 
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using catalyst loadings as low as 0.1 mol%. A scope of medicinally interesting 3-
aminooxindole has been prepared in this way (see Scheme 49). 
 
Scheme 49. Synthesis of oxindoles according to Marsden (complete scope).91 
In 2009, Ackermann reported on the use of 2-chloroaniline-derived amides for this 
intramolecular coupling (see Scheme 50). The scope reported was much wider, and 
included some examples of 4-aza-oxindole derivatives (401-402). Also in this case, the 
use of α-disubstituted amides resulted in better yields.92 
 
Scheme 50. Synthesis of oxindoles according to Ackermann (selected examples, total scope 18 entries).92 
The use of the phosphine oxide ligand 396 was known in a range of challenging cross 
couplings: its mode of action was proved by Ackermann to involve the in situ 
formation of a chelating, bidentate adduct derived from the tautomerisation of the PO 
double bond and its subsequent deprotonation, resulting in the bis-ligated, Pd complex 
405 (see Scheme 51).93 
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Scheme 48. Formation of the active Pd species using phosphine oxide 396 as ligand.93 
1.4.2 Synthesis of benzofurans 
Protocols for the synthesis of benzofurans have been initially reported by Miura94 and 
the group of San Martin and Dominguez.95 This strategy is based on a two step, bis-
deprotonative C– and O–arylation of ketones. Although their significant novelty in the 
context of heterocycles synthesis, these protocols suffer many drawbacks, most 
importantly high reaction temperature (160 °C) and limited regioselectivity. A similar 
strategy was reported by Willis.96 A more convenient method for the preparation of 
benzofurans was reported by Eidamshaus and Burch in 2008, who developed a one pot 
α-arylation / condensation reaction of ketones and 2-bromophenols (see Scheme 52) 
using the DtBPB ligand, an example of bulky, electron rich diarylphosphine.97 
  
Scheme 52. Synthesis of benzofurans according to Burch (selected examples, total scope 20 entries).97 
In the same report, the authors also showed the role of their reaction in the synthesis of 
the bioactive product Eupomatenoid 6, using their one pot protocol as the key step (see 
Scheme53). This adds value to a synthetic strategy that already shows a good 
functional group tolerance. 
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Scheme 53. Synthesis of Eupomatenoid 6 using the arylative protocol developed by Burch.97 
Shaughnessy successfully applied the catalytic system he reported in 2014 to this 
transformation (see Scheme 54).50 The use of a simpler trialkylphosphine (DtBnPP, 
419), as well as lower reaction temperatures (50 °C vs. 80 °C), lower catalyst loadings (1 
mol% vs 5 mol%) and generally improved yields make this protocol extremely 
valuable. Moreover, the intermediate 417, used in the synthesis of Eupomatenoid 6, 
was obtained in better yield (compared to that reported by Burch) using this protocol. 
 
Scheme 54. Synthesis of benzofurans according to Shaughnessy (Selected examples, total scope 12 
entries).50 
1.4.3 Synthesis of indoles and carbazoles 
The first example of α-arylation of carbonyls in the synthesis of indoles was reported 
by Buchwald in 2002. 98  The monoarylation of acetophenone derivatives with 2-
chloronitroarenes leads to the intermediate 422, which upon reduction with TiCl3 and 
condensation of the newly formed amine with the carbonyl of the ketone gave a wide 
range of 2-substituted, N-unprotected indoles. The use of 0.3 equivalents of phenol 
additive provided improved yields in the ketone arylation step (see Scheme 55). The 
authors postulate an interaction between the ketone, the phosphate base and the 
phenol in the deprotonation step, making the protocol suitable for substrates bearing a 
nitro group as substituent. 
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Scheme 55. Two-step ketone arylation-reductive cyclisation for the synthesis of indoles according to 
Buchwald (selected examples, total scope 21 entries).98 
The direct synthesis of N-unprotected 2-substituted azaindole derivatives from 2-
bromoaniline and a ketone via enolate arylation was studied by Spergel.99 This strategy 
is extremely appealing, because of the great availability of a wide range of starting 
materials, both ketones and 2-bromoaniline derivatives, and for its feature of 
producing N-unprotected compounds directly from the palladium-catalysed reaction. 
On the other hand, the presence of a free -NH2 moiety on the electrophilic coupling 
partner creates problems with the selectivity between N– and C–arylation, therefore 
limiting the efficiency and the scope of this approach. Scheme 56 summarises such 
features: the authors were able to synthesise complex compounds such as the polyclic 
derivative 442, but the catalyst loading was high (20 mol% of the relatively expensive, 
NHC-containing complex 433). Moreover, when the NH2 moiety was not electronically 
unactivated, very low yields were observed (entries 435 and 437). 
  
Scheme 56. Synthesis of azaindoles according to Spergel (selected examples, total scope 16 entries).99 
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A similar intermolecular approach was previously reported by Nazarè, whose group 
employed [Pd(PtBu3)2] as catalyst and a mixture of K3PO4 and acetic acid as additives, 
in the presence of a drying agent. Despite the high catalyst loading required (10 mol%) 
and the high temperature, this method shows a great functional group tolerance and 
impressive flexibility, allowing the preparation of highly functionalised compounds 
(see Scheme 57). The additional advantage of not requiring any pre-functionalisation 
of the substrates makes it relatively practical.100 
 
Scheme 57. Synthesis of indoles according to Nazarè (selected examples, total scope 21 entries).100 
In 2015, Kapur reported a related arylation of enone enolates.101 In order to avoid N-
arylation and to increase the functional group tolerance, the enolate was not produced 
by deprotonation, but by deprotection of a silylenol ether with Bu3SnF and CsF and 
subsequent arylation of the tin enolate. The protocol proved useful in the synthesis of 
various 2-vinyl substituted indole derivatives (see Scheme 58). 
 
Scheme 58. Synthesis of 2-vinylindoles according to Kapur (selected examples, total scope 23 entries).101 
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When cyclohexenone-derived silylenolethers were used as starting material, it was 
possible to obtain carbazole derivatives by simple dehydrogenation of the product, 
under Pd/C catalysis (see Scheme 59). 
 
Scheme 59. One pot synthesis of carbazole derivatives according to Kapur (selected examples, total scope 
16 entries).101 
In 2007, Barluenga reported the synthesis of indole derivatives through sequential α- 
and N-arylation of ketoimines with o-dihaloarenes (see Scheme 60).102 The reaction 
works with o-dibromo- and o-dichloroarenes (entry 476), as well as with more 
substituted 2-chlorobromoarenes. Variously 1,2,3-substituted indoles were obtained in 
this way. Acetone-derived imines were also tolerated (entry 479). 
 
Scheme 60. Synthesis of indoles according to Barluenga (selected examples, total scope 14 entries). X = Y = 
Br unless otherwise stated; [a] 2-chloro-4-benzoxy-bromobenzene was used as electrophile.102 
In the same report, a 3-component reaction using an amine, a bromoalkene and a 
dihaloarene was also reported. Although such reactivity would be advantageous, 
because it avoids the need for the synthesis of the imine in a separate step, the need for 
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optimisation in almost each single case, and the lower yields, limited the utility of this 
approach (see Scheme 61) 
 
Scheme 61. Three component synthesis of indoles according to Barlunega.102 
A subsequent report by the same authors expanded the scope of the α-arylation of the 
imine to a very wide range of coupling partners:103 N-tBu imine gave easy-to-deprotect 
indole derivatives; 1,2,3-trihaloarenes were suitable substrates, allowing the synthesis 
of both 4- and 7-halosubstituted compounds; the use of 2-chlorophenol derivatives, 
such as 2-chlorotriflates and 2-chlorononaflates, was also possible (see Scheme 62). In 
particular the use of the nonaflate group as electrophilic coupling partner resulted in a 
wide applicability of this method. 
 
Scheme 62. Expanded scope of electrophiles used for the synthesis of indoles according to Barluenga.103 
Kurth reported an expanded version of this strategy involving o-dihaloarenes, primary 
amines and carbonyl compounds in a three-components synthesis of indoles and 
azaindoles (see Scheme 63). 104  Interestingly, this method allows the coupling of 
aldehyde-derived enolates, whose use is more challenging because of their inherently 
higher reactivity, often leading to undesired side reactions. Heterocyclic moieties were 
tolerated on all the components of the reaction. On the other hand, the isolated yields 
of the reaction ranged between 50% and 70%. 
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Scheme 63. Synthesis of indoles according to Kurth (selected examples, total scope 14 entries).104 
Remarkably, the order of events was determined by the authors, who performed a 
number of control experiments. Their conclusion was that a Buchwald-Hartwig 
amination, affording intermediate 546, is the first step of the catalytic cycle, followed 
by condensation of the resulting secondary amine with the ketone and subsequent 
deprotonation affords the palladacycle 548, which upon reductive elimination gives the 
desired product and the Pd0 catalytic species (see Scheme 64). 
 
Scheme 64. Mechanism of the synthesis of indole according to Kurth: sequential Buchwald-Hartwig / 
condensation /ketone arylation.104 
The three-component reaction, pioneered by Barluenga and Kurth, between amine, 
dihaloarene and ketone was studied by Stradiotto in 2015 (Scheme 65).105 At similar 
palladium loadings, their catalytic system provided higher yields at lower 
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temperature, using the more challenging 2-chloroiodoarene electrophiles, delivering a 
wide range of indole derivatives. 
 
Scheme 65. Synthesis of indoles according to Stradiotto (Selected examples, total scope 29 entries).105 
1.4.4 Synthesis of isoquinolines 
The use of the α-arylation of ketones as key step in the synthesis of isoquinolines was 
reported by Donohoe in 2012.106 This original approach starts with the arylation of a 
ketone using a bromoarene of general formula 518 (see Scheme 66, equation 1). 
Treatment of this dicarbonyl compound with NH4Cl generates the isoquinoline 520 via 
nucleophilic attack of ammonia on one of the carbonyl group of the intermediate 519, 
followed by intramolecular attack of the enamine 522 on the other carbonyl moiety and 
subsequent aromatisation (Scheme 66, equation 2). 
 
Scheme 66. 1) Strategy for the synthesis of isoquinolines according to Donohoe 2) Reaction mechanism.106 
A wide scope of substituted isoquinoline derivatives were prepared by Donohoe 
following this protocol, which shows a good functional group tolerance (entries 527 
and 528) including the use of heterocyclic bromoarenes, such as the thienopyridine 529; 
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oxides 532 and 533. This synthetic strategy was also suitable for one-pot procedures, 
with only slight loss in the final isolated yield (values in parenthesis in Scheme 67). 
 
Scheme 67. Synthesis of isoquinolines according to Donohoe (selected examples, total scope 24 entries). 
The number in parenthesis is the isolated yield for the one-pot procedure.106 
Donohoe subsequently extended the protocol, introducing an additional step in the 
reaction sequence. After the cross coupling takes place, using an acetophenone 
derivative 419 as pro-nucleophile, the authors further functionalised intermediate 519 
by reacting it with various electrophiles. This strategy allows the introduction of 
functionalities such as vinyl bromides (538), esters (537) and thioethers (542). Such one-
pot procedure enables preparation of variously 7-substituted isoquinolines starting 
from the same CC partners and an external electrophile (see Scheme 64).107 
 
Scheme 68. Sequential ketone arylation /electrophilic substitution/cyclisation for the synthesis of 7-
substitued isoquinolines according to Donohoe (selected examples, total scope 14 entries).107 
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The modular functionalization can also involve a subsequent cross coupling reaction, 
leading to 7-arylisoquinolines. The three steps of the reaction (two distinct arylations 
and the cyclisation with ammonia) could be carried out in one pot, with generally good 
yields (see Scheme 69). 
 
Scheme 69. Sequential diarylation/cyclisation for the synthesis of 7-arylisoquinolines according to 
Donohoe (selected examples, total scope 9 entries).107 
Donohoe reported the application of the above-mentioned annulative approach for the 
synthesis of the protoberberine class of natural products.108 The flexibility of this 
approach is highlighted by the wide range of natural and non-natural analogues that it 
can provide, and shows that carbonyl arylation still has a significant untapped 
potential to discover and exploit (see Scheme 70). 
 
Scheme 70. Elements of the protoberberine class of alkaloids synthesised by Donohoe.108 
1.5 Outcome 
The increasing attention received by the area of DCC methodologies enabled their 
development, making them one powerful tool to access biologically or industrially 
relevant compounds. The α-arylation of carbonyls is an appealing synthetic method, 
given the possibility to further derivatise the carbonyl moiety, and is already 
considered one important branch of cross coupling chemistry; the arylation at benzylic 
position, on the other hand, is far less studied, but its utility is emerging in the last few 
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years, and its development would give the synthetic community an easy, modular 
access to important pharmacophores and molecular materials.
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2 Large-yet-flexible NHC ligands in the Pd-catalysed α-
arylation of ketones 
2.1 The use of sterically demanding NHC ligands in Pd-catalysed CC chemistry. 
The paramount importance of CC chemistry for modern organic synthesis is epitomised 
in the escalating progress achieved in the field of ancillary ligands.1 The quest for 
increasingly efficient catalytic system has prompted the study of the structure-activity 
relationship of such ligands, resulting in the development of analytical and 
computational tools enabling the measurement of their steric and electronic properties 
and, to some extent, the prediction of their catalytic activity (see section 1.1.3 of this 
thesis). 
The use of bulky phosphines for CC chemistry was pioneered by Buchwald and Hartwig 
during the ‘90s.2 Specifically, the use of phosphine ligands in the Pd catalysed α-
arylation of ketones is reported by Buchwald, Kwong, Colacot, Stradiotto and 
Shaughnessy (among others), as summarised in Chapter 1 (see Figure 1).3 
 
Figure 1. Selected phosphine ligands reported for Pd catalysed α-arylation of ketones. 
NHC ligands are known to be efficient ancillary ligands in CC chemistry since Nolan’s 
seminal report on their use for the Suzuki-Miyaura reaction.4 In 2004, Glorius and 
coworkers introduced the concept of “flexible steric bulk” while reporting the 
outstanding activity of the Ibiox class of ligands in the Suzuki-Miyaura reaction.5 
Subsequently, more reports on the use of NHC-based catalysts have been published by 
Organ, Dorta, and Markò.6 The main examples of the systems mentioned above are 
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reported in Fig. 2. The utility of these catalytic systems has been proved in different CC 
reactions, including the Buchwald-Hartwig,7 Negishi,8 and sulfination reaction.9 
 
Figure 2. Bulky-yet-flexible NHC ligands used for CC chemistry. 
The good activity of IPr-based catalysts in the α-arylation of ketones was first reported 
by Nolan in 2002, in a seminal paper describing the first [Pd(NHC)] well-defined pre-
catalyst for CCs.10 Since then, Nolan and other authors reported a variety of IPr-based 
pre-catalysts, such as the PEPPSI-like complexes 10 and 11, reported respectively by Shi 
and Shao.11  
 
Figure 3. Examples of NHC-based Pd catalysts for α-arylation of ketones. 
Curiously, at the time we began working on this project, the study of the effect of NHC 
ligands bulkier than IPr 14 in the α-arylation reaction was an underdeveloped field.The 
NHC-based Pd pre-catalysts in our hands display outstanding activity in the Suzuki-
Miyaura and Buchwald-Hartwig reactions, even at low catalyst loading.12 Obviously, the 
development of more efficient catalytic methods for the synthesis of α-arylketones 
would be highly beneficial, especially for industrial applications, as it would make the 
synthesis of such class of compounds cheaper and more environmentally sustainable. 
We therefore focused our attention on pre-catalysts developed by our group, mainly 
based on the IPr* ligand (complexes 18 and 22 in Figure 4), and on the ITent series of 
NHCs (complexes 15-17 and 19-21 in Figure 4). The main difference between the former 
and the latter lies in the substitution at each of the 2-positions of their N-bound aryl 
rings: while the IPr* species bears a bulky diphenylmethyl moiety, the ITent ligands are 
decorated with increasingly long alkyl chains: 3-pentyl (IPent), 4-heptyl (IHept), and 5-
nonyl (INon). 
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Figure 4. Pd pre-catalysts developed by the Nolan group. 
Pre-catalysts based on these ancillary ligands were screened, and successfully employed 
in the α-arylation of aryl-alkyl-ketones. 
2.2 Screening for the optimal conditions. 
With an aim to determine suitability of IPr* or ITent ligands for arylation of ketones, 
acetophenone, acetophenone and 4-chlorotoluene were chosen as model coupling 
partners for the initial screening and optimisation of the reaction conditions. As 
discussed in Section 1.2, the selective arylation of methylketones as pronucleophiles is 
considered difficult, as the coupling product often undergoes subsequent arylation, thus 
lowering the selectivity due to formation of bis-arylated product. The choice of a 
challenging ketone substrate, together with the use of the sterically unhindered 
haloarenes was made under the assumption that once the conditions for a relatively 
difficult reaction have been found, they would allow the coupling of a wide range of 
other, less challenging substrates. 
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Table 1. Selection of the precatalyst. 
 
Entry Pre-catalyst Pd loading (mol %) Conversion %[a] 
1 15 1.0 99 
2 15 0.1 99 
3 18 0.1 12 
4 19 0.1 13 
6 15 0.02 99 
7 16 0.02 99 
8 17 0.02 75 
9 19 0.02 99 
10 20 0.02 99 
11 21 0.02 86 
12 15 0.01 2 
14 16 0.01 22 
15 19 0.01 3 
16 20 0.01 22 
Conditions: 23 (0.7 mmol, 1.4 equiv), 4-Chlorotoluene (0.5 mmol, 1.0 equiv), KOtBu (1.1 mmol, 2.2 equiv), 
catalyst (0.01 mol% or 0.02 mol%), in toluene (1mL), 100°C, 16h. [a] Conversion of 4-Chlorotoluene was 
measured by GC. 
The study of the reaction was initiated using complex 15, [Pd(IPent)(acac)Cl], at 1 mol% 
catalyst loading. This coupling provided complete conversion to the desired product. 
Subsequent screening of ITent- and IPr* based pre-catalysts 15-22 was then performed. 
IPr* showed poor catalytic activity at low catalyst loading (0.1 mol%) while IPent gave 
high conversions of 99% (entries 3 and 4). Comparing the whole ITent family, INon-
based pre-catalysts were less active than the IPent- and IHept congeners at 200 ppm 
catalyst loading (entries 8 and 11), while at 100 ppm only [Pd(IHept)(acac)Cl] 20 was 
catalytically active (entry 14). This pre-catalyst was also proved to be the most active in 
the Buchwald-Hartwig CC.12 It is noteworthy to mention that very few examples of 
catalysts active at a loading lower than 0.5 mol % are known in the literature. 
O
Cl
+
Pre-catalyst
KOtBu 2.2 equiv
O
Toluene, 100 °C
0.5 M, 16 hours
23 24 25
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Table 2. Optimization of the base/solvent system. 
 
Entry Solvent Base G.C Conversion [a] 
1 Toluene KOH 11 
2 Toluene NaOH 0 
3 Toluene LiOH 0 
4 Toluene CsOH 27 
5 Toluene K3PO4 0 
6 Toluene K2CO3 0 
7 Dioxane CsOH 20 
8 Dioxane K3PO4 0 
9 DME CsOH 0[b] 
10 DME K3PO4 11 
11 Toluene KOtBu 22 
12 Toluene NaOtBu 91[b] 
13 Toluene LiOtBu 20[b] 
14 Toluene NaOtBu >99[b,c] (80%)[d] 
15 Toluene KOtAm 0[e] 
16 Isopropanol LiOtBu 0[e] 
17 Isopropanol KOtAm 0[e] 
18 Isopropanol KOtBu 0[e] 
19 Isopropanol NaOtBu 0[e] 
20 Dioxane LiOtBu 15[b] 
21 Dioxane KOtAm 31 
22 Dioxane KOtBu 51 
23 Dioxane NaOtBu 73[b] 
24 DME KOtAm 0 
25 DME LiOtBu 0[b] 
26 DME KOtBu 16 
O
Cl
+
20 0.01 mol%
Base 2.2 equiv
O
Solvent, 100 °C
0.5 M, 16 hours
23 24 25
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27 DME NaOtBu 0[b] 
28 Toluene KOtBu 0[f] 
29 Toluene NaOtBu 0[b][f] 
Conditions: 23 (0.7 mmol, 1.4 equiv), 4-Chlorotoluene (0.5 mmol, 1 equiv), base (1.1 mmol, 2.2 equiv), 
catalyst (0.01 mol%) in the indicated solvent (1 mL), 100°C, 16h. [a] Conversion of the 4-Chlorotoluene, as 
measured by GC; [b] no ketone detected by GC analysis; [c] 0.02 mol% catalyst; [d] isolated yield, average of 
2 runs, after column chromatography; [e] the 4-chlorotoluene signal was not detected; [f] reaction performed 
in the absence of catalyst. 
The optimization of the base/solvent system is crucial for CC reactions, as illustrated by 
Colacot.3a,b To this end, model CC reaction comprising acetophenone 23 and 4-
chlorotoluene 24, using catalyst 20 (0.01 mol%) was studied, systematically varying base 
and solvent. The use of carbonates, phosphates or hydroxides as bases generally resulted 
in poor conversion (see Table 2, entries 1-10). The reason for unsuitability of inorganic 
bases lies mostly in their poor solubility in aprotic solvents, that makes the generation of 
the enolate slow. NaOtBu, on the converse, provided significant conversion to the 
desired product in toluene and dioxane (91% and 73% respectively, entries 12 and 18). 
Subtle change in the counterion of the t-butoxide, switching from sodium to other alkali 
metals, had a profound effect in the reactivity: employing LiOtBu or KOtBu, the 
conversion dropped significantly (entries 11-13), both in toluene and dioxane. The 
correlation between the counterion used and the reaction outcome is not linear: the 
relative efficiencies of each base are influenced by the reaction solvent. Additionally, in 
some cases, the acetophenone signal was not detected in the GC (entries 9, 12, 13, 14, 17, 
19, 21, 23) despite it being used in excess; the signal of 4-chlorotoluene, moreover, was 
still present. Control experiments, using potassium- and sodium t-butoxide without pre-
catalyst, proved that the side reaction leading to consumption of ketone is dependent on 
the counterion (entries 24 and 25): KOtBu does not promote the side reaction, leaving 
acetophenone untouched, whereas the ketone was completely consumed when NaOtBu 
was present. All together, these results suggest that a subtle equilibrium between a side 
reaction (possibly aldol condensation, leading to degradation of the ketone) and the 
desired α-arylation, occurs. Sodium t-butoxide and toluene provided the optimum 
balance. An increase of the catalyst loading, from 0.01 to 0.02 mol%, lead to full 
conversion, and good yield, of the desired product. Other organic solvents (dioxane, 
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DME) used in conjunction with NaOtBu or other organic bases afforded lower yields, 
the best conversion being 73% obtained with NaOtBu in dioxane (entries 20-27). The use 
of isopropanol (entries 16-19) proved detrimental, as it lead to consumption of the 
haloarene without generation of the desired product. Such effect can be attributed to a 
transfer hydro-dehalogenation of the substrate, a well-known process under [Pd(NHC)] 
catalysis.13 
2.3 Scope of the protocol 
Once the optimised reaction conditions were identified, we sought to study the scope of 
the methodology. First, the effect of the electronic properties of the ketone was 
investigated in the coupling with 4-chlorotoluene: the use of electron-rich 4-
methoxyacetophenone resulted in good yield of the desired product when the catalyst 
loading was increased to 0.05 mol% (entry 30 70% yield), while the electron-poor 4-
(trifluoromethyl)-acetophenone required a 10-fold increase (0.5 mol% catalyst), with 
respect to acetophenone, to achieve full conversion and satisfactory yield (entry 31, 82% 
yield). It has to be noted that electron-poor ketones, and especially methyl-ketones, are 
among the most challenging substrates for the α-arylation of ketones, because of the low 
nucleophilicity of the resulting enolate and the remarkable electrophilicity of the 
carbonyl moiety. Obtaining product 31 in 82% yield, at a catalyst loading which is still 
competitive with the current state of the art, is a remarkable result. The use of less 
reactive, electron-rich chloroarenes was also achieved (entry 32 84% yield), as well as 
that of the sterically hindered 2,6-dimethylchlorobenzene (entries 33-34, 89%, 87% and 
92% yield respectively ). Substitution at the 2- and 3- position of the acetophenone was 
also well tolerated (entries 36, 98% yield, and entry 35). An acetylnaphthalene derivative 
was also coupled successfully (entry 37, 87% yield). Propiophenone proved a good 
substrate for the reaction, enabling the coupling with 2- and 4-chloroanisole in excellent 
yields at a catalyst loading of 0.03 mol% (entries 38-39, 91% and 97% yield respectively). 
To test the suitability of the protocol in air, compound 38 was synthesised without the 
use of Schlenk or glovebox technique, still affording a satisfying yield of 75%. 
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Scheme 2. Scope of the reaction: effect of the electronics and sterics of the coupling partners. 
The excellent results showcased in Scheme 1 prompted us to widen our investigation, 
testing compounds bearing pharmaceutically more relevant functional groups (see 
Scheme 2). For example, aromatic N-containing heterocycles were tolerated on both the 
ketone and the chloroarene (entries 40 and 42, 80% and 96% yield respectively), and 3-
chlorothiophene afforded good yield, too (entry 41, 85% yield). A protected catechol 
derivative could be synthesised (entry 45, 84% yield), using acetophenone as coupling 
partner. Chloroarenes bearing relatively base-sensitive functional groups, namely 4- 
chlorophenyl-sulfone and 4-chlorobenzophenone, also underwent the reaction smoothly 
(entries 46-47, 70 and 81% yield respectively). The electron-poor 4-chloro-
trifluorotoluene worked well (entry 43, 81% yield), and coupling partners bearing a 
tertiary amine group were also well suited for this reaction (entries 44 and 48, 85% and 
78% yield respectively). 
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Scheme 3. Scope of the reaction: functional group tolerance. 
The attempt to couple 4-dimethylamino-acetophenone 49 with less sterically hindered 
chloroarene, namely 2-chlorotoluene, highlighted a limit of this protocol: the reaction 
afforded a 5:1 mixture of mono- and di-arylated products (see Scheme 3). This was the 
only case in which we observed lack of complete selectivity towards mono-arylation. We 
postulated that the reason for this behaviour is the high electron-donating properties of 
the dimethylamine group: the enolate formed by deprotonation of the relatively bulky 
product 51 still retains enough nucleophilicity to overcome its steric hindrance, thus 
formed di-arylated product. 
 
Scheme 3. Low selectivity in the arylation of the electron-rich acetophenone derivative  
To verify the usefulness of the protocol, we sought to test it in the synthesis of 
compound 55. This tetralone derivative is a known intermediate towards Nafoxidine 56 
and Lasofoxifene 57, selective estrogen receptor modulator; Lasofoxifene is currently in 
use for cancer treatment.14 Performing the reaction under the optimised conditions, we 
obtain the product in 93% isolated yield using 0.05 mol% catalyst, half than the amount 
used by the authors for their patented procedure.15 
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Scheme 4. Synthesis of an intermediate towards SERMs drugs. 
2.4 Conclusions and outcome 
The development of more efficient Pd-catalysed cross couplings is a key area in modern 
organometallic and synthetic chemistry. The protocol discussed in this chapter is the 
first example known in the literature of general and high-yielding α-arylation of ketones 
at low catalyst loading (0.02-0.05 mol% for most of the examples). The methodology 
enables the coupling of coupling partners bearing functional groups relevant to 
medicinal chemistry applications (for example sulfone, amine and catechol derivatives). 
The good results obtained in the development of this project lead us into further studies 
on this and other related reactions: in particular, the development of [Pd(NHC)]-
catalysed synthesis of heterocycles. In particular, during our work on this project, we 
attempted the direct coupling of an enolizable ketone and 2-chloroaniline, aiming at the 
direct one-pot synthesis of indole derivatives (see Scheme 5). Unfortunately, selective 
formation of the C–C bond between the α position of the ketone and the chloroarene was 
not possible: low conversion was observed at the GC, with a mixture of different 
compounds as products. 
 
Scheme 5. Attempted application of the protocol to the synthesis of indoles. 
Despite this poor preliminary result, we still pursued this objective, looking for ways to 
avoid side products. The results of our efforts in this project are described in the next 
chapter.
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3 Synthesis of N-unprotected indoles and azaindoles 
via [Pd(NHC)] catalysed α-arylation of imines 
3.1 The importance of the indole scaffold in medicinal and material chemistry. 
The vast majority of bioactive compounds, as well as many classes of functional 
materials, contain at least one heterocyclic core in their structure.1 The great deal of 
attention that the synthesis and derivatisation of such molecular architectures has 
gained, 2 over a timeframe that spans for longer than a century, is hence not surprising. 
The number of medicines and naturally occurring compounds, containing at least one 
heterocyclic moiety, is countless, and cannot be summarised briefly. Although virtually 
any heterocyclic architecture has specific, valuable applications, the indole motif holds 
a key position in heterocyclic chemistry. Indole is considered the most widespread 
heterocycle in nature,3 and its synthesis and functionalization has gathered an ever-
increasing amount of attention by the whole synthetic community. The first reported 
synthetic method for indole derivatives dates back to the end of 19th century, and is still 
cited as a classic reaction in organic chemistry: the Fischer synthesis of indole. 4 This 
reaction takes place between an enolizable carbonyl compound (a ketone or an 
aldehyde) and a phenylhydrazine derivative under acid catalysis. Its key step is the C–
C bond-forming 3,3-sigmatropic rearrangement of intermediate 5, affording the imine 
6; this leads to the generation of the indole product after nucleophilic addition and 
ammonia elimination (see Scheme 1). The Fischer synthesis of indoles is nowadays still 
used for industrial synthesis of indole derivatives, and many variations, starting from 
different substrates or under different conditions, have been developed.5 
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Scheme 1. Fischer’s synthesis of indoles.4 
A transition metal-catalysed approach to the Fischer N-arylhydrazone 4, considered 
the key intermediate in this chemistry, was reported in 1999 by Buchwald (see Scheme 
2): the Buchwald-Hartwig-type cross coupling between arylhydrazones and 
bromoarenes affords intermediate 4, which results in formation of the desired indole 
product under heating. The authors proved the excellent flexibility of their method, 
allowing the synthesis of highly functionalised indole derivatives.6 
 
Scheme 2. Buchwald’s approach to Fischer’s intermediate 4.6 
Other approaches relying on Pd catalysis have proven useful for the synthesis of the 
indole core. The field was actually pioneered by Hegedus, who reported the synthesis 
of indole derivatives via a Heck-type reaction of (2-Br-phenyl)-allylamines (see Scheme 
3) between the late 1970z’s the early 80’s.7 A closely related approach, also relying on a 
Heck-type reaction, was reported, by Mori and Ban.8 
 
Scheme 3. Hegedus’ synthesis of indoles.7 
One decade later, Larock reported one of the most successful Pd-mediated synthesis of 
indole derivatives, starting from a o-haloaniline and an internal alkyne (see Scheme 4). 
This protocol, nowadays known with the name of its inventor, is based on the reaction 
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mechanism showed in Scheme 4: the Pd0 catalytic species 13 undergoes oxidative 
addition on the Ar–X bond (an iodide in the figure), affording intermediate 15, 
followed by carbopalladation of the internal alkyne, resulting in the formation of the 
cyclopalladated intermediate 18. The desired product 3 and the catalytic species are 
formed in a reductive elimination step.9 
 
Scheme 4. Larock’s synthesis of indoles.9 
A related protocol was reported one year later by Cacchi (see Scheme 5): the Pd0 
catalyst activates the C–X bond of an aryl electrophile, forming intermediate 20, which 
then in turn activates the triple bond of substrate 21. Carbopalladation to compound 
22, followed by reductive elimination, produce the desired product, regenerating the 
Pd0 catalyst.10  
 
Scheme 5. Cacchi’s synthesis of indoles.10 
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These early reports have generated a vast amount of literature, to the extent that entire 
reviews have been devoted to the Pd-catalysed synthesis of indole-type heterocycles, 
allowing the preparation of highly functionalised derivatives.11 Recently, new Pd-
catalysed strategies for the synthesis of complex molecules have been developed, 
involving the α-arylation of ketones as key step. By interlocking the vast inventory of 
transformations known for carbonyl derivatives and the rapid developments of this 
CC reaction, these new synthetic pathways often provide elegant and creative routes 
for the synthesis of natural products and other bioactive compounds (for an exhaustive 
treatment of the topic, see Section 1.4). Molecular architectures such as indole, 
pyridine, isoquinoline, benzofuran and oxindole have been synthesized under α-
arylation conditions. Once again, indole targets gather much of the attention devoted 
by researchers in the field. A summary of the retrosynthetic approaches adopted so far 
is given in Fig. 1. 
 
Figure 1. α-Arylative strategies towards polysubstituted indoles. 
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3.2 Optimisation of the [Pd(NHC)] catalysed reaction system for the 
intermolecular α-arylation of imines. 
As showed in the previous chapter, our study of [Pd(NHC)] catalysts as catalysts for 
the α-arylation of ketones proved the remarkable effect that the new generation of 
“bulky yet flexible” N-heterocyclic carbenes have in the efficiency of the process. 
Attracted by the possibility to extend their utility in related synthetic processes, we 
decided to explore their activity in the synthesis of indoles. Unfortunately, the direct 
coupling of 2-chloroaniline and propiophenone, under the conditions reported in 
Chapter 2, lead to mixtures of coupled products, due to the low selectivity towards α-
arylation and N-arylation (see Scheme 6, equation 1).12 We envisaged that preforming 
the N–C bond, by pre-synthesizing the imine 33 by condensation, would possibly 
prevent side-reactions, thus overcoming this drawback (see Scheme 6, equation 2). 
Moreover, subjecting a pre-formed substrate to an intramolecular reaction brings the 
additional advantage to minimize the need for excess reagents, potentially improving 
the overall atom economy of the protocol. A similar protocol, converting the same type 
of substrates into indoles under Pd catalysis, was reported in 2005 by Lachance.13 
Despite this conceptually close precedent, we aimed at developing a method which 
would overcome the limitations of Lachance’s: high catalyst loading (5 mol% 
Pd(PPh3)4, high temperature under microwave irradiation, lower yields when using 
chloroaniline derivatives. Moreover, these authors postulate a Heck-type reaction 
mechanism for their protocol, rather than a deprotonative α-arylation. 
 
Scheme 6. Intermolecular approach to indoles and synthesis of imine 33. 
The imine 33 was subjected to the reaction conditions showed in Chapter 2, using 
different NHC-based pre-catalysts (see Scheme 7). We found that less sterically 
hindered ligand, such as IPr derivatives 35-37 and the ITent series 38-41, provided poor 
conversion at a catalyst loading of 0.5 mol%. On the other hand, the flexible bulkiness 
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of IPr*-based ligands provided outstanding results: pre-catalysts 42 and 43, bearing 
IPr* and IPr*OMe ligands, respectively, afforded > 90% conversions to the desired 
product. Complex 44, whose only difference to complex 42 is the substitution of the 
cinnamyl sacrificial ligand an acetylacetonate moiety, showed only slightly inferior 
reactivity, whereas changing the catalytic metal to Ni-based catalyst 45 resulted in very 
poor conversion, even at a relatively high catalyst loading of 5 mol%. The effect of the 
IPr*-derived ligands on Pd-catalysed processes is remarkable, and well documented in 
the literature.14 The steric properties provided by this class of ligands have been useful 
in the study of highly unstable complexes based on Group 11 metals (especially Au).15 
 
Scheme 7. Optimisation of the intramolecular approach towards indole 34. Conditions: 33 (0.25 mmol, 1.0 
equivalents), NaOtBu (0.28 mmol, 1.1 equivalents), catalyst (0.5 mol%) 0.125 M in toluene, 110°C, 16 hours. 
Conversion measured by G.C. [a] 5 mol% catalyst employed. 
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Table 1. Base-solvent optimisation  
 
Entry T °C Base Solvent Conversion % [a] 
1 110 LiOtBu Toluene 3 
2 110 LiOtBu Dioxane 81 
3 110 LiOtBu DME 95 
4 110 NaOtBu Toluene 93 
5 110 NaOtBu Dioxane >99 
6 110 NaOtBu DME 68 
7 110 KOtBu Toluene 96 
8 110 KOtBu Dioxane 16 
9 110 KOtBu DME 33 
10 110 NaHMDS Toluene 70 
11 110 NaHMDS Dioxane 95 
12 110 NaHMDS DME 49 
13 110 KOtAm Toluene 4 
14 110 KOtAm Dioxane 14 
15 110 KOtAm DME 36 
16 110 KOH Toluene 25[b] 
17 110 KOH Dioxane 75 [b] 
18 110 KOH DME 34 [b] 
19 110 K3PO4 Toluene 0 
20 110 K3PO4 Dioxane 10 
21 110 K3PO4 DME 7 
22 80 NaOtBu Toluene 20 
23 80 NaOtBu Dioxane 67 
24 80 LiOtBu DME 33 
25 80 KOtBu Toluene 10 
26 80 NaHMDS Dioxane 41 
 
Conditions : 33 (0.25 mmol, 1.0 equivalents), base (0.28 mmol, 1.1 equivalents), 42 (0.5 mol%) 0.125 M in 
solvent, 80 or 110 °C, 16 hours. [a] Conversion measured by G.C. [b] 5 mol% catalyst employed. 
After the identification of [Pd(IPr*)(cinnamyl)Cl] 42 as optimal catalyst for this 
reaction, we turned our attention towards the base/solvent system in which to perform 
the reaction. Three different solvents (toluene, 1,4-dioxane, and dimethoxyethane) 
were screened in combination with a wide range of organic and inorganic bases, 
namely tertiary alkoxides, NaHMDS (HMDS: hexamethyl-disilylamide) KOH, and 
Cl
N Ph
42 0.5 mol%
Base 1.1 equiv.
N
H
Ph
Solvent, 110 °C 
16 hours
33 34
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K3PO4 (See Table 1). Of the abovementioned bases, K3PO4 afforded very low 
conversion in all the solvents tested (entries 19-21), while the employment of KOH 
resulted in higher conversion, but also a more complex reaction outcome, as many 
signals were detected in the GC track. Low conversions were also observed with 
KOtAm (tAm = t-amylate). On the converse, t-butoxides and NaHMDS provided high 
conversion (> 90%) in at least one of the solvents tested: NaOtBu gave high conversion 
in both toluene and dioxane (entries 4 and 5, 93% and >99% respectively), while 
LiOtBu and KOtBu gave a satisfactory result in DME and toluene, respectively (entries 
3 and 7, 95% and 96% respectively) and NaHMDS worked best in dioxane (entry 11, 
95%). To discriminate between these catalytic systems and find the most favourable 
reaction parameters, the abovementioned conditions affording conversion >90% were 
tested at a lower temperature, 80 °C, in order to comprare their relative efficiency 
(entries 22-26). NaOtBu in dioxane gave by far the higher conversion, 67% (entry 23), 
whereas all the other conditions tested proved remarkably less performing (41% 
conversion or less).  
Table 2. Fine tuning of the conditions. 
 
Entry Pd loading (mol%) Concentration Reaction time (h) Conversion %[a] 
1 0.1 0.125 M 16 17 
2 0.5 0.250 M 16 95 
3 0.5 0.125 M 4 >99 
 
33 (0.25 mmol, 1.0 equivalents), NaOtBu (0.28 mmol, 1.1 equivalents), 42 (0.5 mol%) 0.125 or 0.250 M in 
solvent, 110°C, 4 or16 hours. [a] Conversion measured by G.C.  
A further fine tuning of the reaction was performed (see Table 2): lowering the catalyst 
loading from 0.5 mol% to 0.1 mol% lead to a dramatic drop of conversion (17 %), while 
raising the concentration from 0.125 M to 0.250 M only slightly lowered the conversion 
to 95%; to our pleasure, the time needed for this reaction to reach completion was only 
4 hours. The optimised conditions are summarised in entry 3, Table 2: 0.5 mol% 
catalyst, 0.125 M concentration in dioxane, 1.1 equivalents of NaOtBu at 110 °C. 
Although in some cases we were able to maintain these conditions, some other entries 
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of the scope required increased reaction time and catalyst loading (vide infra). It has to 
be noticed that this protocol, even when the most forcing conditions were required (2 
mol% catalyst, 24 hours), has remarkably low requirements: only a slight excess of 
base, a substrate/catalyst ratio of 50 or higher, and a single-component substrate, are 
needed to obtain the desired product, making it potentially suitable for scale-up. 
3.3 Scope of the reaction 
 
Scheme 8. Synthesis of imines 33 and 48-58. For details on the protocol, see Section 7.3. 
The imines 48-60 were synthesized by direct condensation of the selected ketone and 
chloroaniline, using basic alumina or p-toluensulphonic acid as catalyst, in the 
presence of excess of activated 3Å molecular sieves (see Scheme 8). The reaction 
generally proceeded smoothly, affording the desired imine in 61-77% yield after simple 
workup. Different ketones (dialkyl, aryl-alkyl, cyclic) could be used successfully, with 
the exception of deoxybenzoin (entry 59). This is probably due to the large steric bulk 
associated with the contemporary presence of a phenyl and a benzyl groups at the 
carbonyl moiety. The imine substrates were then treated under the conditions 
previously optimised (see Scheme 9).  
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Scheme 9. Synthesis of indole derivatives. Imine (0.25 mmol, 1.0 equivalents), NaOtBu (0.28 mmol, 1.1 
equivalents), 42 (0.5 mol%) 0.250 M in dioxane, 110°C, 4, 16 or 24 hours. [a] Yield obtained in a gram-scale 
reaction. 
The product 34, arising from model compound 33, was isolated in 91% yield after 
column chromatography. The acetophenone-derived congener (entry 60) also afforded 
good yield (86%) under the same reaction conditions. Dialkylketones proved suitable 
for this reaction: the pentanone derivative was obtained in a good 80% yield (entry 61), 
although in this case the reaction time had to be extended to 16 hours, whereas a 
cyclohexanone-derived (entry 62) required to increase of the catalyst loading to 2%, 
and 24 hours time, to reach full conversion, affording 82%. Entries 63 and 64, derived 
from 2- and 1-acetylnaphthalene respectively, were also obtained in good yields (84% 
the former, 80% the latter). The steric properties of the substituent in the 2-position of 
the indole have a remarkable effect on the reaction kinetics: while the less bulky 2-
napthtalene moiety lead to slower reaction, requiring 16 hours to reach completion, the 
1-naphthalene congener could be converted in only 4 hours. The fluorinated analogues 
of these compounds, (entries 65 and 66), could also be synthesized using this protocol 
in good yields (84% and 90% respectively). The tetracyclic core 68, which is known to 
have application in medicinal chemistry and optoelectronics,16 was also obtained in 
90% yield. The tolerance of our method to base-sensitive functional groups was proved 
by the successful synthesis of a nitrile-containing compound (entry 65). The electronic 
deactivation introduced by the methoxy group in the para-position relative to the C–Cl 
bond could also be overcome easily, affording 72% yield of product 69. The synthesis 
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of compound 61 could also be performed on a gram scale, showing the potential 
scalability of this protocol. 
 
Scheme 10. Synthesis of imines 73-78. For details on the protocol, see Section 7.3. 
The wide substrate scope of this methodology prompted us to extend it to more 
challenging target compounds, such as azaindole derivatives. These compounds are of 
great interest in medicinal chemistry, and therefore a straightforward access to some of 
their functionalized congener would be of high value. Another set of imines, derived 
by various o-chloro-amino pyridine derivatives, was prepared and tested. The 2-
chloro-3-aminopyridine derivatives 73-75 and 77 could easily be accessed by 
condensation, as well as the 3-amino-4-chloropyridine derivative 76. On the converse, 
imine 78, which would formally form from the condensation of the very electron-poor 
2-amino-3-chloropyridine and propiophenone, could not be synthesized using this 
method. Our hypothesis is that the electronic deactivation of the NH2 moiety leads to 
very poor reactivity. 
 
Scheme 11. Synthesis of azaindole derivatives. Imine (0.25 mmol, 1.0 equivalents), NaOtBu (0.28 mmol, 1.1 
equivalents), 42 (0.5 mol%) 0.250 M in dioxane, 110°C, 16 or 24 hours.  
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The 4-azaindole derivative 81, which is the direct congener of the model target 
compound 34, could be obtained in 80% isolated yield, using 0.5% mol catalyst loading 
for 16 hours. 2-acetylnaphthalene derivatives (entries 80 and 84), respectively a 4- and 
6-azaindole derivatives, were obtained in 74% and 87% isolated yield, respectively, 
under the harsher conditions (2 mol% catalyst, 24 hours). Under the same conditions, 
compounds 82 and 83, bearing a methoxy substituent, were also obtained smoothly, 
both in 87% yield. 
As it relies on a bench-stable pre-catalyst, without the need of carrying out any 
manipulation in the glovebox, this intramolecular synthesis of (aza)indole is 
remarkably practical. The commercial availability of 2-chloroanilines and enolizable 
ketones, from which the required substrates can be easily prepared, further highlights 
its utility. 
3.4 Mechanistic studies 
The synthetic utility of our protocol and its high efficiency lead us into more detailed 
studies of its mechanism. As mentioned above, Lachance postulated that, in a closely 
related protocol, based on [Pd(PPh3)4] as catalyst and triethylamine as base, a Heck-
type reaction pathway would take place. Our initial assumption, however, was that a 
deprotonative, α-arylative cross coupling process, rather than a carbopalladation, is the 
preferred reaction path when NHCs are used as ligands.17 
Computational experiments were carried out to distinguish between three possible 
reaction mechanisms (see Scheme 12): Path A, based on a deprotonative α-arylation of 
the imine followed by formation of the C–C bond via reductive elimination; Path B, 
based on the carbopalladation of the enamine double bond, followed by β-hydride 
elimination; and Path C, which is proposed to proceed through deprotonation of the 
imine without prior coordination of the t-butoxide anion on the Pd center, thus 
proceeding through to the ionic species 93. 
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Scheme 12. The three proposed mechanisms for the reaction. 
Despite several efforts, the current computational model did not discriminate between 
Path A and Path B, as the activation barriers of these two mechanisms were found to be 
very close in energy (∆∆G‡= 0.5 Kcal/mol), and the identification of the actual reaction 
mechanism by this mean was not doable. Path C, however, could be excluded, as the 
formation of the anionic species 92 would have too high an activation barrier to 
overcome it at the reaction conditions (see Scheme 13). 
 
Scheme 13. Comparison between the three energy profiles of reactions Path A-C. 
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All the attempts to isolate any reaction intermediate proved unsuccessful. To overcome 
this ambiguity, we focused our attention towards the role of the base in Paths A and B. 
In the first case, as it really acts as a Brönsted base towards the imine α-carbon, its 
nature (and particularly its strength) is a key feature, influencing its activity. On the 
converse, the base acts as a simple proton sponge in Path B, quenching the HCl 
produced by reductive elimination of the [Pd(NHC)(H)Cl] complex 92, implying a 
lower influence of its strength. Indeed, Mizoroki-Heck protocols normally involve the 
use of weak organic bases, such as triethylamine (TEA), as base additive (see Scheme 
14). The profound influence of the base-solvent system, discussed above in relation to 
the data summarised in Table 2, already points toward a deprotonative mechanism.18 
We therefore postulate that a series of test reactions involving TEA as base would give 
us an additional indication on the mechanism of this process. 
 
Scheme 14. Ruling out a Mizoroki-Heck pathway by assessing the role of the strong base. 
When substituting NaOtBu with TEA, the reaction completely stopped, and only 
starting material was recovered unreacted (see Scheme 14, equation 1). Such an effect 
of a weaker base could be due to the inability of the TEA base to activate the pre-
catalyst, as a nucleophilic activation is required with the cinnamyl-based pre-catalyst 
43.19 The reaction summarised in equation 2 substances this hypothesis: adding 10 
mol% of NaOtBu, the reaction does happen, although it stops when the strong t-
butoxide base is consumed. Even with a higher catalyst loading and longer reaction 
time, TEA failed to convert the starting material into product, as highlighted in 
equation 3. Additional computational studies proved that TEA would enable the 
quenching of the HCl produced by a Mizoroki-Heck mechanism, whereas its basicity is 
insufficient to afford the imine enolate which is necessary to sustain a deprotonative 
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mechanism. This results provide an indication towards a deprotonative mechanism, 
however more detailed mechanistic studies would be required to identify the complete 
mechanism. 
3.5 Conclusions and outcome. 
An efficient and user-friendly synthetic access to indole and azaindole scaffolds was 
disclosed. As it requires only a small excess of base and a relatively low catalyst 
loading, it has great potential for applications on a larger scale. The choice of the 
ancillary ligand is crucial, as the strongly electron-donating, bulky IPr* N-heterocyclic 
carbene (and derivatives thereof) was required for obtaining highly active catalysts, 
thus highlighting the remarkable effect of the steric and electronic parameters of the 
ligand. Computational and experimental studies were performed to clarify the 
mechanism of such transformation, leading us to claim that a Mizoroki-Heck-type 
mechanism is unlikely, although the mechanism of the reaction is not clearly 
understood.
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4 Ni-catalysed α-arylation of ketones using 
chloroarenes as electrophiles 
4.1 Nickel catalysis in C–C and C–X bond forming reactions 
The use of rare transition metals in synthetic processes has caused increasing concerns 
in recent years:1 their rarity in the earth crust had caused the price of some of them to 
increase to an economically unsustainable level. The synthetic community has tackled 
this situation by developing catalytic methods based on first row transition metals, 
most notably Fe, Co, Ni and Cu, which are far more readily available, significantly less 
expensive, and often less toxic than their heavier congeners.2 The need for such 
protocols is compelling, in the perspective of a future world where the more used 
second- and third-row transition metals will be exceedingly expensive. 
In the context of CC catalysis, in which Pd still holds a preferred position, the use of its 
first-row congener Ni is not uncommon. In fact, the first “modern” CC reported, the 
Kumada-Tamao-Corriu reaction, is based on Ni catalysis.3 Moreover, Ni is a well-
established industrial catalyst.4 Ni shows catalytic properties that are closely related to 
those of Pd; its poor stability, however, often leads to inferior catalytic efficiency, 
namely lower turnover numbers, and narrower scope.5 On the other hand, its high 
reactivity, due to the nucleophilicity of the Ni0 moiety, opens the door to entirely new 
modes of action. The development of the activation of “inert” C–O bonds, namely 
those belonging to esters and ethers, and their subsequent use as electrophiles in CC 
chemistry, is one of the most interesting examples of this renaissance.6 Moreover, on a 
molar basis, the market price of Pd is 1500 times higher than the price of Ni, making its 
economically appealing.7 Many reviews have been published in the last few years, 
focusing on various aspects of Ni-catalysed CC chemistry.8 
One early example of the use of Ni in CC chemistry was reported by Cramer, who 
studied “displacement reactions of aryl halides” with amines or phenoxides. In this 
case, simple aryl- or alkylphosphines, and ligand-free systems were employed, finding 
that NiBr2 promoted the reaction, although it required very high temperatures (see 
Scheme 1).9 The use of simple monodentate phosphine has been widely explored in the 
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late 70’s. In a series of reports, Kochi showed the reactivity of different species, 
including paramagnetic NiI and NiIII complexes, in some of the believed key steps of 
the catalytic cycle.10  
 
Scheme 1. Ni-catalysed C–X bond formation according to Cramer.9 
More recently, complexes of formula [Ni(PR3)2(Ar)Cl] were found to be competent 
catalysts for the Suzuki-Miyaura reaction (see Scheme 2).11 As they are easily accessible 
and air stable, this class of catalysts has attracted the attention of many groups, whose 
studied their mechanism of action and their structure/activity relationships.12 
 
Scheme 2. [Ni(PR3)2(Ar)Cl] complex as catalyst for the Suzuki Miyaura.11 
Bidentate phosphines were found useful in typical CC reactions such as the Buchwald-
Hartwig amination and the Suzuki-Miyaura biaryl synthesis. 13 Buchwald reported the 
use of [Ni(COD)2]/DPPF in the amine arylation reaction, and, subsequently, an 
improved version of this catalyst was reported by the same author, enabling the 
coupling of a vast number of functionalised coupling partners (see Scheme 3).14 
 
Scheme 3. [Ni(DPPF)]-catalysed Buchwald-Hartwig reaction according to Buchwald.13 
In 2012, Hartwig reported the use of a single component, DPPF-based catalyst for the 
Suzuki-Miyaura CC. The protocol based on this catalyst shows high efficiency and a 
wide scope, and still represents the state of the art for the Ni-catalysed Suzuki-Miyaura 
reaction, in terms of functional group compatibility and catalytic efficiency (see 
Scheme 4).15 
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Scheme 4. [Ni(DPPF)]-catalysed Suzuki-Miyaura reaction according to Hartwig.15 
More recently, Stradiotto and Hartwig almost contemporarily reported two closely 
related protocols for the mono-arylation of ammonia under Ni catalysis.16 The ancillary 
ligands used belong to the JosiPhos family, chiral ferrocenyl-based bidentate 
phosphines (see Scheme 5). While both groups started their studies with the use of 
ammonia solution, they then focused on different possible alternative sources. While 
Stradiotto successfully focused on the direct use of ammonia gas, Hartwig’s method 
enabled the use of ammonium salts as the ammonia sources. 
 
Scheme 5. [Ni(JosiPhos)]-catalysed ammonia arylation according to Stradiotto and Buchwald.16 
NHCs have proved highly effective as ancillary ligands in Ni catalysis. Monoligated 
NHC-Ni complexes showed activity in the Buchwald-Hartwig arylation. 17  Nolan 
reported that complexes of general formula [Ni(NHC)(Cp)Cl] (Cp = cyclopentadienyl) 
are active in the Buchwald-Hartwig CC (see Scheme 6).18 The same complexes were 
also used for hydrothiolation reactions.19 
 
Scheme 6. [Ni(NHC)]-catalysed Buchwald-Hartwig reaction according to Nolan.17 
 
Subsequent works on complexes of formula [Ni(NHC)(allyl)Cl] 20 were reported by 
Nicasio and successfully applied as pre-catalysts for the Buchwald-Hartwig 
amination.20 Chloroarenes could easily be coupled with both alkyl- and arylamines, 
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and the thiolation of bromo- and iodoarenes was also possible using these catalysts 
(see Scheme 7). As stated in the original report of such complexes, their air stability is 
very low, as they readily react with molecular oxygen.21 
 
Scheme 7. [Ni(NHC)]-catalysed Buchwald-Hartwig and thiol arylation according to Nicasio.18 
Recently, Nolan reported the greatly enhanced performance of the two aforementioned 
classes of NHC-containing pre-catalysts, when they are endowed with the bulkier IPr* 
and IPr*OMe ligands. The improvement in catalytic activity was striking: the Cp-based 
catalysts, whose activity towards chloroarenes is usually very poor, could couple such 
electrophiles smoothly and in good yields. The allyl derivatives, on the other hand, 
enabled the arylation of amines and sulfides at catalyst loadings as low as 0.5-2.0 mol% 
(compare Scheme 8 to the examples reported in Scheme 6 and 7).22 
 
Scheme 8. The effect of bulky NHC ligands on the performances of Ni catalysts according to Nolan.22 
The use of very bulky NHCs as ancillary ligands proved beneficial also in the case of 
other Ni-catalysed processes: Nolan showed that IPr*-based Ni complexes can perform 
the carboxylation of boronic esters, while less sterically hindered ligands provide 
substantially lower activity (see Scheme .23  
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Scheme 9. [Ni(NHC)]-catalysed carboxylation of boronates according to Nolan.23 
The use of NHC ligands in catalysis was also tested in hydroarylation of alkenes by 
Hartwig and Nakao: depending on the nature of the substrate, IPr- or IPr*-derivatives 
provided high yields and selectivity (see Scheme 10).24 
 
Scheme 10. [Ni(NHC)]-catalysed hydroarylation of alkenes according to Hartwig. 
4.2 Synthesis of complexes of formula [Ni(NHC)(cinnamyl)Cl] and their 
evaluation in the α-arylation of ketones  
Our initial aim was the development of a family complexes of formula 
[Ni(NHC)(cinnamyl)Cl]. The synthesis of such complexes proceeds smoothly under 
the conditions developed by Sigman.21 Nolan reported a significant improvement in 
the catalytic performances of Pd pre-catalysts when the allyl throw-away ligand was 
substituted with the more sterically congested cinnamyl moiety; 25 this finding was 
later confirmed by further studies. Based on the protocol of Sigman, the 
[Ni(NHC)(cinnamyl)Cl] family of catalysts 39 was synthesised following a two step-
procedure. A suspension of [Ni(COD)2] in COD was reacted with cinnamyl chloride, to 
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form the [Ni(cinnamyl)Cl]2 dimer 38. The dimer was then opened by addition of 1 
equivalent of NHC ligand, affording the desired complexes 40-43 in very good yield. 
 
Scheme 11. Synthesis of [Ni(NHC)(Cinnamyl)Cl] complexes 39. 
Crystal structures were obtained of the more sterically congested complexes 42 and 43, 
bearing IPr* and IPr*OMe as ancillary ligand, respectively (see Figure 1). The atom 
connectivity showed the expected complexes were formed. With these catalysts in 
hand, we proceeded screening their performances in the α-arylation of ketones. 
 
Figure 1. Crystal structures of complex 42 ([Ni(IPr*)(Cinnamyl)Cl], left-hand side) and 43 
([Ni(IPr*OMe)(Cinnamyl)Cl], right-hand side). 
First, the base/solvent system was optimized using catalyst 42 (see Table 1) with 4-
chlorotoluene 45 and propiophenone 44 as coupling partners. NaOtBu was found to 
perform better than its Li- and K- congeners in THF, and its performances were even 
superior in toluene (entries 1-4). An increase of temperature from 60 to 100 °C resulted 
in a slightly better conversion in toluene, which provided the best level of conversion 
when compared to other solvents (entries 5-7). Increasing the amount of 
propiophenone from 1.2 to 2.0 equivalents, under the same conditions, led to a further 
improvement (entry 8); lowering the temperature to 80°C resulted in full conversion 
N N
NiCl
Ph
40, 81%
[Ni(IPr)(cin)Cl]
41, 75%
[Ni(SIPr)(cin)Cl]
N N
NiCl
Ph
N N
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
NiCl
Ph
43, 83%
[Ni(IPr*OMe)(cin)Cl]
N N
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
NiCl
Ph
42, 84%
[Ni(IPr*)(cin)Cl]
OMeMeO
NHC
NiCl
Ph
[Ni(COD)2] Ph Cl
COD
1h, rt
Ni
Cl
Ni
Cl
Ph
Ph
NHC
+
37
38
39 Yield
 94 
and 77% NMR yield (entry 9); the temperature dependency may be due to thermal 
instability of the catalyst. An increase in the amount of base, from 1.5 to 2.0 equivalents 
sharply increased the NMR yield up to 92% (entry 11). Using the same amount of other 
bases, on the converse, resulted in lower conversion (entries 12-15).  
Table 1. Identification of the base-solvent system. 
 
Entry Equivalents 44 Base (equivalents) Solvent T (oC) Conversion[a] 
(Yield)[b] 
1 1.2 KOtBu (1.5) THF 60 0 
2 1.2 NaOtBu (1.5) THF 60 30 
3 1.2 LiOtBu (1.5) THF 60 20 
4 1.2 NaOtBu (1.5) Toluene 60 56 
5 1.2 NaOtBu (1.5) DME 100 17 
6 1.2 NaOtBu (1.5) Toluene 100 80 
7 1.2 NaOtBu (1.5) Dioxane 100 20 
8 2.0 NaOtBu (1.5) Toluene 100 90 
9 2.0 NaOtBu (1.5) Toluene 80 99 (77) 
10 1.2 NaOtBu (2.0) Toluene 80 85 
11 2.0 NaOtBu (2.0) Toluene 80 99 (92)  
12 2.0 K3PO4 (2) Toluene 80 0  
13 2.0 KHMDS (2) Toluene 80 60  
14 2.0 NaHMDS (2) Toluene 80 81  
15 2.0 NaHMDS (2) THF 80 71 
Conditions: 44 (0.6 or 1.0 mmol, 1.2 or 2.0 equiv.), 45 (0.5 mmol, 1.0 equiv.), base (0.75 or 1.0 mmol, 1.5 or 
2.0 equiv.), 42 (3.0 mol%) in the indicated solvent (2.0 mL), 60-100°C, 16h. [a] Conversion of 45, as 
measured by GC; [b] NMR yield measure using dimethylmalonate as internal standard 
The conditions summarized in entry 11 (2.0 equivalents of propiophenone, 2.0 
equivalents of NaOtBu, 0.25 M in toluene at 80 °C) were therefore adopted as the 
optimal. The following step we performed was the optimization of the ancillary ligand: 
complexes 40-43 were screened in the α-arylation reaction (see Table 2). While IPr- and 
Cl
O O
42
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T°C, 16 hours
+
44 45 46
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SIPr-based complexes 40 and 41 displayed low reactivity, affording 35% and 30% GC 
conversion respectively, their bulkier congeners 42 and 43 were able to fully convert 
the starting material to the desired product (entries 1-4). At a catalyst loading of 1%, 
complex 42, [Ni(IPr*)(cinnamyl)Cl], gave a slightly better result in comparison to its 
congener 43 (entries 5-6). The optimized conditions, therefore, were the same as 
individuated in entry 11, Table 1. 
Table 2. 
 
Entry  Catalyst (mol %) Conversion[a] Yield[b] 
1 40 (3 mol%) 35 - 
2 41 (3 mol%) 30 - 
3 42 (3 mol%) 99 92 (90)[c) 
4 43 (3 mol%) 99 89 
5 43 (1 mol%) 70 - 
6 42 (1 mol%) 80 - 
Conditions: 44 (1.0 mmol, 2.0 equiv.), 45 (0.5 mmol, 1.0 equiv.), base (1.0 mmol, 2.0 equiv.), catalyst (3.0 
mol%) in toluene (2.0 mL), 800°C, 16h. [a] Conversion of the 4-Chlorotoluene, as measured by GC; [b] 
NMR yield measure using dimethylmalonate as internal standard; [c] isolated yield. 
4.3 Scope of the reaction 
Having identified the optimal conditions, we proceeded with the exploration of the 
reaction scope. First, the effect of substituents on the chloroarene was investigated (see 
Scheme 12): we found that substitution with the electron-neutral methyl moiety with 
an electron-donating methoxy group still resulted in good yield (83%, entry 53); on the 
contrary, the electron-withdrawing trifluoromethyl group had a detrimental effect, 
resulting in lower yield of desired product when bound to the electrophile (55%, entry 
49). Sterically hindered chloroarenes, such as 2-chlorotoluene and 2-chloroanisole, 
were suitable for the protocol, although also in this case the yields were moderate (60% 
and 68% respectively, entries 50 and 51); the use of 1-chloronaphthalene, whose steric 
hinderance around the C–Cl bond is comparable to that of 2-chlorotoluene, provided a 
significantly better yield (77%, entry 52). This improved performance can be explained 
Cl
O O
40-43
2.0 equiv. NaOtBu
Toluene, 80°C
16 hours
+
44
2.0 equiv.
45 46
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by the preference of Ni catalysts for polyciclyc aromatic electrophiles, probably due to 
the stabilisation of the Ni0 catalytic species prior to the oxidative addition.26 The 
protocol proved to enable the coupling of functionalised coupling partners: 
chloroarenes bearing tertiary amine (entry 54), ketone (entry 55) and protected catechol 
(entry 56) moieties were successfully coupled with propiophenone in high to very high 
yields (82%, 89% and 89% respectively); the use of heterocyclic chloroarenes, such as 3-
chloropyridine and 3-chlorothiophene, as well as a sulphone-containing one, was still 
possible although it resulted in moderate yields (63%, 61% and 65% respectively, 
entries 57-59).  
 
Scheme 12. Scope of the reaction: substitution on the chloroarene coupling partner. 
The good results obtained in the coupling of differently functionalised chloroarenes led 
us to investigate the suitability of other ketones for this transformation (see Scheme 
13). We found that the electron-rich 4-methoxypropriophenone could be coupled 
successfully with 4-chlorotoluene (79% yield, entry 62), whereas the electron-poor 4-
trifluoromethyl-propiophenone could not be coupled using our protocol, as its use 
resulted in no yield of the desired product (entry 63). The use of a dialkylketone, 
namely 3-pentanone, was possible; to note, although the yield was only moderate, no 
diarylation was detected (63%, entry 64). Moving our attention on the use of 
methylketone derivatives, we found that both electron-neutral and electron-poor 
compounds could not be coupled successfully (entries 65-67). The use of these 
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compounds resulted in decomposition, as indicated by NMR analysis. On the other 
hand, electron-rich methylketones proved suitable: 4-methoxy- and 4-dimethylamino-
derivatives could be reacted, and they afforded the desired product in good to 
moderate yield (86% and 67% yield respectively, entries 68-69). 4-
Methoxyacetophenone was successfully coupled also with 5-chlorobenzodioxol (78% 
yield, entry 70), with 4-chloroanisole (84% yield, entry 72) and with the very bulky 2,6-
dimethylchlorobenzene (51% yield, entry 73). This last result shows the great activity of 
our catalyst, as the use of o-disubstituted electrophiles is remarkably rare under Ni 
catalysis.27 An electron-rich acetylnaphthalene could also be couple with good results 
(83% yield, entry 71). 
 
Scheme 13. Scope of the reaction: electronics and sterics of the ketone, very bulky chloroarenes. 
The reaction scope provided by this protocol is very wide, while at the same time its 
great efficiency even under relatively mild conditions (3 mol% catalyst loading, 80 °C), 
makes it the state of the art for the coupling of haloarenes in the α-arylation of ketones. 
4.4 Preliminary mechanistic studies  
Given the unprecedented activity of complex 42 towards chloroarenes in the α-
arylation of ketones, we focused our attention on the mode of action of such pre-
catalyst. Chetcuti and Ritleng reported the activity of related catalysts, 
[Ni(NHC)(Cp)Cl], in this reaction (see section 1.2), but did not manage to identify the 
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catalytically active species generated by these complexes.28 The same author claimed 
that the activity of the Cp-based pre-catalysts towards chloroarenes was poor, whereas 
our catalyst showed excellent results when such substrates were used as substrates. We 
hypothesised that such a difference in activity might be due to the ability of the 
cinnamyl-bearing complexes to more easily release a monoligated Ni0-NHC species 
upon nucleophilic activation, in a reaction similar to that displayed by their Pd 
congener.25 We therefore tackled the mechanistic study of our pre-catalysts with the 
attempt to isolate the Ni0 species generated by their activation (see Scheme 14). Our 
attempts to trap a complex containing the Ni0-NHC moiety were unsuccessful. 
Treating complex 42 with 1.1 equivalents of NaOtBu in toluene resulted in no 
formation of the postulated Ni0 species, nor the activation by-product 74 (whose 
synthesis has been reported by Ogoshi through a different pathway)29 was observed. 
 
Scheme 14. Attempted isolation of the catalytically active species and of the activation by-product 74. 
The treatment of complex 42 with propiophenone in basic conditions, however, 
provided some useful insights: a 3:1 mixture the α-allylation products 75 and 75’ were 
isolated from the reaction mixture in 84% isolated yield (combined).  
 
 
Scheme 15. Isolation of activation by-products 75 and 75’. 
Although no Ni-containing species could be isolated from this mixture, the formation 
of these propiophenone derivatives hints at the formation of a 
[Ni(IPr*)(cinnamyl)(enolate)] species, from which the α-cinnamyl products 75 and 75’ 
are formed in a reductive elimination step, as observed by Hou using a related Pd-
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based catalyst;30 a Ni0-NHC is probably the other product of this reaction. Our attempts 
to trap such a species as an η6-toluene adduct or by adding one equivalent of 
phosphine, forming the bis-ligated [Ni(NHC)(PR3)] were unsuccessful. Nevertheless, 
the formation of products 75-75’, together with the high catalytic activity observed 
with chloroarenes, strongly hint at a Pd-like, Ni0 catalysed process (see Scheme 16). 
 
Scheme 16. Proposed reaction mechanism. 
4.5 Optimisation of the protocol for the synthesis an industrial intermediate 
With a very efficient protocol in hand, we decided to further optimise for the synthesis 
of compound 79. As showed in Chapter 2, compound 79 is an intermediate towards 
the Selective Estrogen Receptor Modulators (SERMs) Nafoxidine and Lasofoxifene.31  
 
Scheme 17. Schematic synthetic pathways towards Nafoxidine and Lasofoxifene, with compound 79 as a 
key intermediate. 
Our main goal in this further step of reaction optimisation was to enhance the overall 
reaction efficiency, more specifically its atom economy. For this reason, our first 
approach involved the lowering of the amount of ketone, with the double aim of 
reducing the waste of material and making the purification easier (see Table 3). We 
found that, contrarily to what we observed with propiophenone, 1.1 equivalents of 6-
methoxytetralone were sufficient to fully convert the chlorobenzene starting material. 
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More interestingly, the optimal Ni pre-catalyst for this reaction was found to be 
complex 43, bearing the IPr*OMe ligand instead of IPr*. While reinforcing the importance 
of the ligand’s steric bulk, this result further shows that subtle interactions between the 
ligand’s eletronic properties and the nature of the substrates can determine the reaction 
outcome. 
Table 3. Optimisation oft he ligand for the synthesis of 79. 
 
Entry Pre-catalyst (mol%) T °C Conversion[a] 
1 40 (3) 80 0 
2 41 (3) 80 0 
3 42 (3) 80 99 
4 43 (3) 80 99 
5 42 (2) 80 66 
6 43 (2) 80 78 
7 43 (2) 100 >99 
Conditions: 80 (0.28 mmol, 1.1 equiv), 81 (0.25 mmol, 1.0 equiv), NaOtBu (0.5 mmol, 2.0 equiv), catalyst 
(2.0 or 3.0 mol%), in toluene (1 mL), 80 or 100°C, 16h. [a] Conversion of 81 was measured by GC. 
With the finding that a different ancillary ligand, and a lower catalyst loading, could 
provide the desired product in good yield, a second round of optimisation was 
performed (see Table 4). The use of inorganic bases (Na2CO3, Cs2CO3, K3PO4) resulted 
in no reactivity (entries 2-4). As we observed in the case of Pd catalysis (see Chapters 2 
and 3), a complex interaction between the base and the solvent is observed: when 
switching between t-butoxide bases, we observed that Li was the best counterion in 
ethereal solvents (both dioxane and DME, entries 14-15), and gave satisfying 
conversion in toluene too (entry 6); K performed poorly both in toluene and ethers 
(entries 5, 11-12), but gave excellent conversion in DMF (entry 13); NaOtBu, however, 
provided good yield in DMF (entry 10) and was the only base to provide full 
conversion, when used in combination with toluene (entry 1).. The increase of the 
concentration in the reaction vessel, obtained by reducing the amount of solvent, did 
not affect the conversion rate, making the process more atom-economical as the solvent 
waste was halved (entry 19). The reduction of the reaction time, however, was 
O
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MeO
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+
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80
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detrimental, as it led to lower conversion (entry 20), and further lowering the catalyst 
loading led to lower conversion (entry 21). 
Table 4. Optimisation of the base/solvent system fort he synthesis of 81. 
 
Entry Base Solvent mol% 43 Conc. (mol L-1) Conversion[a]  
1 NaOtBu Toluene 2 0.25 99 
2 Na2CO3 Toluene 2 0.25 0 
3 K3PO4 Toluene 2 0.25 0 
4 Cs2CO3 Toluene 2 0.25 0 
5 KOtBu Toluene 2 0.25 0 
6 LiOtBu Toluene 2 0.25 72 
7 NaOH Toluene 2 0.25 15 
8 NaOtBu Dioxane 2 0.25 46 
9 NaOtBu DME 2 0.25 13 
10 NaOtBu DMF 2 0.25 85 
11 KOtBu Dioxane 2 0.25 0 
12 KOtBu DME 2 0.25 0 
13 KOtBu DMF 2 0.25 92 
14 LiOtBu Dioxane 2 0.25 68 
15 LiOtBu DME 2 0.25 74 
16 LiOtBu DMF 2 0.25 25 
17 NaOH Dioxane 2 0.25 0 
18 NaOH DMF 2 0.25 0 
19 NaOtBu Toluene 2 0.5 > 99 
20 NaOtBu Toluene 2 0.5 90[b] 
21 NaOtBu Toluene 1 0.5 75 
Reaction conditions: 80 (0.28 mmol, 1.1 equiv), 81 (0.25 mmol, 1.0 equiv), NaOtBu (0.5 mmol, 2.0 equiv), 
43 (1.0 or 2.0 mol%), in solvent (1 mL), 100°C, 16 h. [a] Conversion of 81 was measured by GC; [b] reaction 
time 6 h. 
The further optimised conditions lead to an isolated yield of the target compound of 
82% on a gram scale reaction. The TON observed for the reaction, 41, is the highest 
ever registered for a Ni-catalysed ketone arylation. The improved reaction conditions 
(lower Ni loading, lower amount of solvent, only at a cost of a slight increase in 
temperature) show that the Ni-catalysed, industrial-scale protocols for the α-arylation 
of ketones, among other Ni-catalysed processes, can be developed. 
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Scheme 18. Gram-scale synthesis of 79. 
4.6 Conclusions and outcome 
The substitution of Pd with Ni as catalyst for the α-arylation of ketones is part of the 
challenge towards the development a more sustainable and economically viable 
synthetic chemistry, both on the industrial and the laboratory scale. This chapter 
focuses the first Ni-catalysed protocol for the α-arylation using chloroarenes as 
electrophiles, at a catalyst loading that is comparable with the state of the art in the 
field. Its further optimization allowed the preparation of an industrially relevant 
intermediate, at the same time providing the most efficient example of Ni-catalysed the 
α-arylation of ketones to date. The steric and electronic properties of the NHC ancillary 
ligand proved crucial, as the very bulky ligands IPr* and IPr*OMe clearly outperformed 
the more commonly used IPr and SIPr. The exploration of further [Ni(NHC)]-catalysed 
protocols for deprotonative couplings is discussed in the following chapter.
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5 Ni-catalysed arylation of benzylic C–H bonds for the 
synthesis of (diarylmethyl)amines. 
5.1 (Diarylmethy)lamines 
The diarylmethylamine motif is widespread in bioactive compounds,1 with examples 
including the antidepressant Meclozine, the antihistamine Zyrtec (cetirizine), and the 
opioid 1.2 More recently, compounds bearing this pharmacophore have shown activity 
as antimicrobials, 3 antimalarials,4 and in Alzheimer’s disease treatment. Given their 
importance as bioactive compounds, the development of synthetic strategies towards 
(diarylmethyl)amines is an important area for synthetic chemists (see Figure 1). 
 
Figure 1. Examples of (diarylmethyl)amine derivatives. 
Traditional synthetic chemistry approaches (see Scheme 1) involve the nucleophilic 
substitution of an amine on a benzhydril-derived electrophile (equation 1),5 or the 
nucleophilic addition of organometallic reagents on a benzaldehyde-derived imine 
(equation 2). 6  Catalytic approaches towards this motif, namely the reduction of 
diarylketimines,7 and the addition of a mild organometallic reagent to a benzaldehyde-
derived imine,8 are also known (equations 3 and 4). 
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Scheme 1. Common approaches towards the (diarylmethyl)amine scaffold.5-8 
Less intuitive approaches have been designed, using transition metal catalysis: the 
activation of a N,O–acetals has been achieved, both under Pd and Cu catalysis (Scheme 
2).9  
 
Scheme 2. Pd- and Cu-catalysed, CC-like approaches towards (diarylmethyl)amines.9 
The synthetic methods presented in Schemes 2-3 doubtlessly represent a good 
selection of pathways to access the (diarylmethyl)amine moiety. However, each of 
these protocols presents drawbacks: often, lack of functional-group tolerance is 
observed, either because of the harsh conditions employed (highly nucleophilic 
organometallic reagents or strong acid catalysts) or because of the sensitivity of the 
catalyst employed towards certain functional groups leading to generally low yields or 
complex mixtures. Moreover, the substrates required for these approaches are often 
not commercially available. 
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The arylation of benzylamine-derived imines belongs to the deprotonative CC class of 
reactions, 10  and has proven useful for the synthesis of a large array of 
(diarylmethyl)amine derivatives, as shown in Section 1.3.2. Such a transformation is 
based on the deprotonation of a benzylic C–H bond belonging to a benzylamine 
derivative, and the subsequent coupling of the aza-allyl anion with a haloarene, 
generally under Pd catalysis (see Scheme 3). The development of a first-row metal-
catalysed protocol would provide a more economically and environmentally 
sustainable alternative to the use of Pd, as explained in Chapter 4. For this reason, we 
saw the study of this C(sp3)–H arylation under Ni catalysis as an intriguing and 
challenging area to showcase the ability of [Ni(NHC)]-based catalysts to perform CC 
chemistry with less reactive coupling partners. 
 
Scheme 3. The mechanism of the deprotonative CC of benzylamine-derived imines with haloarenes. 
5.2 Optimisation of the reaction conditions 
The examination of a reaction on the model compound 22 and 4-chlorotoluene 26 was 
the first step in our study (see Table 1). The effect of the base/solvent was first 
examined using a [Ni(COD)2]/IPr 28 catalytic system. The choice to first test the 
base/solvent system was dictated by previous observations, reported by Walsh, that 
efficient and clean formation of the aza-allyl anion 23 is key in the reaction 
development.10 Good conversion and NMR yields of the desired product were 
observed in toluene when potassium hexamethyldisilylamide (KHMDS) was used as 
base (entry 17); KHMDS also provided quantitative conversion, but low NMR yield, in 
THF (48%, entry 16). Lower conversions were obtained with KHMDS in dioxane and 
dimethoxyethane (63% and 27% respectively, entries 14-15). The other bases tested (Li- 
and NaHMDS and t-butoxides) gave no conversion to the desired product in all the 
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solvents screened (entries 1-13). The effect of the excess of base was also explored, 
leading us to the finding that amounts of base lower or higher than 2 equivalents led to 
a decrease in NMR yield (75% and 72%, respectively, entries 18-19). Increase in 
temperature, too, resulted in lower NMR yield (72%, entry 20).  
Table 1. Optimisation of the base/solvent system. 
 
Entry Base (equiv.) Solvent T° C Conversion%[a] (yield) [b] 
1 NaOtBu (2.0) Toluene 45 - 
2 NaOtBu (2.0) Dioxane 45 - 
3 NaOtBu (2.0) THF 45 - 
5 KOtBu (2.0) Toluene 45 - 
6 KOtBu (2.0) Dioxane 45 - 
7 KOtBu (2.0) THF 45 - 
8 NaHMDS (2.0) Toluene 45 - 
9 NaHMDS (2.0) Dioxane 45 - 
10 NaHMDS (2.0) THF 45 - 
11 LiHMDS (2.0) Toluene 45 - 
12 LiHMDS (2.0) Dioxane 45 - 
13 LiHMDS (2.0) THF 45 - 
14 KHMDS (2.0) Dioxane 45 63 
15 KHMDS (2.0) DME 45 27 
16 KHMDS (2.0) THF 45 >95 (49) 
17 KHMDS (2.0) Toluene 45 >95 (81) 
18 KHMDS (1.5) Toluene 45 >95 (75) 
19 KHMDS (2.5) Toluene 45 >95 (72) 
20 KHMDS (2.0) Toluene 60 >95 (72) 
Conditions: 22 (0.5 mmol, 2.0 equiv), 26 (0.25 mmol, 1.0 equiv), base (1.0 mmol, 2.0 equiv), [Ni(COD)2] (5. 
mol%), IPr (6.0 mol%) in the indicated solvent (2.5 mL), 45 or 60 °C, 16h. [a] Conversion of the 4-
Chlorotoluene, as measured by GC; [b] Yield calculated by NMR analysis using dimethylmalonate as 
internal standard chromatography. 
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With an efficient base/solvent system in hand, we studied the influence of the ancillary 
ligand in the transformation (see Table 2): compared to the “medium-size” IPr NHC 
(entry 1), the use of the less sterically hindered ligands IMes 29 and IDD 30 resulted in 
poor or no conversion (entries 5-6), whereas the closely related SIPr ligand (entry 2) 
provided good conversion, but only moderate NMR yield. The very bulky IPr* ligand, 
that usually gives the best performances when employed in CC chemistry (and 
especially under Ni catalysis), resulted as well in decreased yield compared to IPr 
(entry 3). As IPr was identified as the optimal ligand, we tested well-defined pre-
catalysts 33 and 34, endowed with such ligand. Contrarily to the previous cases of 
[Ni(NHC)] catalysed reactions, both these pre-catalysts proved less efficient compared 
to the in situ prepared [Ni(COD)2]/free IPr system (entries 7-8). This drop in efficiency 
might be attributed to the activation step of the allyl- and cinnamyl- moieties when a 
sterically bulky, poorly nucleophilic 2-azallyl anion is used to generate the active Ni0 
species. It is interesting, however, to notice that the cinnamyl-base complex 34 
provided remarkably higher conversion. The concentration could be increased to 0.17 
M (83%, entry 10), but further increase led to erosion of the yield (53%, entry 9). A 
metal/ligand ratio of 1:2 was found to improve the catalytic performance (93%, entry 
12), whereas the addition of one more equivalent of ligand compared to the metal 
completely switched off the reaction (entry 13). The dramatic effect of the excess ligand 
on the reactivity is surprising, and is discussed in Section 5.4 together with other 
findings on the mechanism. Other Ni sources, namely [Ni(DME)Cl2] and [Ni(acac)2], 
proved ineffective (entries 14-15).  
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Table 2.  
 
Entry Ni source (mol%) L (mol%) Conc. (mol L-1) Conversion[a] (yield)[b] 
1 [Ni(COD)2] (5) IPr 6% 0.10 >95 (81) 
2 [Ni(COD)2] (5) SIPr 6% 0.10 94 (65) 
3 [Ni(COD)2] (5) IPr* 6% 0.10 >95 (60) 
5 [Ni(COD)2] (5) IDD 6% 0.10 - 
6 [Ni(COD)2] (5) IMes 6% 0.10 24 
7 34 5% - 0.10 >95 (70) 
8 33 5% - 0.10 70 (45) 
9 [Ni(COD)2] (5) IPr 6% 0.25 >95 (53) 
10 [Ni(COD)2] (5) IPr 6% 0.17 >95 (85) 
11 [Ni(COD)2] (2.5) IPr 3% 0.17 >95 (72) 
12 [Ni(COD)2] (5%) IPr 10% 0.17 >95 (93) 
13 [Ni(COD)2] (5%) IPr 15% 0.17 - 
14 [Ni(acac)2] (5%) IPr 10% 0.17 traces 
15 [Ni(DME)Cl2] (5%) IPr 10% 0.17 traces 
 
 
Conditions: 22 (0.5 mmol, 2.0 equiv), 26 (0.25 mmol, 1.0 equiv), KHMDS (1.0 mmol, 2.0 equiv), Ni source 
(2.5 or 5.0 mol%), ligand (3 to 10 mol%) toluene (1.0 to 2.5 mL), 60 °C, 16h. [a] Conversion of the 4-
Chlorotoluene, as measured by GC; [b] Yield calculated by NMR analysis using dimethylmalonate as 
internal standard chromatography. 
ClPh N
Ph
Ph
KHMDS 2.0 equiv.)
Toluene, 45 ºC, 16 h
[Ni] , L
Ph N
Ph
Ph
+
22 26 27
N N
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
N N
N N N NN N
N N
28
IPr
29
IMes
30
IDD
32
IPr*31SIPr
Ni Cl
33
[Ni(IPr)(allyl)Cl]
N N
Ni Cl
34
[Ni(IPr)(cinnamyl)Cl]
Ph
 111 
The transformation takes place at low temperature, which makes it possible to avoid 
the formation of mixtures of isomers, contrarily to what observed by Yorimitsu and 
Oshima in their early reports.11 Compared to previous protocols reported by Walsh, 
our system did not require the slow addition of the base, thus rendering this 
methodology more user-friendly.10 The conditions summarised in Table 2, entry 12 
were therefore adopted as optimal, as they lead to 88% isolated yield of compound 27. 
5.3 Scope and limitations 
Once we had established the conditions for our methodology, we investigated the 
generality of our method by varying the substitution pattern of the chloroarene 
reactants for the coupling with the imine 22 (see Scheme 4). Both the electron-donating 
4-methoxy substituent, as well as the electron-withdrawing trifluoromethyl group, led 
to high yields of the desired products (86% and 79% yield respectively, entries 37 and 
39). 4-fluorochlorobenzene could also be coupled smoothly (82%, entry 38). 
Functionalised aryl chlorides, bearing functional groups such as amines (77%, entry 
40), benzodioxole (86%, entry 41) and relatively base-sensitive ketone and nitrile 
derivatives (89 and 80% respectively, entries 42-43) were also considered, and they 
were found to afford good to very good yields of the desired products. 2-
chloropyridine was also successfully coupled in high yield (89%, entry 44), although it 
required a slight increase of the catalyst loading, from 5 to 7.5 mol% to achieve full 
conversion. The same increase was necessary also for the coupling of sterically 
encumbered chloroarenes, namely 2-chlorotoluene and 1-chloronaphthalene, obtaining 
full conversion and fair yield (75% and 61% respectively, entries 45-46). Compound 46 
could not be isolated as such, because an impurity co-eluted with it: the yield was 
therefore calculated after the hydrolysis of the imine and isolation of the free amine 46’. 
The good yields obtained using bulky chloroarenes are unprecedented, as they 
represent challenging substrates even for the Pd-catalysed protocols reported by 
Walsh.10 Scheme 4 also shows products that could not be synthesised by means of this 
protocol: 2- and 3-chlorothiophene and 5-chlorobenzoxazole could not be coupled 
under the reaction conditions (entries 48-49); 3-chloropyridine, too, proved unsuitable, 
in striking opposition to the good yield provided by the 2-chloropyridine isomer (entry 
47).  
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Scheme 4. Scope of the reaction using imine 22 as substrate. 
The use of other imine substrates was also explored (Scheme 5). Imines bearing a 4-
methyl, 4-methoxy and a 4-fluoro substituent on the phenyl ring of the benzylamine 
building block reacted productively with chlorobenzene, generating the desired 
products in 86% and 82% yield respectively, enabling the synthesis of compounds 37 
and 38 from a different route. On the converse, heterocyclic cores were not tolerated on 
the benzylamine moiety, as proven by the lack of production of compounds 52 and 53 
under the reaction conditions. 
 
Scheme 5. Scope of the reaction using different benzylic imine derivatives as substrates. 
The commercially available imine 22’ was next tested. The deprotonation of this 
substrate, converges to the same intermediate 23, generated by the isomer substrate 22 
(as shown in Section 5.1, Scheme 3), leading therefore to the same general product 
after the reductive elimination. Exposure of substrate 22’ to the optimised reaction 
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conditions led to formation of the desired coupling products in good yield regardless 
of the electronic features of the chloroarene: 4-chlorotoluene, 4-chloroanisole and 4-
fluoro-chlorobenzene afforded 82%-84% isolated yield of the arylated products 27, 37 
and 38 (see Scheme 6). 
 
Scheme 6. Scope of the reaction using imine 22’ as substrate. 
5.4 The role of the base and the putative mechanism 
A reaction mechanism can be proposed based on our findings (see Scheme 7): the cycle 
is started when the catalytically active Ni0 54 species activates the C–Cl bond of the 
electrophile, forming the NiII complex 55; this complex undergoes a transmetalation 
step with the aza-allyl anion 23, generated by deprotonation of imine 22 or 22’. The 
species 56 formed this way undergoes a reductive elimination step, forming the 
desired C–C bond and the catalytic species 54. Such a schematic mechanism, however, 
does not explain the effect of the excess ligand, an interesting (and somehow 
surprising) feature of this protocol. As showed in the optimisation table, increasing the 
equivalents of IPr from 1.2 to 2.0 with respect of Ni, a small improvement in the NMR 
yield of the desired product, from 85% to 93% (see Table 2, entries 10 and 12) was 
observed. When the amount of ligand was further increased to 3.0 equivalents, 
however, the reaction was completely shut down and led to no desired product at all 
(Table 2, entry 13). This observation can be rationalised by postulating that a 
monoligated species is involved in the rate-limiting step of the reaction, whereas a bis-
ligated species 57 acts as an off-cycle species. A deleterious effect of excess of NHC 
ligand was previously observed in the Buchwald-Hartwig reaction by Yang; 12 
interestingly, the preferred L/Ni ratio in this case was 1 and not 2, using the same 
ligand (IPr). Two hypothesis can be proposed: 1) the bis-ligated species is formed by 
coordination of one IPr ligand to the unstable [Ni0(IPr)]catalytic species 54, preventing 
its decomposition by means of steric shielding and increased electronic saturation; 2) 
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the second IPr ligand coordinates the NiII species 55, generating a complex of formula 
[Ni(L)2X1X2], which would be thermally and chemically stable. The coordination of an 
additional NHC to species 56, bearing already the very bulky aza-allyl moiety, is less 
likely for steric reasons, although it cannot be excluded at this stage of development of 
the reaction. In both cases, the increased concentration of IPr in the reaction medium 
would lead to a shift of the equilibrium towards an off-cycle, inactive bis-ligated 
species, causing the dramatic drop in conversion. 
 
Scheme 7. Proposed mechanism for the benzylic arylation of imines. 
The peculiar effect of the nature of the base in this reaction prompted us to further 
study the deprotonation step, clarifying the role of this additive. We first performed 
the alkylation of substrate 22 under the reaction conditions (toluene, 45 °C) in the 
absence of the catalyst (see Table 3). Three different bases were employed: KOtBu, 
NaHMDS and the optimal KHMDS. The use of a base weaker than the azaallyl anion 
(pka = 24.7), such as a t-butoxide (pka = 29.4),13 generated lower amounts of benzylated 
product (entry 3); NMR analysis revealed the presence of significant amounts of side-
products, that were completely absent in the reactions using HMDS containing-bases 
(entries 1 and 2). The observation that both the HMDS bases led to improved results, 
with no clear effect of the cation, led us to test NaHMDS and KHMDS in the absence of 
the benzyl chloride electrophile: while the latter leads only to the formation the 
expected starting material (together with the isomeric compound 22’, entry 4), the use 
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of NaHMDS resulted in the formation of other products, as showed by the NMR 
analysis (entry 5). Finally, KHMDS was tested in the presence of the [Ni(COD)2]/IPr 
catalytic system, and also in this case only starting material 22 and the isomerised 
imine 22’ were detected. The subtle effect of the base on the overall reaction outcome is 
therefore explained by the generation of side products when using a non-optimal base. 
The contribution of the anionic part of the base is clearly related to its relative strength 
and nucleophilicity: the strong, non-nucleophilic HMDS performs much better than t-
butoxides, which on the convert lead to the formation of by-products. The effect of the 
cation, instead, could be attributed to its hard-soft properties (as already demonstrated 
for other deprotonative couplings, namely the α-arylation of ketones). 
Table 3. Study of the role of the base. 
 
Entry Base (equiv.) 58 
(equiv.) 
22[a] 22’[a] 59[a] Notes 
1 KHMDS (2.0) 2.0 - - 81 - 
2 NaHMDS (2.0) 2.0 - - 80 - 
3 KOtBu (2.0) 2.0 - - 60 Side products observed 
4 KHMDS (0.5) - 74 26  Only 22 and 22’ observed 
5 NaHMDS (0.5) - 74 26  Side products observed 
6[b] KHMDS (0.5) - 74 26  Only 22 and 22’ observed 
Conditions: 22 (0.2 mmol, 1.0 equiv), 58 ( none to 0.24 mmol, 1.2 equiv ), base (0.4 mmol or 0.1 , 2.0 or 0.5 
equiv.), toluene (0.6 mL), 45 °C, 3h. a) Conversion calculated by NMR analysis; b) reaction performed in 
the presence of 5.0 mol% [Ni(COD)2], 10 mol% IPr. 
The systematic rationalisation of the role and the effect of the base is a very important 
challenge in CC chemistry, and it is still far from being accomplished. For the purpose 
of our work, we can only take note of the fact that closely related bases have 
significantly different effects on the reaction. 
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5.5 Conclusions and outcome 
The first Ni-catalysed deprotonative CC involving benzylic C–H bond was disclosed. 
The protocol involves the use of a catalyst prepared in situ using IPr as the optimal 
ligand, which outperformed the well-defined pre-catalysts that are often the most 
efficient tool to achieve such reactivity. The method shows a satisfyingly wide scope, 
including biologically important functional groups, and it is user-friendly, as it does 
not involve slow addition of the base and is based on a commercially available catalytic 
system. The role of the base proved crucial, and the ability of KHMDS to cleanly 
provide the nucleophilic coupling partner, the aza-allyl anion, is the basis of its 
superior performances. The optimisation shows that the metal/ligand ratio has a 
paramount effect on the reaction outcome, although deeper mechanistic studies are 
necessary to understand the exact reaction pathway. This project shows the possibility 
to expand the use of Ni catalysis to a CC reaction that is both challenging and highly 
valuable. Further developments of Ni catalysis are foreseeable, as this metal is proving 
to be a valuable alternative to Pd for many applications. 
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6 Aqueous Pd-catalysed α-arylation of ketones  
6.1 Aqueous cross couplings: from methodology development to 
functionalisation of biomolecules 
The development of synthetic methods that are tolerant towards complex and highly 
functionalised substrates, allowing the modification of challenging biological 
(macro)molecules and natural products, has received ever-increasing attention over the 
last decades.1 To this aim, Pd-catalyzed CCs represent an irreplaceable toolbox, as they 
provide synthetic access to numerous scaffolds of great interest. The effort towards 
milder and more efficient protocols has resulted in the development of improved 
methodologies, requiring lower temperatures and milder additives. Such 
methodologies display wider functional group tolerance, and allow the modification of 
remarkably complex and highly functionalised molecules.2 Many catalytic systems 
have been designed for performing aqueous CC chemistry. Examples of water-soluble 
ligands, allowing such class of reactions to occur, are shown in Figure 1.  
 
Figure 1. Water-soluble ligands for aqueous CC chemistry. 
PPh3-derived compounds, whose solubility in water is improved by anionic 
(sulphonate, entries 1 and 2) or cationic (guanidium, entry 3) substituents on the 
aromatic rings, are commonly used for aqueous CC.3 Other, more complex ligands, 
namely specifically designed phosphines (for example sSphos 6 and sXPhos 7) and 
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NHCs (entry 8), are also known. Trialkylphosphines bearing a cationic ammonium 
moiety (entries 4 and 9) and ferrocenyl derivatives, harnessed with an amino acid 
moiety, are reported, too (entry 5).4  
The derivatisation of complex biomolecules is often a challenging task, as the rich 
substitution patterns of proteins, (pseudo)peptides and most natural products hampers 
the reactivity by poisoning the Pd-phosphine catalyst through chelation, or leading to 
side-reactions. However, cases of functionalization of biomolecules using phosphines 
as ligands are known. One important early example was reported by Schmidtchen in 
1998, using the guanidine-containing phosphine 3 to enable the Sonogashira coupling 
on iodophenylalanine-containing peptides (see Eq. 1 in Scheme 1), 5 while Fukuzawa 
disclosed the use of the anionic TPPTS phosphine 1 in the Heck reaction on proteins 
(Eq. 2 in Scheme 1).6  
 
Scheme 1. Examples of Sonogashira (equation 1) and Mizoroki-Heck (equation 2) on biomolecules, 
according to Schmidtchen and Fukuzawa respectively.5,6 
Goss reported the use of sSPhos 6 and sXPhos 7, respectively, for the derivatisation of 
the halogenated analogues of the peptidic natural products Pacidamycin and 
Cystargamide. These protocols show the great flexibility of CC chemistry (Suzuki-
Miyaura and Sonogashira coupling), even in the case of heavily functionalised 
substrates (see equation 1 and 2, respectively, in Scheme 2).7 
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Scheme 2. Aqueous Suzuki-Miyaura (equation 1) and Sonogashira (equation 2) on natural products, 
according to Goss.7 
More recently, the issue of coupling biomolecules in aqueous conditions has been 
addressed by the employment of the class of nitrogen-based ligands reported by Davis, 
who employed the simple guanidine derivatives 21-23 previously disclosed by Li for 
the Sonogashira coupling.8 These simple, inexpensive compounds proved extremely 
active for the aqueous Suzuki-Miyaura CC of halogen-containing biomolecules (see 
Scheme 3).9 Davis subsequently reported the use of this class of ligands for the 
modification of proteins, including cell surface labeling10 and 19F-tagging.11  
 
Scheme 3. Coupling of biomolecules according to Davis, using the guanidine-derived ligands 21-23.9-11 
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Ligand 22 was reported to promote the Sonogashira coupling on proteins by two 
different groups: Wombacher proved its utility when a halogen-containing protein 
derivative was reacted with an alkyne endowed with a fluorescein moiety (equation 1 
in Scheme 4),12 whereas Li employed an alkyne-containing protein, labelling it with a 
fluorogenic iodoarene (equation 2 in Scheme 4). 13  Notably, all the examples 
summarised in Scheme 3-4 required the presence of an iodo-derivative, whereas 
examples of chloro- and bromo-arene derivatives as substrates for peptide 
functionalization remain scarce, given their lower reactivity with most catalytic 
systems. 
 
Scheme 4. Sonogashira coupling on proteins according to Li (equation 1) and Wombacher (equation 2).12,13 
Aqueous CC protocols are not widespread for all the CC-like reactions known: for 
example, only few examples of aqueous Buchwald-Hartwig amination protocols are 
known, working under Pd-phosphine catalysis (some examples are reported in Figure 
2).14 No applications of such protocols on proteins or other types of bio-macromolecule 
are reported so far. 
 
Figure 2. Examples of phosphine ligands for the aqueous Buchwald-Hartwig amination. 
For α-arylation of ketones (whose chemical equation is reported in Scheme 5, equation 
1), no aqueous protocols are known. The development of such an aqueous version 
would need to overcome the challenges arising from the use of enolates, generated by 
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in situ deprotonation of the ketone pro-nucleophiles. The α-proton of organic carbonyl 
compounds is, indeed, significantly less acidic than water (pKa = 14);15 therefore its 
conjugated base (the enolate) would be present in small concentrations at the 
equilibrium when water is present (see Scheme 5). Although the complete 
deprotonation of the ketone is generally not necessary for this CC to happen, the 
presence of a vast amount of a relatively acidic compound as solvent surely represents 
a challenge. The well-known use of surrogates (namely, silyl-enolethers) would lead to 
formation of the enolate under milder conditions,16 but the equilibrium mentioned 
above would still be problematic. 
 
Scheme 5. The equation α-arylation of ketones (equation 1) and the enolate-ketone equilibrium (equation 
2). 
The development of a deprotonative aqueous methodology would represent an 
important step in the field, as it will make the α-arylation of ketones more 
environmentally sustainable, while widening its potential applicability. In particular, 
our aim was to develop a protocol allowing the coupling of halogenated tryptophan 
derivatives. S-tryptophan is a natural, proteinogenic amino acid, often found to have a 
role in the secondary and tertiary structure of proteins; it is also a widespread moiety 
found in natural products. As it contains an indole moiety in the side chain, tryptophan 
is also often responsible for the fluorescence properties of such compounds.17 The 
synthesis of enantiopure, halogenated analogues of this compound has been achieved 
by our group in two ways, both involving biosynthetic transformation: 1) using 
tryptophan synthase, an enzyme that generates S-tryptophan through coupling of a 
substituted indole and serine, in the presence of PLP cofactor;18 2) via enzymatic 
halogenation in vivo.19  
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Scheme 6. Biosynthetic pathways towards halotryptophans 36.18,19 
The insertion of an orthogonal chemical handle (the halogen atom) to the amino acid 
opens the possibility for subsequent derivatisation of the compound itself, or of its 
(bio)synthetic derivatives. The halogenation/CC approach potentially allows the late-
stage functionalisation of such compounds, and would represent a powerful tool for 
molecular diversification. 
6.2 Identification of the pre-catalyst, optimisation, and troubleshooting 
The first step of our studies involved the identification of suitable conditions for α-
arylation of ketones in mixed aqueous media. First, a number of precatalysts, with 
varying ancillary ligands, were tested in the test reaction between propiophenone 35 
and 5-bromoindole 40. While propiophenone represents a common model compound 
for this CC, heterocyclic compounds like haloindoles are notoriously more difficult 
coupling partners. We chose 5-bromoindole because our aim was to develop a protocol 
suitable for a wide range of heterocyclic and functionalized coupling partners, 
including the halogenated tryptophan derivatives biosynthesized in our lab. 
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Scheme 7. Catalytic systems tested for the aqueous α-arylation. Conditions: 35 (0.4 mmol, 2.0 equiv. ), 40 
(0.2 mmol, 1.0 equiv. ), NaOH (0.5 mmol, 2.5 equiv), catalyst (5.0 mol %), 0.5 M in THF/water 1:1 mixture , 
100 °C, 16h. Conversion measured by GC analysis. 
Of all the pre-catalysts tested, only complex 43, [Pd(DtBPF)Cl2], was found to be active 
in water/solvent mixtures, while other phosphine- and NHC-based catalysts were 
unable to perform the reaction (see Scheme 7). Complex 42 is known to catalyse the α-
arylation of ketones in presence of traces of water, and its activity under mixed 
aqueous conditions is therefore not surprising. To note, the pre-treatment of the 
solvent through basic alumina was required to guarantee the reproducibility of the 
reaction outcome, as already observed by Colacot.20 
Once the precatalyst was identified, we proceeded to screen the base/solvent system, 
which plays a crucial role in this cross coupling (as shown in previous Chapters). We 
found that, of the five water-miscible solvents tested, three provided quantitative GC 
conversion using NaOH as base (THF, Dioxane and t-amyl alcohol, entries 1-3 in Table 
1). On the contrary, ethanol (entry 4) gave no conversion to the desired product, 
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affording the de-halogenation product indole instead.21 DMF (entry 5) gave conversion 
lower than 10%, with traces of de-halogenation as well. The selection of the best 
base/solvent system was then performed by lowering both temperature and catalyst 
loading, screening LiOH, NaOH and KOH in the three successful solvents (entries 6-
15). NaOH in dioxane was found to be the optimal system for the reaction, affording 
full conversion (entry 14), whereas other bases proved less efficient: the second-highest 
conversion observed was 77% using KOH in dioxane (entry 10). The reaction 
summarized in entry 14 was monitored by quantitative 1H NMR, using (1,3,5-tris-t-
butyl)-benzene as internal standard, to verify the yield obtained. Surprisingly, the 
NMR yield of this reaction was remarkably low (65%). Increasing the catalyst loading 
to 5 mol% and/or the temperature to 80°C, did not significantly improve the 
perfomances, leading to NMR yields as high as 70% at best (entries 16-18). The use of 
weaker bases, namely K3PO4 and Na2CO3, gave even lower yield (22% and 41% 
respectively, entries 19-20). The NMR spectrum showed absence of 5-bromoindole in 
the reaction crude after a simple filtration on magnesium sulfate.  
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Table 1. Optimisation of the base/solvent system. 
 
Entry Pd loading 
(mol %) 
Base Solvent T °C Conversion%[a]  
(Yield %[b]) 
1 5 NaOH THF 100 >99 
2 5 NaOH Dioxane 100 >99 
3 5 NaOH tAmOH 100 >99 
4 5 NaOH EtOH 100 n.r. [c] 
5 5 NaOH DMF 100 <10 [c] 
6 2 LiOH THF 60 51 
7 2 LiOH Dioxane 60 67 
8 2 LiOH tAmOH 60 41 
9 2 KOH THF 60 65 
10 2 KOH Dioxane 60 77 
11 2 KOH tAmOH 60 48 
12 2 LiOH Dioxane 60 67 
13 2 NaOH THF 60 57 
14 2 NaOH Diox 60 >99 (65) 
15 2 NaOH tAmOH 60 67 
16 2 NaOH Dioxane 80 >99 (70) 
17 5 NaOH Dioxane 60 >99 (66) 
18 5 NaOH Dioxane 80 >99 (70) 
19 2 K3PO4 Dioxane 60 >99 (22) 
20 2 Na2CO3 Dioxane 60 >99 (41) 
21[d] 2 NaOH Dioxane 60 >99 (90) 
Reaction conditions: 35 (0.4 mmol, 2.0 equiv), 40 (0.2 mmol, 1 equiv), base (0.5 mmol, 2.5 equiv), 
[Pd(DtBPF)Cl2] 2–5 mol %, 0.5 M in solvent/water 1:1 mixture , 60 or 80 °C, 16h. [a] Conversion of 40 was 
measured by GC analysis. [b] Yield was determined by quantitative 1H NMR spectroscopy by using 1,3,5-
tri-t-butylbenzene as internal standard. [c] dehalogenation product (indole) was detected at the GC; [d] 
Propiophenone (4.0 equiv) and NaOH (4.0 equiv) were used; 84% isolated yield.  
Base 2.5 equiv.
Solvent/water 1:1, 
 T °C, 16 hours
43 O
H
NO
+
35 41
N
H
Br
40
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We hypothesized that a parasitic side reaction, involving coupling between the N–H 
bond and the C–Br bond of 5-bromoindole, producing insoluble oligomers, was 
responsible for the low yields observed. Such a behavior was confirmed by the control 
reaction between 5-methoxyindole 52 and 4-(dimethylamino)-bromobenzene 53, which 
lead to 74% isolated yield of the N-arylated product 54 under the reaction conditions 
used for the α-arylation of ketones. 
 
Scheme 8. Parasitic, Pd-catalysed N–H arylation under the reaction conditions. 
To overcome this drawback, we decided to increase the amount of both propiophenone 
and base to 4 equivalents each, and therefore forcing the desired coupling by mass 
action (according to Le Chatelier’s principle). The approach proved successful, as the 
NMR yield was increased to 90%, leading to an isolated yield of 84% after column 
chromatography (entry 21 in Table 1). This relatively large excess of propiophenone is 
doubtlessly a drawback of this method. However, we expected it to not be needed in 
cases where the competitive N-arylation is not possible (for example, when a N–H 
bond is not present, vide infra). The reaction temperature and catalyst loading are 
comparable to previous reports. 
6.3 Scope of the reaction using “conventional” haloarenes 
Once the optimal conditions for the reaction were found, we started exploring its scope 
(see Scheme 9). At first, we investigated the suitability of our protocol in the coupling 
of various haloindoles: 5-, 6- and 7-bromoindole were all successfully coupled with 
propiophenone in high yields (84%, 82% and 90% isolated yield respectively, entries 
57-59). To verify the effect of the halogen, compound 59 was synthesized employing 7-
chloro-and 7-iodoindole: while the latter gave only a slightly lower yield compared to 
its brominated congener (85%), the former required an increased catalyst loading to 
restore full conversion and a synthetically useful yield (from 2 to 5 mol%, 81% yield). 
Different ketones were screened: the use o-methylacetophenone resulted in modest 
yield of the monoarylated compound 60 when 7-Bromoindole was used (69%), with 
the contemporary formation of the diarylated congener 60’ (9%). The lack of selectivity 
54
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of pre-catalyst 43 when acetophenone derivatives are used is well known in the 
literature,22 and this result confirms this feature, independently from the base/solvent 
system chosen. 
 
Scheme 9. Scope of the reaction using haloindole derivatives.  
The extension of the reaction to other functionalised haloarenes was then investigated: 
medicinally relevant functional groups, such as sulphones and tertiary amines, were 
compatible (both 92% isolated yield, entries 62 and 63). Both electron-rich and electron-
poor propiophenone derivatives were tolerated, and afforded high to very high yields 
(88% and 95% yield, entries 64 and 65), while cyclic derivatives proved less efficient 
under the same conditions, as a significantly lower yield was obtained (63% yield, 
entry 66). The effect of N-protection of 5-bromoindole was also studied: 
functionalization of the N-benzylated derivative was possible (83% yield, entry 67). 
Notably, lower amounts of ketone and base were required, compared to haloindoles, in 
all of these cases (2.0 and 2.5 equiv. respectively), confirming the presence of a side 
reaction involving the unprotected N–H bond. 
Other heterocyclic cores, namely quinolines, isoquinolines and pyridines, could also be 
coupled with propiophenone in good yield (83%, 95% and 74% yield respectively, 
entries 68, 70 and 71). Deoxybenzoin (phenyl-benzyl-ketone) provided fair yield of the 
coupled product with 6-chloroquinoline (65% yield, entry 69). Functional groups that 
are not well-tolerated by the excess of strong bases usually employed in this reaction,23 
such as the nitro and the nitrile moiety, were successfully coupled, although only in 
low to moderate yields (58% and 19% isolated yield respectively, entries 72 and 73). 
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Scheme 10. Scope of the reaction using other haloarenes.  
6.4 Coupling of Prochlorperazine and halotryptophans. 
To test the applicability of this methodology to “real-world” bioactive molecules, the 
halogenated over-the-counter drug Prochlorperazine 74 was chosen as a more complex 
model substrate. 74 was developed as an antipsychotic drug and antiemetic, and recent 
research has proven its antimicrobial activity. 24  The reaction protocol was then 
followed using 5.0 mol% catalyst loading and 4 equivalents of base, affording 86% 
isolated yield of the product 75.  
 
Scheme 11. Coupling of Prochlorperazine.  
Once the scope of the reaction was addressed with “conventional” coupling partners 
and small-molecule drugs, the stage was set for the extension of the protocol to 
halogenated tryptophan derivatives. Attempts to perform the reaction on fully 
unprotected 5-Bromotryptophan 76 afforded no conversion to the desired product, 
even when the reaction was performed under more forcing conditions (see equation 1 
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in Scheme 12). Hence, the amine group of compound 76 was protected, affording the 
desired S-(N-Boc)-5-bromotryptophan 78 in 87% yield (see equation 2 in Scheme 12). 
Pleasantly, 78 was found to react under the developed conditions, affording 87% yield 
of the desired coupled product 77 (see equation 3 in Scheme 12). 
 
Scheme 12. Attempted coupling of unprotected S-5-Bromotryptophan 76 (equation 1); Boc-protection of 76 
affording S-(N-Boc)-5-bromotryptophan 78 (equation 2); coupling of 78.  
The amine group of S-6-chlorotryptophan and S-7-bromotryptophan were also Boc-
protected (affording 88% and 91% yield, respectively), and the N-capped amino acids 
80 and 82 were subsequently coupled with propiophenone. The coupling was 
successful, affording 70% and 94% yield, respectively (entries 81 and 83 in Scheme 13).  
 
Scheme 13. Coupling of S-(N-Boc)-6-chlorotryptophan 78 (equation 1) and of S-(N-Boc)-7-
bromotryptophan (equation 2).  
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The compatibility of the reaction conditions (especially the excess of base) with 
enantiomerically pure amino acids was a critical point of concern. Racemisation of the 
stereocenter of the biosynthesised, enantiopure amino acid could lead to undesired 
mixtures of enantiomers, which would represent a significant drawback for 
applications on biomolecules. To verify the tolerance of our protocol towards the 
stereocenter of the amino acid, Marfey’s test was performed. This analytical method 
entails the coupling of an amino acid with Marfey’s reagent, N-(2,4-dinitro-5-
fluorophenyl)-S-alaninamide (FDDA) 84. The two diastereomers that arise when a non-
enantipure amino acid is employed are separable by HPLC analysis (see Scheme 14). 
As such, Marfey’s test provides a semi-quantitative assessment of the enantiomeric 
purity of an amino acid derivative.25 
 
Scheme 14. General equation for Marfey’s test of enantiopurity. 
As Marfey’s reagent requires an N-free amino acid substrate, we devised a stepwise 
sequence: product 83 was first deprotected using trifluoroacetic acid (TFA) in DCM, 
under microwave irradiation. The crude solid obtained was directly coupled with S-
FDDA, according to the protocol developed by Marfey. The resulting compound was 
dissolved, centrifuged and diluted to the required concentration for HPLC, comparing 
its analysis with standard substrates treated in parallel under the same conditions. 
 
Scheme 15. Marfey’s test on compound 83. For experimental detail see Chapter 7.6. 
Figure 3 contains the HPLC tracks of the following, Marfey-derivatised compounds: a) 
S-tryptophan b) S+R-tryptophan c) S-7-bromotryptophan and d) compound 89. The 
analysis shows no detectable racemisation occurring during the coupling process, 
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demonstrating the suitability of our protocol for protected, enantiopure amino acid 
derivatives. Interestingly, the additional racemic stereocenter generated at the α-
position of propiophenone during the reaction had no effect on the Marfey’s test, 
probably because of its relatively great distance from the two stereocenters of the 
peptide.  
 
Figure 3. HPLC tracks of Marfey’s analysis of S-Tryptophan (1), non-enantiopure tryptophan (2), S-7-
bromotryptophan (3), and compound 89, (4). 
The coupling of amino acids is unprecedented in the α-arylation of ketones under Pd 
catalysis,26 and represent a significant step towards the application of this DCC to 
biomolecules and natural products. 
6.5 Conclusions and outcome 
The extension of the α-arylation of ketones to aqueous media has been successfully 
achieved. The reaction conditions required are comparable to the related reports using 
the same catalyst in non-aqueous solvents, and allow the coupling of a wide range of 
reaction partners. As this method allows the coupling of halogenated amino acids and 
small-molecule bioactive molecules, it represents a significant advance both in the field 
of deprotonative couplings as well as in the broader context of late-stage 
functionalization of biomolecules and natural products. The future work will focus on 
the application of this method on peptides, proteins and natural products. 
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7 Experimental Section 
7.1 General Remarks 
Anhydrous, oxygen-free dioxane, DME, DMF and isopropanol were purchased from 
Sigma-Aldrich, stored in glovebox and used as received. Anhydrous, oxygen free 
toluene and THF were obtained from an SPR machine and stored in a glovebox. 
Anhydrous bases (LiOtBu, NaOtBu, KOtBu, K2CO3, Na2CO3,K3PO4, LiOH, NaOH, 
KOH, CsOH, KHMDS, LiHMDS, NaHMDS) were purchased from Sigma-Aldrich or 
Alfa-Aesar, stored in a glovebox and used as received. KOtAm, received as a 1.7 M 
solution in toluene, was dried on a Schlenk line, stored in a glovebox and used as a 
powder. Anhydrous dioxane, DME, DMF and DMA were purchased from Sigma-
Aldrich and used as received. 
Non-anhydrous solvents (EtOH, tAmOH, DMF) and bases (Na2CO3,K3PO4, LiOH, 
NaOH, KOH) used for the protocol reported in Chapter 6 were purchased from Sigma-
Aldrich or Alfa-Aesar and used as received. Non-anhydrous dioxane and THF were 
purchased from Sigma-Aldrich or Alfa-Aesar and filtered through a pad of basic 
alumina before use. 
All commercially available chloroarene and ketone substrates were purchased from 
Sigma-Aldrich, Alfa-Aesar or TCI and used as received, unless otherwise noted. 
[Pd(cinnamyl)Cl]2 and [Pd(acac)2] were purchased from Strem and used as received. 
[Ni(COD)2] was purchased from Strem and stored at -20 °C in a glovebox. 
[Ni(DME)Cl2] and [Ni(acac)2] were purchased from Sigma-Aldrich and used as 
received. [Pd(DtBPF)Cl2], [Pd(XantPhos)Cl2], QPhos, Tol-BINAP, and the Buchwald 
Precatalyst Kit G1 were purchased from Sigma-Aldrich or Alfa-Aesar and used as 
received. 
NHC ligands and [Pd(NHC)] precatalysts were synthesized according to previously 
reported procedure.1  
Halotryptophan derivatives were synthesized according to a previously reported 
procedure.2 
Flash chromatography was performed on silica gel 60 Å pore diameter and 40-63 µm 
particle size. 
1H, 13C and 19F Nuclear Magnetic Resonance (NMR) spectra were recorded on a Bruker- 
400 or 500 MHz spectrometer, at ambient temperature, in CDCl3 or CD3OD. Chemical 
shifts (δ) are reported in ppm, relative to the solvent residual proton CDCl3 (7.26 ppm 
for 1H and 77.00 ppm for 13C) or CD3OD (3.31 ppm for 1H and 49.00 ppm for 13C). For 
19F NMR, chemical shifts refer to an external calibration using CFCl3 (δ = 0.00 ppm). 
Data for 1H NMR are reported as follows: chemical shift, multiplicity (s = singlet, d = 
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doublet, t = triplet, br = broad signal, m = multiplet), coupling constants (J) in Hz and 
integration.  
Gas chromatography analyses (GC) were performed on an Agilent 7890A apparatus 
equipped with a flame ionization detector and a (5%-Phenyl)-methylpolysiloxane 
column (30 m, 320 µm, film: 0.25 µm). Flow rate 1 mL/min constant flow, inlet 
temperature 260°C, column temperature 50°C, 20°C/min increase to 300°C (held for 1 
min), total time 7.6 min. 
UPLC analysis was aquired on a Waters Acquity H-Class UPLC system fitted with a 
Waters Acquity UPLC BEH C18 column (1.7 mm, 2.1×50 mm). 
All isolated yields are average of 2 runs, except from the yields reported in Chapter 6, 
which are average of 3 runs. 
7.2 Experimental details for Chapter 2 
Synthesis of [Pd(IHept)(acac)Cl] 20 
IHept•HCl (520 mg 0.80 mmol, 1.2 eq.) and [Pd(acac)2] (192 mg, 0. 64 mmol, 1 eq.) were 
added in a dry Schlenk flask equipped with a stirring bar. They were purged three 
time with vacuum/ nitrogen cycles, and then dry 1,4-dioxane (10 ml) was added under 
a nitrogen atmosphere. The reaction mixture was refluxed overnight. The solvent was 
evaporated and the crude was dissolved in pentane. The solution was filtered through 
a pad of silica covered with Celite, washing with pentane. After evaporation of the 
solvent and drying under high vacuum, the pure desired complex was obtained as a 
yellow powder (432 mg, 81%). 
General procedure for the α-arylation of ketones using pre-catalyst 20 
Inside a glovebox, a vial containing a stir bar was charged with NaOtBu (105 mg, 1.1 
mmol, 2.2 equivalents), Solid ketones (0.7 mmol, 1.4 equivalents) and/or aryl chlorides 
(0.50 mmol, 1.0 equivalents) were added at this point and dissolved in toluene, and the 
vial was sealed. A stock solution of 20 [Pd(IHept)(acac)Cl] in toluene was prepared and 
dispensed with a syringe (e.g.: 4.3 mg in 2 mL. 0.1 mL of this solution correspond to 
500 ppm catalyst loading. Total reaction volume was 1 mL). Outside of the glovebox, 
ketone and/or the aryl chloride were added if liquids, followed by the stock solution. 
Finally, the vial was stirred at 600 rpm, at T= 100 °C for 16 hours. The solution was then 
cooled to room temperature, some drops of water were added and the crude was 
filtered through silica eluting with ethyl acetate. The organic layers were dried under 
vaccum. Column chromatography of the crude (typically hexane/ethyl acetate 9/1) 
gave the desired product.  
Synthesis of compound 38 in air 
In a screw cap vial equipped with a stirring bar, NaOtBu (105 mg, 1.1 mmol, 2.2 eq.) 
was weighted and dissolved in 0.9 mL of dry toluene. A stock solution of 20 was 
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prepared in a second vial (2.6 mg in 2 mL of dry toluene). Propiophenone (90 µL, 91 
mg, 0.68 mmol, 1.36 eq.), 2-Cl-anisole (71 mg, 0.5 mmol, 1 eq.) and 0.1 mL of the stock 
solution (corresponding to 300 ppm) were added to the vial containing the base. The 
vial was then sealed and magnetically stirred at 100°C overnight. The workup reported 
above afforded 181 mg (75%) of the desired product. 
Characterisation data 
20 [Pd(IHept)(acac)Cl]  
1H NMR (300 MHz, CDCl3): δ 7.36 (t, J = 7.8 Hz, 2H), 7.21 (d, J = 7.8 Hz, 4H), 7.02 (s, 
2H), 4.98 (s, 1H), 2.82 (m, 4H), 2.17 (m, 4H), 1.77 (s, 3H), 1.40 (s, 3H), 1.73-1.25 (m, 20H), 
1.15-1.08 (m, 8H), 0.80 (t, J = 7.1 Hz, 24H).  
13C NMR (75 MHz, CDCl3): δ 186.4, 184.1, 154.4, 144.8, 137.0, 129.3, 125.3, 125.6, 99.9, 
40.0, 39.9, 39.1, 26.9, 26.0, 21.7, 21.2, 15.14. 
Anal. Calcd for C48H75ClN2O2Pd: C, 67.51; H, 8.85; N, 3.28. Found: C, 67.39; H, 8.77; N, 
3.39.  
 
29. 1-Phenyl-2-(p-tolyl)ethan-1-one:3 
 
Pd loading 0.02 mol%. Yield 80%, 176 mg, yellow oil. 
1H NMR (500 MHz, CDCl3): δ 8.03-8.01 (m, 2H), 7.57-7.55 (m, 1H), 7.48-7.44 (m, 2H), 
7.18-7.13 (m, 4H), 4.26 (s, 2H), 2.33 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 197.8, 136.4, 133.1, 131.4, 129.4, 129.3, 128.6, 45.1, 21.0. 
Analytical data matches previously reported characterisation. 
 
30. 1-(4-Methoxyphenyl)-2-(p-tolyl)ethan-1-one:3 
 
Pd loading 0.05 mol%. Yield 70%, 168 mg, white solid. 
1H NMR (500 MHz, CDCl3): δ 7.97-7.94 (m, 2H), 7.49-7.45 (m, 1H), 7.40-7.36 (m, 2H), 
7.22-7.19 (m, 2H), 6.85-6.82 (m, 2H), 4.65 (q, J= 6.8Hz, 1H), 3.88 (s, 3H), 1.51 (d, J= 7.8Hz, 
3H). 
13C NMR (125 MHz, CDCl3): δ 200.5, 158.4, 136.6, 133.4, 132.7, 128.7, 128.7, 128.4, 114.3, 
55.2, 46.9, 19.5. 
Analytical data matches previously reported characterisation. 
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31. 2-(p-Tolyl)-1-(4-(trifluoromethyl)phenyl)ethan-1- one:4 
 
Pd loading 0.2 mol%. Yield 82%, 228 mg, pale yellow solid. 
1H NMR (500 MHz, CDCl3): δ 8.10 (d, J= 8.2 Hz, 2H), 7.71 (d, J= 8.3 Hz, 2H), 7.15 (s, 
4H), 4.27 (s, 2H), 2.33 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 196.8, 139.2, 136.8, 134.3 (q, JCF= 32.6 Hz), 130.6, 129.5, 
129.2, 128.9, 125.7 (q, JCF= 3.5 Hz), 123.5 (q, JCF= 272.7 Hz), 45.5, 21.1. 
19F NMR (471 MHz, CDCl3): δ -63.1 
Analytical data matches previously reported characterisation. 
 
32. 1-Mesityl-2-(4-methoxyphenyl)ethan-1-one: 
 
Pd loading 0.05 mol%. Yield 84%, 225 mg. 
1H NMR (500 MHz, CDCl3): δ 7.13 (d, J= 8.6 Hz, 2H), 6.87 (d, J= 8.6 Hz, 2H), 6.84 (s, 
2H), 3.95 (s, 2H), 3.80 (s, 3H), 2.29 (s, 3H), 2.14 (s, 6H). 
13C NMR (125 MHz, CDCl3): δ 207.9, 158.6, 139.1, 138.4, 132.7, 130.8, 128.4, 125.2, 113.9, 
55.2, 50.8, 21.0, 19.1. 
HRMS: Calculated for C18H20O2: 269.1542, Found: [M+H]+ 269.1536  
 
33. 2-(2,6-Dimethylphenyl)-1-phenylethan-1-one:3 
 
Pd loading 0.03 mol%. Yield 89%, 200 mg, colourless oil. 
1H NMR (500 MHz, CDCl3): δ 8.09 (d, J= 8.1 Hz, 2H), 7.62 (t, J= 7.4 Hz, 1H), 7.52 (t, J= 
7.2 Hz, 2H), 7.14-7.06 (m, 3H), 4.39 (s, 2H), 2.23 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 196.9, 137.1, 137.0, 133.2, 132.4, 128.7, 128.1, 128.0, 126.9, 
39.6, 20.4. 
Analytical data matches previously reported characterisation. 
 
34. 2-(2,6-Dimethylphenyl)-1-(4-methoxyphenyl)ethan-1-one:3 
 
Pd loading 0.02 mol%. Yield 87%, 222 mg, white solid. 
1H NMR (400 MHz, CDCl3): δ 8.09-8.04 (m, 2H), 7.12-7.04 (m, 3H), 7.00-6.96 (m, 2H), 
4.33 (s, 2H), 3.90 (s, 3H), 2.22 (s, 6H).  
13C NMR (100 MHz, CDCl3): δ 195.5, 163.6, 137.0, 132.9, 130.4, 130.2, 128.0, 126.8, 113.9, 
55.5, 39.3, 20.5. 
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Analytical data matches previously reported characterisation. 
 
35. 2-(2,6-Dimethylphenyl)-1-(3-methoxyphenyl)ethanone:5 
 
Pd loading 0.05 mol%. Yield 92%, yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.71 (d, J=7.6 Hz, 1H), 7.60 (br s, 1H), 7.45 (t, J=7.9 Hz, 
1H), 7.17 (dd, J=8.2 Hz, J= 2.2 Hz), 7.15-7.12 (m, 1H), 7.10-7.08 (m, 2H), 4.38 (s, 2H), 3.89 
(s, 3H), 2.24 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 196.7, 159.8, 138.4, 136.9, 132.4, 129.6, 127.9, 126.9, 120.6, 
119.5, 112.4, 55.4, 21.0, 39.7, 20.3. 
Analytical data matches previously reported characterisation. 
 
36. 1,2-Di-(2-methylphenyl)ethanone:6 
 
Pd loading 0.05 mol%. Yield 98%, 221 mg, colourless oil. 
1H NMR (500 MHz, CDCl3): δ 7.74 (d, J= 7.5 Hz, 1H), 7.39 (dt, J1= 7.5 Hz, J2 = 1Hz, 1H), 
7.29-7.24 (m, 2H), 7.21-7.11 (m, 4H), 4.24 (s, 2H), 2.46 (s, 3H), 2.27 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 201.3, 138.3, 137.8, 136.8, 133.3, 132.0, 131.3, 130.5, 130.3, 
128.4, 127.2, 126.1, 125.6, 46.4 21.2, 19.8. 
Analytical data matches previously reported characterisation. 
 
37. 1-(6-Methoxynaphthalen-2-yl)-2-(p-tolyl)ethan-1-one: 
 
Pd loading 0.05 mol%. Yield 87%, 254 mg. 
1H NMR (400 MHz, CDCl3): δ 8.47 (d, J= 1.5 Hz, 1H), 8.04 (dd, J= 8.6 Hz, J= 1.6 Hz, 1H), 
7.85 (d, J= 9.0 Hz, 1H), 7.76 (d, J= 8.7 Hz, 1H), 7.22-7.18 (m, 3H), 7.15-7.12 (m, 3H), 4.35 
(s, 2H), 3.95 (s, 3H), 2.32 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 197.8, 159.9, 137.4, 136.6, 132.2, 131.9, 131.3, 130.4, 129.5, 
129.4, 128.0, 127.3, 125.2, 119.8, 105.9, 55.6, 45.2, 21.2. 
HRMS: Calculated for C20H18O2: 291.1385, Found: [M+H]+ = 291.1382 
 
38. 2-(2-Methoxyphenyl)-1-phenylpropan-1-one:3 
 
Pd loading 0.03 mol%. Yield 91%, 218 mg, yellow oil. 
When performed in air, yield 75%, 179 mg. 
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1H NMR (500 MHz, CDCl3): δ 7.99-7.94 (m, 2H), 7.47-7.42 (m, 1H), 7.37-7.34 (m, 2H), 
7.18 (td, J= 8Hz, J= 1.7 Hz, 1H), 7.12 (dd, J= 8Hz, J= 1.6 Hz, 1H), 6.88 (d, J= 7.8Hz, 2H), 
5.09 (q, J= 6.8Hz, 1H), 3.88 (s, 3H), 1.47 (d, J= 7.8Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 201.3, 155.7, 136.4, 132.5, 130.1, 128.4, 128.2, 128.0, 127.9, 
120.9, 110.7, 55.4, 40.3, 17.5. 
Analytical data matches previously reported characterisation. 
 
39. 2-(4-Methoxyphenyl)-1-phenylpropan-1-one:3 
 
Pd loading 0.03 mol%. Yield 97%, 233 mg, yellow solid. 
1H NMR (500 MHz, CDCl3): δ 7.97-7.94 (m, 2H), 7.49-7.45 (m, 1H), 7.40-7.36 (m, 2H), 
7.22-7.19 (m, 2H), 6.85-6.82 (m, 2H), 4.65 (q, J= 6.8Hz, 1H), 3.88 (s, 3H), 1.51 (d, J= 7.8Hz, 
3H). 
13C NMR (125 MHz, CDCl3): δ 200.5, 158.4, 136.6, 133.4, 132.7 , 128.7, 128.7, 128.4, 114.3, 
55.2, 46.9, 19.5. 
Analytical data matches previously reported characterisation. 
 
40. 1-(6-Methylpyridin-3-yl)-2-(p-tolyl)ethan-1-one: 
 
Pd loading 0.05 mol%. Yield 80%, 180 mg, brown oil. 
1H NMR (400 MHz, CDCl3): δ 9.10 (d, J= 2.0 Hz, 1H), 8.13 (dd, J= 8.1 Hz, J= 2.3 Hz, 1H), 
7.22 (d, J= 8.1 Hz, 1H), 7.16-7.10 (m, 4H), 4.21 (s, 2H), 2.60 (s, 3H), 2.30 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 196.5, 163.3, 149.9, 136.8, 136.3, 130.8, 129.6, 129.4, 129.3, 
123.4, 45.5, 24.9, 21.1. 
HRMS: Calculated for C15H15NO: 226.1231, Found: [M+H]+ = 226.1225 
 
41. 1-Phenyl-2-(thiophen-3-yl)propan-1-one: 7 
 
Pd loading 0.05 mol%. Yield 84%, 182 mg, brown oil. 
1H NMR (400 MHz, CDCl3): δ 7.88-7.85 (m, 2H), 7.42-7.35 (m, 1H), 7.33-7.26 (m, 2H), 
7.13 (dd, J= 4.9 Hz, J= 2.9 Hz, 1H), 6.99 -6.96 (m, 1H), 6.91 (dd, J= 5.0 Hz, J= 1.4 Hz, 1H), 
4.74 (q, J= 6.9 Hz, 1H), 1.43 (d, J= 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 200.0, 141.3, 136.2, 132.8, 128.6, 128.4, 127.0, 126.0, 121.3, 
42.7, 18.8. 
Analytical data matches previously reported characterisation. 
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42. 1-Phenyl-2-(pyridin-3-yl)propan-1-one:3 
 
Pd loading 0.05 mol%. Yield 96%, 202 mg, brown oil. 
1H NMR (400 MHz, CDCl3): δ 8.60 (d, J= 2.0 Hz, 1H), 8.46 (dd, J= 4.8 Hz, J= 1.6 Hz, 1H), 
7.96-7.93 (m, 2H), 7.60 (dt, J= 7.9 Hz, J= 1.9 Hz, 1H), 7.54-7.49 (m, 1H), 7.43-7.38 (m, 2H), 
4.74 (q, J= 6.9 Hz, 1H), 1.56 (d, J= 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 199.7, 149.6, 148.5, 137.0, 136.0, 135.2, 133.4, 128.8, 128.8, 
123.9, 45.0, 19.5. 
Analytical data matches previously reported characterisation. 
 
43. 1-Phenyl-2-(4-(trifluoromethyl)phenyl)propan-1-one:3 
 
Pd loading 0.05 mol%. Yield 81%, 225 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 7.95-7.92 (m, 2H), 7.56 (d, J= 8.1 Hz, 1H), 7.54-7.49 (m, 
1H), 7.44-7.38 (m, 4H), 4.77 (q, J= 6.9 Hz, 1H), 1.56 (d, J= 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 199.8, 145.5, 136.2, 133.3, 129.2 (q, JCF= 32.5 Hz), 128.9, 
128.8, 128.3, 126.1 (q, JCF= 3.7 Hz), 124.1 (q, JCF= 271.9 Hz), 47.6, 19.6. 
19F NMR (377 MHz, CDCl3): δ -62.5 
Analytical data matches previously reported characterisation. 
 
44. 2-(3-(Dimethylamino)phenyl)-1-phenylpropan-1-one: 
 
Pd loading 0.05 mol%. Yield 85%, 215 mg, green solid. 
1H NMR (400 MHz, CDCl3): δ 7.98-7.95 (m, 2H), 7.48-7.43 (m, 1H), 7.39-7.34 (m, 1H), 
7.16 (t, J= 7.9 Hz, 1H), 6.64 (d, J= 7.6 Hz, 1H), 6.61-6.55 (m, 2H), 4.61 (q, J= 6.8 Hz, 1H), 
2.91 (s, 6H), 1.53 (d, J= 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 200.5, 151.0, 142.4, 136.7, 132.6, 129.6, 128.7, 128.4, 116.1, 
111.5, 111.0, 48.5, 40.5, 19.5. 
HRMS: Calculated for C17H19NO: 254.1445, Found: [M+H]+ = 254.1541 
 
45. 2-(Benzo[d][1,3]dioxol-5-yl)-1-phenylethan-1-one:4 
 
Pd loading 0.02 mol%. Yield 84%, 203 mg, yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.02-7.99 (m, 2H), 7.59-7.54 (m, 1H), 7.49-7.43 (m, 2H), 
6.78-6.69 (m, 3H), 5.93 (s, 2H), 4.20 (s, 2H). 
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13C NMR (100 MHz, CDCl3): δ 197.8, 148.0, 146.7, 136.7, 133.3, 128.8, 128.7, 128.2, 122.7, 
110.0, 108.6, 101.1, 45.2. 
Analytical data matches previously reported characterisation. 
 
46. 2-(4-(Methylsulfonyl)phenyl)-1-phenylpropan-1-one: 
 
Pd loading 0.05 mol%. Yield 70%, 203 mg, white solid. 
1H NMR (400 MHz, CDCl3): δ 7.93 (d, J= 7.4 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.55-7.48 
(m, 3H), 7.41 (t, J= 7.7 Hz, 2H), 4.81 (q, J= 6.9 Hz, 1H), 3.01 (s, 3H), 1.56 (d, J= 6.9 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ 199.4, 147.7, 139.2, 136.0, 133.5, 129.0, 128.9, 128.8, 128.1, 
47.5, 44.6, 19.5. 
HRMS: Calculated for C16H16O3S: 306.1164, Found: [M+NH4]+ = 306.1161 
 
47. 2-(4-Benzoylphenyl)-1-phenylpropan-1-one:8 
 
Pd loading 0.05 mol%. Yield 81%, 225 mg, yellow solid. 
1H NMR (400 MHz, CDCl3): δ 7.98-7.94 (m, 2H), 7.77-7.73 (m, 4H), 7.60-7.55 (m, 1H), 
7.54-7.49 (m, 1H), 7.48-7.39 (m, 6H), 4.79 (q, J= 6.9 Hz, 1H), 1.58 (d, J= 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 199.8, 196.3, 137.7, 136.4, 133.2, 132.5, 131.0, 130.1, 128.9, 
128.8, 128.4, 127.9, 47.9, 19.5. 
Analytical data matches previously reported characterisation. 
 
48. 1-(4-(Dimethylamino)phenyl)-2-(2,6-dimethylphenyl)ethan-1-one: 
 
Pd loading 0.05%. Yield 78%, 208 mg, green solid. 
1H NMR (400 MHz, CDCl3): δ 8.03-7.99 (m, 2H), 7.12-7.04 (m, 3H), 6.72-6.68 (m, 2H), 
4.30 (s, 2H), 3.08 (s, 6H), 2.24 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 194.8, 153.4, 137.0, 133.4, 130.2, 127.8, 126.5, 125.1, 110.6, 
40.0, 38.8, 20.4. 
HRMS: Calculated for C18H21NO: 268.1701, Found: [M+H]+ = 268.1695 
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55. 6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one:9 
 
Pd loading 0.05%. Yield 93%, 235 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.08 (d, J= 8.7 Hz, 1H), 7.37-7.31 (m, 2H), 7.28-7.23 (m, 
1H), 7.20-7.17 (m, 3H), 3.88 (s, 3H), 3.79-3.74 (m, 1H), 3.09-2.95 (m, 2H), 2.44-2.38 (m, 
2H). 
13C NMR (100 MHz, CDCl3): δ 197.1, 163.7, 146.7, 140.2, 130.4, 128.6, 128.5, 127.0, 126.7, 
113.4, 112.7, 55.6, 54.2, 31.5, 29.1. 
Analytical data matches previously reported characterisation. 
7.3 Experimental details for Chapter 3 
Synthesis od [Pd(IPr*)(cinnamyl)Cl] 42 
In a glovebox, in a 500 mL round bottom flask equipped with a magnetic stirring bar 
were charged IPr*·HCl (2.08 g, 2.2 mmol) and KOtBu (0.28 g, 2.4 mmol) along with 
THF (160 mL). The reaction mixture was stirred at room temperature for 4 h and then 
[{Pd(cinnamyl)(m-Cl)}2] (0.512 g, 1 mmol) was added as a THF (40 mL) solution. The 
reaction mixture was then stirred overnight at room temperature. After this time, the 
reaction flask was taken outside the glovebox where THF was evaporated under 
reduced pressure, the crude product was dissolved in CH2Cl2, filtered on a pad of silica 
covered with celite, and eluted with CH2Cl2. After evaporation of the solvents, the 
complex was precipitated from pentane, and the solid collected by filtration. After 
drying under high vacuum for 1 hr, the analytically pure complex was obtained as an 
off-white powder (2.23 g, 95 %). 
Synthesis of imines 33-57 and 73-77. 
METHOD A: The ketone (2.0 mmol, 1.0 equivalents), the 2-chloroaniline (2.4 mmol, 1.2 
equivalents) NaHCO3 (840 mg, 10 mmol, 5 equivalents), and activated molecular sieves 
along with 8 mL toluene were charged in a 50 mL Schlenk flask under anhydrous 
conditions. The reaction was then stirred for 16 hours at 90°C. After this time the 
mixture was filtered though celite, the solvent and the excess aniline were evaporated 
under reduced pressure. The imine was used without further purification. 
METHOD B: The ketone (2.0 mmol, 1.0 equivalents), the 2-chloroaniline (2.4 mmol, 1.2 
equivalents) p-toluene-sulphonic acid monohydrate (38 mg, 0.2 mmol, 10%) and 
activated molecular were charged along with 10 mL toluene into a 50 mL Schlenk flask 
under anhydrous conditions. The reaction was then stirred for 16 hours at 110°C. After 
this time the mixture was quenched with sodium carbonate, filtered though celite, the 
solvent and the excess aniline were evaporated under reduced pressure. The imine was 
used without further purification. 
O
MeO
  
144 
LARGE SCALE SYNTHESIS OF 49: A flame-dried 100 mL round bottom flask, 
equipped with a stirring bar and a condenser, was loaded with 30 g of activated 3Å 
molecular sieves, 21.2 mL of 3-pentanone (17. 3 g, 0.2 mol, 10 equivalents) and 2.1 mL 
of 2-chloroaniline (2.51 g, 20 mmol). The mixture was heated to reflux for 48 hours, 
then allowed to cool down and filtered through MgSO4 washing with EtOAc, then the 
excess of pentanone was evaporated at the rotavapor and the traces of 2-chloroaniline 
removed leaving the mixture at the pump for two days at 35 °C under stirring. The 
desired product was obtained as a yellow liquid (2.5 g, 64%) 
Optimized protocol for the cyclization of imines to indoles. 
Method Cy-A: The precatalysts 42 [Pd(IPr*)(cinnamyl)Cl] (1.5 mg, 0.5 mol%), the imine 
(0.25 mmol, 1 equivalents) and NaOtBu (26.4 mg, 0.28 mmol, 1.1 equiv) were weighted 
in a screw-cap vial equipped with a magnetic stirring bar. The vial was closed with a 
septum cap and purged by 3 vacuum/nitrogen cycles. Dry dioxane (2 mL) was added 
by syringe, and the reaction was then stirred at 110°C for 4 hr. The vessel was then 
allowed to cool to rt and the reaction was quenched with 3 drops of water, the organic 
phase was filtered through magnesium sulfate washing with ethyl acetate. The two 
reaction duplicates were purified together via flash chromatography to afford the pure 
product. 
Method Cy-B: The precatalysts 42 [Pd(IPr*)(cinnamyl)Cl] (1.6 mg, 0.5 mol%), the imine 
(0.25 mmol, 1 equivalents) and NaOtBu (26.4 mg, 0.28 mmol, 1.1 equiv) were weighted 
in a screw-cap vial equipped with a magnetic stirring bar. The vial was closed with a 
septum cap and purged by 3 vacuum/nitrogen cycles. Dry dioxane (2 mL) was added 
by syringe, and the reaction was then stirred at 110°C for 16 hr. The vessel was then 
allowed to cool to rt and the reaction was quenched with 3 drops of water, the organic 
phase was filtered through magnesium sulfate, washing with ethyl acetate. The two 
reactions duplicate were purified together via flash chromatography to afford the 
desired product. 
Method Cy-C: The precatalysts 42 [Pd(IPr*)(cinnamyl)Cl] (5.9 mg, 2.0 mol%), the imine 
(0.25 mmol, 1 equivalents) and NaOtBu (26.4 mg, 0.28 mmol, 1.1 equiv) were weighted 
in a screw-cap vial equipped with a magnetic stirring bar. The vial was closed with a 
septum cap and purged by 3 vacuum/nitrogen cycles. Dry dioxane (2 mL) was added 
by syringe, and the reaction was then stirred at 110°C for 24 hours. The vessel was then 
allowed to cool to rt and the reaction was quenched with 3 drops of water, the organic 
phase was filtered through magnesium sulfate, washing with ethyl acetate. The two 
reactions duplicate were purified together via flash chromatography to afford the 
desired product. 
Large scale cyclisation: A flame dried 250 mL Schlenk flask equipped with a stirring 
bar was loaded with NaOtBu (1.15 g, 12 mmol, 1.2 equivalents), filled with argon and 
then 60 mL of dry, degassed dioxane were added. The imine (1.95 g, 10 mmol) was 
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weighted in a vial and added with a syringe, washing both vial and syringe with 
dioxane (2x5 mL). 42 [Pd(IPr*)(cinnamyl)Cl] (55 mg, 0.5 mol%) was dissolved in 5 mL 
of dioxane and added to the reaciton mixture with a syringe, washing with 5 mL 
dioxane. The flask was then immerged in a pre-heated oil bath at 110°C, stirring at 300 
rpm for 24 hours. The reactor was then cooled down and the reaction was quenched 
with 20 mL of water and extracted with diethyl ether (4 x 20 mL). The combined 
organic layers where dried over MgSO4, filtered and evaporated under vacuum. The 
crude was left unde rhigh vacuum for two hours, after which NMR analysis showed 
the pure product (>95 %). Isolated yield 1.31 g, 83%. 
Characterisation data. 
42. [Pd(IPr*)(cinnamyl)Cl] 
1H NMR (400 MHz, CD2Cl2): δ 7.48-7.18 (m, 25H), 7.14-7.07 (m, 12H), 6.90 (s, 4H), 6.87-
6.77 (m, 8H), 5.91 (s, 2H), 5.78 (s, 2H), 5.26 (s, 2H), 5.05-4.94 (m, 1H), 4.50 (d, J = 13.4 Hz, 
1H), 2.56 (d, J = 8.4 Hz, 1H), 2.25 (s, 6H), 1.16 (d, J = 12.6 Hz, 1H).  
13C NMR (100 MHz, CDCl3): δ 182.6, 144.6, 143.8, 141.4. 140.6, 138.4, 137.8, 135.9, 130.6 , 
130.3, 129.3, 128.7, 128.4, 128.2, 127.7, 127.2, 126.5, 126.4, 123.5, 109.0, 91.3, 51.5, 47.4, 
22.0.  
Anal. Calcd. for C78H65ClN2Pd: C, 79.92; H, 5.59; N, 2.39. Found: C, 80.09; H, 5.46; N, 
2.29.  
 
33. N-(2-Chlorophenyl)-1-phenylpropan-1-imine: 
 
Method A. Yield 61 %, 302 mg, brown oil. 
1H NMR (400 MHz, CDCl3): δ. 7.99 (m, 2H), 7.52-7.45 (m, 3H9, 7.43 (d,d, J= 8.0, 1.2 Hz, 
1H), 7.25 (td, J= 7.6, 1.2 Hz, 1 H), 7.03 (td, J= 8.0, 1.6 Hz, 1 H), 6.83 (dd, J= 8.0, 1.6 Hz, 
1H), 2.63 (q, J= 7.6 Hz, 2H), 1.08 (t, J= 7.6 Hz, 3H) 
 
48. N-(2-Chlorophenyl)-1-phenylethan-1-imine: 
 
Method A. Yield 77%, 353 mg, brown oil. 
1H NMR (400 MHz, CDCl3): δ. 8.05-8.01 (m, 2H), 7.51-7.47 (m, 3H), 7.43 (dd, J= 8.0, 1.2 
Hz, 1H), 7.26 (dd, J= 7.6, 1.2 Hz, 1H), 6.84 (dd, J= 7.6, 1.2 Hz, 1H),, 2.22 (s, 3H). 
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49. N-(2-Chlorophenyl)pentan-3-imine: 
 
Method A. Yield 69%, 272 mg, yellow liquid. 
1H NMR (500 MHz, CDCl3): δ 7.34 (dd, J= 8.0, 1.4 Hz, 1H), 7.17 (td, J= 7.6, 1.4 Hz, 1H), 
6.96 (td, J= 8.0, 7.4, 1.6 Hz, 1H), 6.71 (dd, J= 7.9, 1.6 Hz, 1H), 2.50 (q, J= 7.4 Hz, 2H), 2.09 
(q, J= 7.7 Hz, 2H), 1.08-1.02 (m, 6H). 
 
50. N-(2-Chlorophenyl)cyclohexanimine: 
 
Method A. Yield 65%, 270 mgrown oil, b. 
1H NMR (500 MHz, CDCl3): δ 7.34 (dd, J= 8.0, 1.4 Hz, 1H), 7.17 (td, J= 7.6, 1.4 Hz, 1H), 
6.97 (ddd, J= 8.0, 7.4, 1.6 Hz, 1H), 6.74 (dd, J= 7.8, 1.6 Hz, 1H), 2.55-2.49 (m, 2H), 2.11-
2.04 (m, 2H), 1.92-1.82 (m, 2H), 1.67 (p, J= 3.1 Hz, 4H). 
 
51. N-(2-Chlorophenyl)-1-(naphthalen-2-yl)ethan-1-imine: 
 
Method A. Yield 76%, 425 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.44-8.37 (m, 1H), 8.26 (dd, J= 8.7, 1.8 Hz, 1H), 8.00-7.85 
(m, 3H), 7.61-7.50 (m, 2H), 7.45 (dd, J= 8.0, 1.4 Hz, 1H), 7.32-7.24 (m, 1H), 7.05 (dt, J= 8.1, 
7.4, 1.6 Hz, 1H), 6.87 (dd, J= 7.9, 1.6 Hz, 1H), 2.33 (s, 3H). 
 
52. N-(2-Chlorophenyl)-1-(naphthalen-1-yl)ethan-1-imine: 
 
Method B. Yield 69%, 390 mg, pale brown solid. 
1H NMR (400 MHz, CDCl3): δ. 8.6 (d, J=8.8 Hz, 1H), 7.92 (m, 2H), 7.71 (d, J= 8.8 Hz, 1H), 
7.61 (td, J= 6.8, 1.2 HZ, 1H), 7.57 (t, J= 8.0 HZ, 2H), 7.50 (dd, J= 8.0, 0.9 HZ, 1H), 7.32 (dd, 
J= 7.6, 1.2 Hz, 1H), 7.09 (ddd, J= 8, 7.5, 1.6 Hz, 1H), 7.00 (dd, J= 7.8, 1.5 Hz, 1H), 2.36 (s, 
3H). 
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53. N-(2-Chloro-4-fluorophenyl)-1-(147aphthalene-2-yl)ethan-1-imine: 
 
Method A. Yield 58%, 345 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.43-8.34 (m, 1H), 8.23 (dd, J= 8.6, 1.8 Hz, 1H), 8.01-7.83 
(m, 3H), 7.63-7.50 (m, 2H), 7.21 (dd, J= 8.4, 2.7 Hz, 1H), 7.02 (ddd, J= 8.7, 8.0, 2.8 Hz, 
1H), 6.82 (dd, J= 8.8, 5.6 Hz, 1H), 2.33 (s, 3H). 
 
54. N-(2-Chloro-4-fluorophenyl)-1-(naphthalen-1-yl)ethan-1-imine: 
 
Method B. Yield 56%, 388 mg, pale brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.53 (d, J = 8.4 Hz, 1H), 7.92 (t, J = 7.0 Hz, 2H), 7.81 (dd, J 
= 12.2, 8.1 Hz, 1H), 7.68 (dd, J = 7.1, 1.2 Hz, 1H), 7.59 (ddd, J = 8.5, 6.9, 1.6 Hz, 1H), 7.26 
(dd, J=8.4, 2.8 Hz, 1H) 7.05 (ddd, J = 8.7, 8.0, 2.7 Hz, 1H), 6.97-6.93 (m, 1H), 6.48-6.37 (m, 
1H), 2.32 (s, 3H). 
 
55. N-(2-Chlorophenyl)-6-methoxy-3,4-dihydronaphthalen-1(2H)-imine: 
 
Method B. Yield 70%, 402 mg, brown solid. 
1H NMR (500 MHz, CDCl3): δ 8.32 (d, J= 8.8 Hz, 1H), 7.39 (dd, J= 8.0, 1.4 Hz, 1H), 7.22 
(td, J= 7.6, 1.4 Hz, 1H), 6.99 (ddd, J = 8.1, 7.4, 1.6 Hz, 1H), 6.86 (dd, J= 8.8, 2.7 Hz, 1H), 
6.81 (dd, J= 7.9, 1.6 Hz, 1H), 6.70 (d, J= 2.5 Hz, 1H), 3.86 (s, 3H), 2.88 (t, J= 6.1 Hz, 2H), 
2.45-2.35 (m, 2H), 1.99-1.88 (m, 2H). 
 
56. 4-(1-((2-Chlorophenyl)imino)ethyl)benzonitrile: 
 
Method A. Yield 69%, 354 mg, yellow solid. 
1H NMR (400 MHz, CDCl3): δ 8.16-8.08 (m, 2H), 7.79-7.73 (m, 2H), 7.43 (dd, J= 8.0, 1.3 
Hz, 1H), 7.27 (m, 1H), 7.07 (ddd, J= 8.0, 7.4, 1.6 Hz, 1H), 6.80 (dd, J= 7.9, 1.5 Hz, 1H), 
2.22 (s, 3H). 
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57. 2-Chloro-5-methoxy-N-(1-phenylethylidene)aniline: 
 
Method B. Yield 70%, 362 mg, yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.03-7.98 (m, 2H), 7.51-7.43 (m, 3H), 7.29 (d, J= 8.0 Hz, 
1H), 6.60 (dd, J= 8.8, 3.0 Hz, 1H), 3.79 (S, 3H), 2.22 (s, 3H). 
 
73. 2-Chloro-N-(1-(naphthalen-2-yl)ethylidene)pyridin-3-amine: 
 
Method B. Yield 55%, 341 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 11.94-11.99 (s. 1H), 8.47-8.51 (S,1H), 8.33-8.37 (dd, J= 
4.8Hz, 1.6Hz 1H), 8.07-8.13 (dd, J= 8.8, 2.0Hz 1H), 7.93-8.06(m, 3H), 7.77-7.83 (m, 2H), 
7.52-7.62 (m, 2H), 7.22-7.25(m, 1H), 7.10-7.16 (m, 1H). 
 
74. 2-Chloro-N-(1-phenylpropylidene)pyridine-3-amine: 
 
Method A. Yield 66%, 323 mg, brown oil. 
1H NMR (400 MHz, CDCl3): δ 8.14-8.13 (m, 1H), 7.96 (d, J= 6.8 Hz, 2H), 7.49 (m, 3H), 
7.23 (m, 1H), 7.14 (m, 1H), 2.61 (q, J= 7.6 Hz, 2H), 1.08 (t, J= 7.6 Hz, 3H). 
 
75. 2-Chloro-N-(1-(3-methoxyphenyl)ethylidene)pyridin-3-amine: 
 
Method B. Yield 77%, 477 mg, yellow solid. 
1H NMR (500 MHz, CDCl3): δ 8.16-8.19 (dd, J= 4.5, 2Hz, 1H), 7.60-7.65 (m, 1H), 7.53-
7.57 (m, 1H), 7.38-7.43 (t, J= 8Hz, 1H), 7.24-7.30 (m, 1H), 7.16-7.21 (dd, J=7.5, 1.5Hz, 1H), 
7.06-7.11 (m , 1H), ), 3.90 (s, 3H), 2.23 (s, 3H). 
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76. 4-Chloro-N-(1-(naphthalen-2-yl)ethylidene)pyridin-3-amine: 
 
Method B. Yield 45%, 268 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.40-8.45 (s, 1H), 8.17-8.33 (m, 3H), 7.88-8.02 (m, 3H), 
7.54-7.63 (m, 2H), 7.40-7.45 (d, 5.2Hz, 1H), 2.37-2.41 (S, 3H). 
 
77. 2-Chloro-6-methoxy-N-(1-phenylpropylidene)pyridin-3-amine: 
 
Method B. Yield 52%, 286 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 7.95-7.99 (m, 2H), 7.46-7.53 (m, 3H), 7.11-7.15 (d, 8.4Hz, 
1H), 6.71-6.76 (d, 8.4Hz, 1H), 3.95-4.00 (s, 3H), 2.60-2.69 (q, 7.6Hz, 2H), 1.05-1.13 (t, 
7.6Hz, 3H). 
 
34. 3-Methyl-2-phenyl-1H-indole:10 
 
Method Cy-A. Yield 91%, 94 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ. 8.01 (bs, 1H), 7.65-7.57 (m, 3H), 7.49 (t, J= 7.7 Hz, 2H), 
7.40-5.33 (m, 2H), 7.22 (ddf, J= 8.1, 7.1, 1.3 Hz, 1H), 7.16 (1H, ddd, J= 8.1, 7.5, 1.1 Hz), 
2.48 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 135.8, 134.0, 133.3, 130.0, 128.8, 127.7, 127.3, 122.3, 119.5, 
118.9, 110.6, 108.7, 9.6. 
Analytical data matches previously reported characterisation. 
 
60. 2-Phenyl-1H-indole:10 
 
Method Cy-A. Yield 86%, 83 mg, brown solid. 
1H NMR (500 MHz, CDCl3): δ 8.33 (s, 1H), 7.67 (ddd, J= 8.1, 7.2, 1.3 Hz, 3H), 7.46 (t, J= 
7.7 Hz, 2H), 7.41 (dd, J= 8.1, 1.0 Hz, 1H), 7.37-7.32 (m, 1H), 7.25-7.20 (m, 1H), 7.19-7.11 
(m, 1H), 6.85 (dd, J= 2.2, 0.9 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ 137.9, 136.8, 132.4, 129.3, 129.1, 127.8, 125.2, 122.4, 120.7, 
120.3, 110.9, 100.0. 
Analytical data matches previously reported characterisation. 
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61. 2-Ethyl-3-methyl-1H-indole:11 
 
Method Cy-B. Yield 80%, 64 mg, brown oil. 
1H NMR (500 MHz, CDCl3): δ 7.68 (s, 1H), 7.52 (ddd, J= 7.4, 1.8, 0.8 Hz, 1H), 7.29 (dt, J= 
8.0, 0.9 Hz, 1H), 7.18-7.08 (m, 2H), 2.77 (q, J= 7.6 Hz, 2H), 2.27 (s, 3H), 1.29 (t, J= 7.6 Hz, 
3H). 
13C NMR (125 MHz, CDCl3): δ 136.5, 135.1, 129.4, 120.9, 119.0, 118.1, 110.0, 106.2, 19.4, 
14.1, 8.4. 
Analytical data matches previously reported characterisation. 
 
62. 2,3,4,9-Tetrahydro-1H-carbazole:11 
 
Method Cy-C. Yield 82%, 70 mg, brown solid. 
1H NMR (500 MHz, CDCl3): δ 7.66 (s, 1H), 7.52-7.47 (m, 1H), 7.27 (d, J= 8.0 Hz, 1H), 7.12 
(m, 2H), 2.74 (q, J= 6.3 Hz, 4H), 2.00-1.85 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ 135.6, 134.1, 127.8, 121.0, 119.1, 117.7, 110.3, 110.2, 23.3, 
23.3, 23.2, 20.9. 
Analytical data matches previously reported characterisation. 
 
63. 2-(Naphthalen-2-yl)-1H-indole:12 
 
Method Cy-B. Yield 84%, 102 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.48 (s, 1H), 8.06 (d, J= 1.7 Hz, 1H), 7.95-7.80 (m, 4H), 
7.71-7.63 (m, 1H), 7.57-7.41 (m, 3H), 7.23 (ddd, J= 8.2, 7.1, 1.2 Hz, 1H), 7.15 (ddd, J= 8.0, 
7.1, 1.1 Hz, 1H), 6.99-6.93 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ 137.9, 137.0, 133.6, 132.9, 129.7, 129.4, 128.8, 128.0, 127.8, 
126.7, 126.2, 123.8, 123.1, 122.6, 120.8, 120.4, 110.9, 100.7. 
Analytical data matches previously reported characterisation. 
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64. 2-(Naphthalen-1-yl)-1H-indole:12 
 
Method Cy-A. Yield 80%, 97 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.38-8.17 (m, 2H), 7.98-7.86 (m, 2H), 7.73 (m, 1H), 7.65 
(dd, J= 7.1, 1.3 Hz, 1H), 7.60-7.49 (m, 3H), 7.45 (m, 1H), 7.31-7.17 (m, 2H), 6.82 (dd, J= 
2.1, 0.9 Hz, 1H). 
13C NMR (400 MHz, CDCl3): δ 136.7, 136.4, 134.0, 131.6, 131.1, 128.9, 128.6, 128.5, 127.2, 
126.7, 126.2, 125.7, 125.4, 122.2, 120.7, 120.2, 110.9, 103.7. 
Analytical data matches previously reported characterisation. 
 
65. 4-(1H-Indol-2-yl)benzonitrile:13 
 
Method Cy-C. Yield 52%, 57 mg, yellow solid. 
1H NMR (500 MHz, CDCl3): δ 8.51 (s, 1H), 7.72 (q, J= 8.4 Hz, 4H), 7.66 (dd, J= 8.0, 1.0 
Hz, 1H), 7.43 (dq, J= 8.2, 0.9 Hz, 1H), 7.29-7.23 (m, 1H), 7.16 (ddd, J= 8.0, 7.1, 1.0 Hz, 
1H), 6.96 (dd, J= 2.2, 0.9 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ 137.4, 136.6, 135.5, 132.9 (X2), 128.9, 125.3 (X2), 123.7, 
121.4, 120.8, 118.9 (X2), 111.3, 110.5, 102.6. 
Analytical data matches previously reported characterisation. 
 
66. 5-Fluoro-2-(naphthalen-2-yl)-1H-indole:14 
 
Method Cy-C. Yield 84%, 110 mg, brown solid. 
1H NMR (500 MHz, CDCl3): δ 8.47 (s, 1H), 8.05 (d, J= 1.7 Hz, 1H), 7.93-7.83 (m, 3H), 7.80 
(dd, J= 8.5, 1.8 Hz, 1H), 7.51 (m, 2H), 7.32 (m, 2H), 6.96 (td, J= 9.0, 2.5 Hz, 1H), 6.91 (dd, 
J= 2.1, 0.9 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 159.4, 157.1, 139.6, 133.5 (X2), 133.0, 12945, 128.9, 128.0, 
127.8, 126.8, 126.3, 123.7, 123.3, 111.5 (d, J= 9.7 Hz), 110.8 (d, J= 26.3 Hz), 105.5 (d, J= 23.5 
Hz), 100.7 (d, J= 4.7 Hz). 
19F NMR (376.6 MHz, CDCl3): δ -124.07. 
Analytical data matches previously reported characterisation. 
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67. 5-Fluoro-2-(naphthalen-1-yl)-1H-indole: 
 
Method Cy-C. Yield 9%,118 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.24-8.34(m, 2H), 7.91-7.99(m, 2H), 7.62-7.66(dd, 1H 
7.8hz & 1.8hz), 7.56-7.61(m, 3H), 7.33-7.42(m, 2H), 7.00-7.07 (m, 2H), 6.78-6.8 (dd 2.4hz 
& 1.2hz , 1H) 
13C NMR (125 MHz, CDCl3): δ 159.1, 157.2 , 138.5 , 133.9 , 132.9 , 131.4 , 130.7 , 129.2 (d, 
Cq), 128.9 , 128.6 , 127.3 , 126.8 , 126.3 , 125.6 , 125.4 , 111.49 (d, 9.5hz, CH), 110.54 (d, J= 
28.7 Hz), 105.39 (d, J= 23.7Hz), 103.8 (d, J=5Hz). 
19F NMR (376.6 MHz, CDCl3): δ -118.90. 
HRMS–ESI (m/z): [M+H]+ calcd for [C18H13FN]+, 262.1027 ; found, 262.1029. 
Analytical data matches previously reported characterisation. 
 
68. 3-Methoxy-6,11-dihydro-5H-benzo[a]carbazole:15 
 
Method Cy-C. Yield 90%, 112 mg, brown solid. 
1H NMR (500 MHz, CDCl3): δ 8.13 (s, 1H), 7.54 (dd, J= 7.5, 1.4 Hz, 1H), 7.41-7.31 (m, 
1H), 7.24 (d, J= 8.3 Hz, 1H), 7.15 (m, 2H), 6.88 (d, J= 2.6 Hz, 1H), 6.79 (dd, J= 8.3, 2.6 Hz, 
1H), 3.84 (s, 3H), 3.05 (dd, J= 8.6, 6.5 Hz, 2H), 3.01-2.94 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ 158.6, 138.6, 136.8, 133.2, 127.6, 122.2, 121.8, 120.9, 119.82, 
118.4, 114.9, 111.3, 111.0, 110.8, 55.4, 30.0, 19.7. 
Analytical data matches previously reported characterisation. 
 
69. 6-Methoxy-2-phenyl-1H-indole:13 
 
Method Cy-C. Yield 72%, 80 mg, yellow solid. 
1H NMR (500 MHz, CDCl3): δ 8.25 (br s, 1H), 7.21 (d,J= 7.5 Hz, 2H), 7.50 (d,J= 8.5 Hz, 
1H), 7.44 (t,J= 7.5Hz, 2H),7.24–7.30(m, 1H), 6.90 (d, J= 2.2 Hz, 1H), 6.80 (dd,J= 6.5, 2.0 
Hz, 1H), 6.76 (d, J = 1.4 Hz, 1H), 3.87 (s, 3H) 
13C NMR (125 MHz, CDCl3): δ156.7, 137.6 (X2), 136.8, 132.5, 129.0, 127.2, 124.7 (X2), 
123.6, 121.3, 110.2, 99.8, 94.5, 55.7. 
Analytical data matches previously reported characterisation. 
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80. 2-(Naphthalen-2-yl)-1H-pyrrolo[3,2-b]pyridine: 
 
Method Cy-C. Yield 74%, 94 mg, brown solid. 
Method Cy-C afforded 90 mg, 74% of the desired product as a brown solid. 
1H NMR (400 MHz, CDCl3): 11.94-11.99 (s. 1H) 8.47-8.51 (S,1H), 8.33-8.37 (dd, 4.8Hz & 
1.6Hz 1H), 8.07-8.13 (dd,8.8Hz & 2.0Hz 1H), 7.93-8.06(m, 3H), 7.77-7.83 (m, 2H), 7.52-
7.62 (m, 2H), 7.22-7.25(m, 1H), 7.10-7.16 (m, 1H). 
13C NMR (125 MHz, CDCl3): δ 147.4 , 143.5, 141.3, 133.6 , 133.1 , 130.8, 129.6, 129,2, 
128.5, 128.2, 127.4 , 126.9 , 124.4 , 124.5 , 118.5 , 117.5 , 100.5. 
HRMS–ESI (m/z): [M+H]+ calcd for [C17H13N2]+, 245.1073 ; found, 245.1073. 
 
81. 3-Methyl-2-phenyl-1H-pyrrolo[3,2-b]pyridine:16 
 
Method Cy-B Yield 80%, 83 mg, brown solid. 
1H NMR (400 MHz, CD3OD3): δ 8.27 (dd, J= 4.8, 1.2 Hz, 1H), 7.76 (dd, J= 8.0, 1.2 Hz, 
1H), 7.71-7.65 (m, 2H), 7.50 (t, J= 7.6 Hz, 2H), 7.39 (t, J= 7.6 Hz, 1H), 7.14 (dd, J= 8.0, 4.8 
Hz, 1H), 2.50 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 147.3, 142.4, 140.0, 134.0, 131.2, 129.8, 129.1, 119.9, 117.7, 
108.4, 19.0. 
Analytical data matches previously reported characterisation. 
 
82. 3-Methyl-2-phenyl-1H-pyrrolo[3,2-b]pyridine: 
 
Method Cy-C. Yield 87%, 97 mg, off-white solid. 
1H NMR (500 MHz, CDCl3): δ 8.16-8.19 (dd, 4.5hz & 2Hz, 1H ), 7.60-7.65 (m, 1H), 7.53-
7.57 (m, 1H), 7.38-7.43 (t, 8Hz, 1H), 7.24-7.30 (m, 1H), 7.16-7.21 (dd, 7.5Hz & 1.5Hz, 1H), 
7.06-7.11 (m , 1H), 3.89-3.91 (s, 3H), 2.22-2.25 (S, 3H). 
13C NMR (125 MHz, CDCl3): δ 168.7, 159.7, 144.8 , 144.2 , 141.3 , 139.8 , 129.5 , 128.6 , 
122.9 , 120.1 , 117.5 , 112.2 , 55.5, 18.5. 
HRMS–ESI (m/z): [M+H]+ calcd for [C14H13N2O]+, 225.1022 ; found, 225.1021. 
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83. 2-(Naphthalen-2-yl)-1H-pyrrolo[2,3-c]pyridine: 
 
Method Cy-C. Yield 88%, 98 mg, brown solid. 
1H NMR (400 MHz, DMSO-d6): δ 12.1-12.5 (s, 1H), 8.80-8.84 (s, 1H), 8.49-8.53 (s, 1H), 
8.02-8.15 (m, 3H), 7.94-8.01(m, 2H), 7.54-7.62 (m, 3H), 7.12-7.16(s, 1H). 
13C NMR (125 MHz, DMSO-d6): δ 142.0 , 138.5 , 134.8 , 134.5 , 133.5 , 133.4 , 133.3 , 129.2 
, 129.1 , 128.3 , 128.1 , 127.2 , 127.0 , 124.9 , 124.5 , 115, 99.9. 
HRMS–ESI (m/z): [M+H]+ calcd for [C17H13N2]+, 245.1073 ; found, 245.1071. 
 
84. 5-Methoxy-3-methyl-2-phenyl-1H-pyrrolo[3,2-b]pyridine: 
 
Method Cy-A. Yield 87%, 104 mg, yellow solid. 
1H NMR (400 MHz, CDCl3): δ 7.98-7.07 (s, 1H), 7.60-7.65 (m, 2H), 7.54-7.58 (d, 8.8Hz, 
1H), 7.47-7.54 m, 2H), 7.36-7.42 (m, 1H), 6.61-6.65 (d, 8.8Hz, 1H), 4.06-4.08 (S, 3H), 2.52-
2.55 (S, 3H). 
13C NMR (125 MHz, CDCl3): δ 159.9 , 143.8, 136.4 , 133.2 , 128.9 , 127.6 , 127.3 , 124.7 , 
121.2 , 109.4 , 105.4 , 53.3 (CH3), 8.7 (CH3). 
HRMS–ESI (m/z): [M+H]+ calcd for [C15H14N2O]+, 239.1179; found, 239.1178. 
7.4 Experimental details for Chapter 4 
Synthesis and characterization of the [Ni(NHC)(cin)Cl] complexes 40-43.17 
The complexes were synthesized following a reported procedure. Inside a glovebox, 
[Ni(COD)2] (275 mg, 1.0 mmol) was suspended in cyclooctadiene (0.5 ml) in a 100 ml 
Schlenk flask. Cinnamyl chloride (152.6 mg, 1.0 mmol) was added dropwise while 
stirring, and fast appearance of a dark red colour was observed. After ten minutes, a 
solution of the selected NHC free ligand (1 mmol) in THF (10 ml) was added. After one 
hour, the brown solution was filtered through a plug of celite, and concentrated under 
vacuum. The brown solid were suspended and scratched in hexane twice, and after 
evaporation a yellow/orange powder was obtained. 
 
40. [Ni(IPr)(cinnamyl)Cl]:17 
 
Yield 81%, 424 mg.  
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1H-NMR (300 MHz, Benzene-d6): δ 7.10-7.27 (m, 7H), 7.02 (m, 2H), 7.0 (m, 2H), 6.58 (s, 
2H), 5.0 (ddd, J = 12.8, 12.8, 6.8 Hz, 1H), 3.6 (d, J = 13.2 Hz, 1H), 3.2 (m, 2H), 3.0 (m, 2H), 
2.4 (d, J = 6.9 Hz, 1H), 1.49 (d, J = 6.7 Hz, 6H), 1.33 (d, J = 6.7 Hz, 6H), 1.01 (m, 13H). 
13CNMR (75 MHz, Benzene-d6): δ 188.4, 146.8, 146.7, 140.4, 136.4, 130.3, 128.5, 125.9, 
124.6, 124.1, 102.7, 83.9, 41.9, 28.9, 28.8, 26.5, 26.4, 23.0, 22.9, 22.7. 
Anal. Calc. for C36H45ClN2Ni: C, 72.08; H, 7.56; N, 4.67. Found: C, 71.97; H, 7.46; N, 4.55. 
 
41. [Ni(SIPr)(cinnamyl)Cl]: 
 
Yield 75%, 394 mg. 
1H NMR (400 MHz, Benzene-d6): δ 7.25-7.18 (m, 6H), 7.16-7.07 (m, 3H), 7.03-6.96 (m, 
2H), 4.93 (td, J = 12.9, 6.9 Hz, 1H, Hcin), 3.63 (d, J = 13.2 Hz, 1H, Hcin), 3.51 (s, 2H), 2.45 
(dd, J = 6.9, 1.6 Hz, 1H, Hcin), 1.58-1.53 (m, 6H), 1.39 (d, J = 6.6 Hz, 6H), 1.20 (dd, J = 12.7, 
1.4 Hz, 1H, Hcin), 1.13 (d, J = 6.9 Hz, 6H), 1.09 (d, J = 6.9 Hz, 6H). 
13C NMR (100 MHz, Benzene-d6): δ 217.8, 139.8, 136.5, 129.2, 128.0, 127.9, 127.6, 125.6, 
124.2, 102.7, 85.2, 53.5, 41.4, 28.4, 26.5, 23.3. 
Anal. Calc. for C36H47ClN2Ni: C, 71.83; H, 7.87; N, 4.65. Found: C, 71.93; H, 7.91; N, 4.61. 
 
42. [Ni(IPr*)(cinnamyl)Cl]: 
 
Yield 83%, 870 mg. 
1H NMR (400 MHz, CDCl3): δ 7.50-7.00 (m, 36H), 6.98-6.73 (m, 13H), 6.21 (s, 2H), 5.85 
(s, 2H), 5.66-5.64 (m, 1H, Hcin), 5.21 (s, 2H), 5.03 (s, 1H, Hcin), 4.04 (d, J = 13.5 Hz, 1H, 
Hcin), 2.49-2.20 (m, 6H), 1.02-0.84 (m, 1H, Hcin). 
13C NMR (100 MHz, CDCl3): δ 183.1, 144.6, 144.5, 143.9, 142.6, 142.0, 141.5, 140.7, 140.6, 
139.4, 138.4, 136.1, 130.9, 130.9, 130.6, 130.5, 129.9, 129.9, 129.9, 129.4, 129.3, 128.9, 128.8, 
128.7, 128.7, 128.4, 128.4, 128.3, 128.3, 127.9, 127.2, 127.1, 126.5, 126.5, 126.4, 126.4, 126.3, 
124.2, 123.8, 103.4, 86.5, 51.6, 51.5, 51.4, 41.6, 28.2, 22.0.  
Anal. Calc. for C78H65ClN2Ni: C, 83.31; H, 5.83; N, 2.49. Found: C, 83.16; H, 5.85; N, 2.61. 
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43. [Ni(IPr*OMe)(cinnamyl)Cl]: 
 
Yield 83%, 896 mg. 
1H NMR (400 MHz, CDCl3): δ 7.49-7.46 (m, 2H), 7.37-7.27 (m, 14H), 7.24-7.15 (m, 11H), 
7.11-7.05 (m, 12H), 6.86-6.74 (m, 8H), 6.15 (s, 2H), 5.86 (s, 2H), 5.11 (s, 2H), 5.06 (m, 1H, 
Hcin) 4.06 (d, J = 13.6 Hz, 1H, Hcin), 3.67 (s, 6H), 2.22 (d, J = 6.8, 1H, Hcin), 0.97 (d, J = 12.4, 
1H, Hcin). 
13C NMR (100 MHz, CDCl3): δ 183.7, 158.9, 144.3, 144.2, 143.7, 143.7, 143.5, 142.7, 142.4, 
141.4, 139.4, 131.7, 130.5, 129.9, 129.3, 129.2, 128.9, 128.8, 128.4, 128.4, 127.9, 127.3, 127.2, 
126.6, 126.6, 126.4, 126.4, 123.9, 115.7, 115.3, 115.2, 103.4, 86.5, 55.2, 51.7, 51.7, 41.7, 28.2. 
Anal. Calc. for C78H66ClN2NiO2: C, 81.01; H, 5.66; N, 2.42. Found: C, 80.91; H, 5.48; N, 
2.49. 
Isolation of the activation product 75+75´: 
 
In a vial fitted with a screw cap, in the glove box, complex 42 (0.1 mmol) and NaOtBu 
(19.2 mg, 0.2 mmol) were dissolved in 3 mL of toluene, and the vial was then closed 
with a septum cap THF (0.5 mL). Outside the glovebox, propiophenone (0.2 mmol) was 
added via a syringe. The solution was stirred overnight at 60°C. The reaction was 
cooled down to room temperature and the vial was introduced in the glovebox. The 
solvent was evaporated under vacuum. The crude was then extracted with pentane (3 
x 5 mL). The combined organic phases of were taken out of the glovebox and filtered 
through a pad of celite. The solvent was then evaporated under vacuum and the crude 
was purified by flash chromatography (pentane:AcOEt = 100:1) to afford an 
unseparable mixture of 75/75´ (75/25) in 84% yield. 
 
1H NMR (500 MHz, CDCl3) 5: δ 8.03-7.97 (m, 2H), 7.61-7.55 (m, 1H), 7.53-7.46 (m, 2H), 
7.38-7.29 (m, 3H), 7.28-7.22 (m, 2H), 5.95 (ddd, J = 17.1, 10.3, 7.4 Hz, 1H), 5.03-4.85 (m, 
2H), 3.97-3.84 (m, 1H), 3.84-3.74 (m, 1H), 0.98 (d, J = 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 203.8 (5), 203.7 (5´), 141.8, 140.0, 137.5, 137.3, 136.5, 133.2, 
133.1, 132.1, 128.8, 128.8, 128.7, 128.6, 128.5, 128.4, 128.4, 127.7, 127.2, 126.8, 126.2, 115.7, 
52.9 (5), 45.1 (5), 41.1 (5´), 37.0 (5´), 17.4 (5´), 17.1 (5). 
HRMS (EI+): m/z calculated for C18H19O: 251.1433, found [M+H]+: 251.1430. 
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General procedure for the Ni-catalysed arylation of ketones: 
Inside a glovebox, [Ni(IPr*)(cin)Cl] 42 (0.015 mmol, 16.9 mg) and NaOtBu (96 mg, 1 
mmol), were put in a screw cap vial equipped with a stirring bar. Aryl chloride (0.5 
mmol) and/or ketone (1.0 mmol) were added at this stage, if solid. The vial was then 
sealed. Outside the glovebox, the solvent (toluene, 2 mL) and the aryl chloride and/or 
the ketone were added, if liquid. The reaction was then stirred for 16 hours at 80°C. 
The reaction was quenched adding some drops of water and filtered through 
magnesium sulphate. After checking the gas chromatogram conversion, the crude was 
absorbed on silica and purified by flash chromatography (typically with a n-
hexane:AcOEt = 9:1) to afford the desired product. 
Procedure for the synthesis of compound 79: 
Inside a glovebox, [Ni(IPr*OMe)(cinnamyl)Cl] 43 (2 mol%, 0.103 mmol, 119 mg), 6-
methoxytetralone (1.00 g, 5.68 mmol, 1.1 equivalents) and NaOtBu (992 mg, 10.32 
mmol, 2.0 equivalents), were put in a 100 ml Schlenk flask equipped with a stirring bar. 
The Schlenk was then closed with a septum cap. Outside the glovebox, the solvent 
(toluene, 10 mL) and chlorobenzene (5.16 ml, 5.16 mmol, 1 equivalents) were added via 
syringe. The reaction was stirred for 16 hours at 100°C, at 500 rpm in an oil bath. The 
reaction was quenched adding 10 ml of water and exctracted with ethyl acetate (3x10 
mL). The organic phase was concentrated was dried over magnesium sulphate and the 
volatiles were evaporated. The crude was crystallized from ethyl acetate / hexane to 
afford 1.075 g of the desired product (82% yield) as a yellow solid. 
 
Characterisation data. 
48. 2-(4-Methylphenyl)-1-phenylpropan-1-one:4 
 
Yield 90%, 202 mg, yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.97 (dd, J = 7.3, 1.2 Hz, 2H), 7.50-7.44 (m, 1H), 7.44-7.34 
(m, 2H), 7.20 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 7.9 Hz, 2H), 4.67 (q, J = 6.8 Hz, 1H), 2.30 (s, 
3H), 1.54 (dd, J = 6.8, 1.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 200.5, 138.6, 136.6, 136.6, 132.8, 129.8, 128.8, 128.6, 127.7, 
47.6, 21.1, 19.6. 
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49. 1-Phenyl-2-(4-(trifluoromethyl)phenyl)propan-1-one: 
 
Yield 55%, 153 mg.  
For characterisation, see entry 43, Chapter 2. 
 
50. 2-(p-Tolyl)-1-phenylpropan-1-one:19 
 
Yield 60%, 135 mg. 
1H NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 8.4, 1.4 Hz, 2H), 7.50-7.42 (m, 1H), 7.39-7.32 
(m, 2H), 7.24-7.19 (m, 1H), 7.15-7.01 (m, 3H), 4.78 (q, J = 6.8 Hz, 1H), 2.51 (s, 3H), 1.49 
(d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 201.1, 140.2, 136.7, 134.6, 132.7, 131.1, 128.6, 128.6, 127.1, 
127.0, 126.9, 44.7, 19.7, 18.1. 
 
51. 2-(2-Methoxyphenyl)-1-phenylpropan-1-one: 
 
Yield 68%, 163 mg. 
For characterisation, see entry 38, Chapter 2. 
 
51. 2-(Naphthalen-1-yl)-1-phenyl-propan-1-one:6 
 
Yield 77%, 200 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.34-8.25 (m, 1H), 7.97-7.87 (m, 3H), 7.76 (d, J = 8.3 Hz, 
1H), 7.71-7.62 (m, 1H), 7.62-7.53 (m, 1H), 7.46-7.40 (m, 1H), 7.41-7.32 (m, 2H), 7.35-7.26 
(m, 2H), 7.27-7.23 (m, 1H), 5.43 (q, J = 6.8 Hz, 1H), 1.68 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 200.7, 138.0, 136.4, 134.4, 132.74, 130.6, 129.3, 128.8, 128.6, 
128.5, 128.5, 127.6, 126.7, 125.9, 125.8, 125.1, 122.6, 43.7, 18.6. 
Analytical data matches previously reported characterisation. 
 
53. 2-(4-Methoxyphenyl)-1-phenylpropan-1-one: 
 
Yield 83%, 199 mg. 
For characterisation, see entry 39, Chapter 2. 
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54. 2-(3-(Dimethylamino)phenyl)-1-phenylpropan-1-one: 
 
Yield 82%, 208 mg. 
For characterisation, see entry 44, Chapter 2. 
 
55. 2-Benzo[1,3]dioxol-5-yl-1-phenyl-propan-1-one:18 
 
Yield 89%, 226 mg, yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.95 (dd, J = 8.4, 1.4 Hz, 2H), 7.54-7.44 (m, 1H), 7.45-7.33 
(m, 2H), 6.82-6.67 (m, 3H), 5.94-5.86 (m, 2H), 4.61 (q, J = 6.8 Hz, 1H), 1.50 (d, J = 6.9 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ 200.3, 148.2, 146.6, 136.6, 135.3, 132.9, 128.9, 128.6, 121.1, 
108.8, 108.2, 101.1, 47.5, 19.7. 
Analytical data matches previously reported characterisation. 
 
56. 2-(4-Benzoylphenyl)-1-phenylpropan-1-one: 
 
Yield 89%, 279 mg. 
For characterisation, see entry 47, Chapter 2. 
 
57. 2-(4-(Methylsulfonyl)phenyl)-1-phenylpropan-1-one: 
 
Yield 65%, 187 mg. 
For characterisation, see entry 46, Chapter 2. 
 
58. 1-Phenyl-2-(pyridin-3-yl)propan-1-one: 
 
Yield 63%, 133 mg. 
For characterisation, see entry42, Chapter 2. 
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59. 1-Phenyl-2-(thiophen-3-yl)propan-1-one: 
 
Yield 61%, 132 mg. 
For characterisation, see entry 41, Chapter 2. 
 
62. 1-(4-Methoxyphenyl)-2-(4-methylphenyl)-propan-1-one:19 
 
Yield 79%, 201 mg, white solid. 
1H NMR (400 MHz, CDCl3): δ 7.95 (d, J = 8.9 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 7.10 (dd, J 
= 8.1, 0.9 Hz, 2H), 6.88-6.83 (m, 2H), 4.61 (q, J = 6.8 Hz, 1H), 3.81 (s, 3H), 2.28 (s, 3H), 
1.50 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3) : δ 199.1, 163.2, 139.0, 136.5, 131.2, 129.7, 129.6, 127.7, 113.7, 
55.5, 47.2, 21.1, 19.7. 
Analytical data matches previously reported characterisation. 
 
64. α-(4-Methylphenyl)pentan-3-one:19 
 
Yield 63%, 139 mg, dark yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.17 – 7.07 (m, 4H), 3.73 (q, J = 7.0 Hz, 1H), 2.46-2.34 (m, 
2H), 2.33 (s, 3H), 1.38 (d, J = 6.9 Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 211.8, 138.0, 136.8, 129.6, 127.8, 52.4, 34.3, 21.14, 17.7, 8.1. 
Analytical data matches previously reported characterisation. 
 
68. 1-(4-Methoxyphenyl)-2-(p-tolyl)ethan-1-one: 
 
Yield 86%, 207 mg. 
For characterisation, see entry 30, Chapter 2. 
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69. 1-(4-(Dimethylamino)phenyl)-2-(p-tolyl)ethan-1-one: 
 
Yield 67%, 170 mg, green solid. 
1H NMR (400 MHz, CDCl3): δ 7.97-7.88 (m, 2H), 7.18 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 7.8 
Hz, 2H), 6.75-6.58 (m, 2H), 4.15 (s, 2H), 3.04 (s, 6H), 2.31 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 196.1, 153.5, 136.1, 132.8, 131.0, 129.37, 129.3, 124.6, 110.8, 
44.7, 40.1, 21.2. 
HRMS (EI+): m/z calcd for C17H20NO: 254.1539, found [M+H]+: 254.1539. 
 
70. 2-(Benzo[d][1,3]dioxol-5-yl)-1-(4-methoxyphenyl)ethanone: 
 
Yield 78%, 211 mg, white solid. 
1H NMR (500 MHz, CDCl3): δ 7.98 (d, J = 9.0 Hz, 2H), 6.95-6.89 (m, 2H), 6.78-6.72 (m, 
2H), 6.72-6.69 (m, 1H), 5.92 (s, 2H), 4.14 (s, 2H), 3.86 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 196.3, 163.6, 147.9, 146.6, 131.0, 129.6, 128.6, 122.6, 113.9, 
109.9, 108.5, 101.1, 55.6, 44.9. 
HRMS (EI+): m/z calcd for C16H15O4: 271.0963, found [M+H]+: 271.0965. 
Analytical data matches previously reported characterisation. 
 
71. 1-(6-Methoxynaphthalen-2-yl)-2-phenylethanone:20 
 
Yield 83%, 229 mg, white solid. 
1H NMR (400 MHz, CDCl3): δ 8.48 (dd, J = 1.8, 0.8 Hz, 1H), 8.04 (dd, J = 8.7, 1.8 Hz, 1H), 
7.85 (dd, J = 9.0, 0.7 Hz, 1H), 7.78-7.74 (m, 1H), 7.38-7.30 (m, 4H), 7.30-7.21 (m, 1H), 7.20 
(dd, J = 8.9, 2.5 Hz, 1H), 7.15 (d, J = 2.5 Hz, 1H), 4.39 (s, 2H), 3.95 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 197.4, 160.0, 137.4, 135.0, 132.2, 131.3, 130.4, 129.6, 128.8, 
127.9, 127.3, 127.0, 125.2, 119.9, 105.8, 55.6, 45.5. 
Analytical data matches previously reported characterisation. 
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72. 1-(4-Methoxyphenyl)-2-(4-methoxyphenyl)ethanone: 
 
Yield 84%, 215 mg, white solid. 
1H NMR (500 MHz, CDCl3): δ 8.03-7.96 (m, 2H), 7.21-7.15 (m, 2H), 6.96-6.90 (m, 2H), 
6.89-6.83 (m, 2H), 4.17 (s, 2H), 3.85 (s, 3H), 3.78 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 196.6, 163.6, 158.5, 131.0, 130.5, 129.7, 127.0, 114.2, 113.9, 
55.6, 55.3, 44.5. 
HRMS (EI+): m/z calcd for C16H17O3: 257.1172, found [M+H]+: 257.1172 
 
73. 2-(2,6-Dimethylphenyl)-1-(4-methoxyphenyl)ethan-1-one:3 
 
Yield 51%, 130 mg, white solid. 
1H NMR (400 MHz, CDCl3): δ 8.09-8.04 (m, 2H), 7.12-7.04 (m, 3H), 7.00-6.96 (m, 2H), 
4.33 (s, 2H), 3.90 (s, 3H), 2.22 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 195.5, 163.6, 137.0, 132.9, 130.4, 130.2, 128.0, 126.8, 113.9, 
55.5, 39.3, 20.5. 
Analytical data matches previously reported characterisation. 
 
79. 6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one: 
 
Yield 82%, 1.18 g (5.7 mmol scale). 
For characterisation, see entry 55, Chapter 2. 
7.5 Experimental data for Chapter 5 
Synthesis and characterization of imines 22-50. 21 
Benzophenone (3.6 g, 20 mmol), NaHCO3 (8.4 g, 0.1 mol), the corresponding benzyl 
amine (21 mmol) and activated molecular sieves (4Å) were weighted in a round 
bottom flask under dry conditions. Then, dry toluene (40 mL) was added. The reaction 
was then stirred for 16 hours at 90°C. After this time, the mixture was filtered through 
celite. The desired imine was obtained pure, in quantitative yield, after 
recrystallization (AcOEt:n-hexane). 
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22 N-(Diphenylmethylene)-1-phenylmethanamine: 
 
1H NMR (400 MHz, CDCl3): δ 7.71-7.65 (m, 2H), 7.51-7.34 (m, 10H), 7.25-7.20 (m, 3H), 
4.62 (m, 3H), 7.10-7.07 (m, 4H), 5.52 (s, 2H), 2.31 (s, 3H). 
 
N-(Diphenylmethylene)-1-(4-methoxyphenyl)methanamine: 
 
1H NMR (400 MHz, CDCl3): δ 7.69-7.65 (m, 2H), 7.51-7.34 (m, 6H), 7.26-7.19 (m, 4H), 
6.89 (m, 2H), 4.55 (s, 2H), 5.52 (s, 2H), 3.80 (s, 3H). 
 
N-(Diphenylmethylene)-1-(4-fluorphenyl)methanamine: 
 
1H NMR (400 MHz, CDCl3): δ 7.72-7.68 (m, 2H), 7.51-7.28 (m, 8H), 7.23-7.19 (m, 2H), 
7.05-6.99 (m, 2H), 4.58 (s, 2H). 
 
General procedure for the arylation of imines. 
Inside a glovebox, [Ni(COD)2] (3.4 or 5.2 mg, 5.0 or 7.5 mol%, 0.0125 or 0.0188 mmol), 
IPr (10 or 15 mg, 2.0 equivalents with respect of Ni) the selected imine (0.5 mmol, 2.0 
equivalents), KHMDS (100 mg, 0.5 mmol, 2 equivalents) were weighted in a screw cap 
vial equipped with a stirring bar. The aryl chloride (0.25 mmol, 1 equivalents) was 
added at this stage, if solid. The vial was sealed and carried out from the glovebox, 
where and the aryl chloride, if liquid, and the dry, degassed solvent (toluene, 1.5 ml) 
were added. The reaction was then stirred for 16 hours at 45°C. The reaction was then 
quenched adding some drops of water and filtered through Mg2SO4. After checking the 
NMR, the crude was absorbed on silica previously basified (stirring it overnight with 
2% triethylamine in pentane) and purified by flash chromatography (typically with a 
pentane / diethyl ether = 95 / 5 eluent mixture) to afford the desired product 
quantitatively. 
Procedure for the hydrolisys of 46 to 46’. 
HCl 1N in diethyl ether (1 mL) was added to the solution of imine 3k (39.7 mg, 0.1 
mmol) in THF (1 mL) at 0°C. The solution was warmed to room temperature and 
stirred, monitoring by TLC until all the imine was consumed. The THF was evaporated 
under vacuum. Another 1 mL HCl (1N) was added and a white precipitate was 
observed. The white solid was filtered and washed with cold Et2O (1.0 mL×3). After 
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drying under vacuum for 12 h, the hydrochloride salt was obtained as a white solid 
(25.4 mg, 99% yield). 
Procedure for the studies of the effect of the bases (Table 3). 
Entries 1-3: Inside a glovebox, 22 (54 mg, 0.2 mmol, 1.0 equivalents) and the base (2.0 
equivalents) were weighted in a screw cap vial equipped with a stirring bar. Outside 
the glovebox, toluene (0.6 mL) and benzyl chloride (0.25 µL, 2.4 mmol, 1.2 equivalents) 
were added, and the reaction was then stirred at 45 °C for 3 hours. The reaction was 
then quenched with 2 drops of water, filtered through MgSO4 and dried under 
vacuum. The yield was then assessed via quantitative 1H-NMR, using diethylmalonate 
as internal standard. 
Entries 4-6: Inside a glovebox, 22 (54 mg, 0.2 mmol, 1.0 equivalents) and the base (0.5 
equivalents) were weighted in a screw cap vial equipped with a stirring bar. Outside 
the glovebox, dry degassed toluene (0.6 mL) was added using a syringe through the 
septum, and the reaction was then stirred at 45 °C for 3 hours. The reaction was then 
quenched with 2 drops of water, filtered through MgSO4, dried under vacuum and 
analyzed via 1H-NMR. 
Characterization data. 
27. N-(Diphenylmethylene)-1-phenyl-1-(p-tolyl)methanamine: 21 
 
From 22 and 4-chlorotoluene, 5% Ni loading. Yield 88%, 159 mg, yellow solid. 
From 2’ and 4-chlorotoluene, 5% Ni loading. Yield 84%, 152 mg. 
1H NMR (400 MHz, CDCl3): δ 7.51 (m, 2H), 7.45-7.41 (m, 3H), 7.38-7.27 (m, 7H), 7.22-
7.18 (m, 3H), 7.10-7.07 (m, 4H), 5.52 (s, 2H), 2.31 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 166.6, 141.9, 139.9, 136.7, 136.1, 130.0, 129.0, 128.7, 128.4, 
128.4, 128.3, 127.9, 127.8, 127.5, 127.4, 126.6, 69.6, 21.1. 
Analytical data matches previously reported characterisation. 
 
37. N-(Diphenylmethylene)-1-(4-methoxyphenyl)-1-phenylmethanamine:21 
 
From 22 and 4-chloroanisole, 5% Ni loading. Yield 86%, 163 mg, white solid. 
From 22-OMe and chlorobenzene, 5% Ni loading Yield 86%, 163 mg. 
From 22’ and 4-chloroanisole, 5% Ni loading, yield 83%, 157 mg. 
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1H NMR (400 MHz, CDCl3): δ 7.76 (d, J= 7.2 Hz, 2H), 7.45-7.25 (m, 10H), 7.22-7.18 (m, 
3H), 7.11-7.08 (m, 2H), 7.10-7.07 (m, 4H), 6.83 (d, J=8.8 Hz, 2H), 5.53 (s, 1H), 3.78 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ 166.57, 158.31, 145.11, 139.85, 137.15, 136.73, 129.98, 
128.71, 128.58, 128.42, 128.37, 128.27, 127.96, 127.73, 127.44, 126.56, 113.70, 69.19, 55.20. 
Analytical data matches previously reported characterisation. 
 
38. N-(Diphenylmethylene)-1-(4-fluorophenyl)-1-phenylmethanamine:21 
 
From 22 and 4-fluorochlorobenzene, 5% Ni loading. Yield 82%, 150 mg, yellow solid. 
From 22-F and chlorobenzene, 5% Ni loading. Yield 82%, 149 mg. 
From 22’ and 4-fluorochlorobenzene, 5% Ni loading. Yield 82%, 149 mg 
1H NMR (400 MHz, CDCl3): δ 7.77 (m, 2H), 7.47-7.44 (m, 3H), 7.40-7.30 (m, 2H), 7.30-
7.26 (m, 6H), 7.24-7.18 (m, 1H), 7.10-7.06 (m, 2H), 7.00-6.94 (m, 2H), 5.55 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ 167.1, 162.0 (d, 1JC-F= 243.0 Hz), 144.7, 140.6 (d, 4JC-F= 3.0 
Hz), 139.7, 136.6, 130.1, 129.0 (d, 3JC-F= 7.8 Hz), 128.7, 128.5, 128.4, 128.4, 128.0, 127.6, 
127.4, 126.8, 115.0 (d, 2JC-F= 31.2 Hz), 69.3. 
19F NMR (376.8 MHz, CDCl3): δ -116.4 
Analytical data matches previously reported characterisation. 
 
39. N-(Diphenylmethylene)-1-phenyl-1-(4-(trifluoromethyl)phenyl)methanamine:21 
 
5% [Ni] loading. Yield 79%, 164 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 7.77 (m, 2H), 7.55 (app. d, J= 8.4 Hz, 2H), 7.48-7.26 (m, 
12H), 7.25-7.21 (m, 1H), 7.24-7.18 (m, 1H), 7.09-7.05 (m, 2H), 5.61 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ 167.7, 148.8, 144.0, 139.5, 136.5, 130.3, 129.0, 128.8, 128.7, 
128.5, 128.0, 127.8, 127.6, 127.0, 125.3 (q, JC-F= 3.4 Hz), 123.4 (q, JC-F= 270.1 Hz), 69.5 
19F NMR (376.8 MHz, CDCl3): δ -62.4 
Analytical data matches previously reported characterisation. 
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40. 3-(((Diphenylmethylene)amino)(phenyl)methyl)-N,N-dimethylaniline:22 
 
5% Ni loading. Yield 77%, 151 mg, brown solid. 
1H NMR (400 MHz, CDCl3): δ 7.75 (m, 2H), 7.45-7.42 (m, 3H), 7.37-7.33 (m, 5H), 7.29-
7.25 (m, 3H), 7.20-7.08 (m, 4H), 6.74 (m, 1H), 6.70 (m, 1H), 6.59 (ddd, J= 8.4 Hz, 2.8 Hz, 
0.8 Hz, 1H),5.51 (s, 2H), 2.90 (s, 6H). 
13C NMR (125 MHz, CDCl3): δ 166.5, 150.6, 145.6, 145.0, 139.9, 136.8, 129.9, 128.9, 128.72, 
128.4, 128.3, 128.2, 127.9, 127.8, 127.5, 126.5, 116.2, 112.0, 111.0, 70.1, 40.7. 
Analytical data matches previously reported characterisation. 
 
41. 1-(Benzo[d][1,3]dioxol-5-yl)-N-(diphenylmethylene)-1-phenylmethanamine: 
 
5% Ni loading. Yield 86%, 169 mg, white solid.  
1H NMR (400 MHz, CDCl3): δ 7.79 (m, 2H), 7.48-7.28 (m, 11H), 7.26-7.20 (m, 1H), 7.13 
(d, J= 2 Hz, 1H), 7.11 (m, 1H), 6.95 (d, J= 1,6 Hz, 1H), 6.78 (dd, J1=8.4 Hz, J2=1.6 Hz, 1H), 
6.74 (d, J= 8 Hz, 1H), 5.92 (s, 2H), 5.51 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ 166.8, 147.6, 146.2, 144.9, 139.7, 138.9, 136.6, 130.1, 128.71, 
128.5, 128.4, 128.3, 128.0, 127.7, 127.3, 126.7, 120.4, 108.3, 107.9, 100.8, 69.4. 
HRMS (EI+): m/z calcd for C27H21NO2: 390.1489, found [M+H]+: 390.1481 
 
42. 4-(((Diphenylmethylene)amino)(phenyl)methyl)phenyl)(phenyl)methanone: 
 
5% Ni loading. Yield 89%, 201 mg, yellow solid.  
1H NMR (500 MHz, CDCl3): δ 7.85-7.80 (m, 6H), 7.59 (t, J= 7.5 Hz, 1H), 7.53-7.47 (m, 
7H), 7.45-7.39 (m, 5H), 7.35 (t, J= 7.5 Hz, 2H), 7.29-7.24 (m, 1H), 7.14-7.11 (m, 2H), 5.69 
(s, 2H), 2.31 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 196.4, 167.6, 149.6, 144.1, 139.5, 137.7, 132.2, 130.3, 130.25, 
130.0, 128.7, 128.6, 128.4, 128.2, 128.0, 127.6, 127.5, 127.4, 127.0, 69.7. 
HRMS (EI+): m/z calcd for C33H25NO: 450.1852, found [M+H]+: 450.1548 
43. 4-(((Diphenylmethylene)amino)(phenyl)methyl)benzonitrile:21 
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5% Ni loading. Yield 80%, 149 mg, off white solid. 
1H NMR (400 MHz, CDCl3): δ 7.76-7.73 (m, 2H), 7.57 (d, J= 8.4 Hz, 2H), 7.47-7.36 (m, 
15H), 7.06-7.3 (m, 2H), 5.57 (s, 2H). 
13C NMR (100 MHz, CDCl3): δ 168.1, 150.2, 143.6, 139.3, 136.3, 132.2, 130.4, 128.7, 128.61, 
128.6, 128.2, 128.1, 127.5, 127.5, 127.2, 119.0, 110.5, 69.5. 
Analytical data matches previously reported characterisation. 
 
44. N-(Diphenylmethylene)-1-phenyl-1-(pyridin-2-yl): 
 
7.5% Ni loading. Yield 89%, 155 mg, brown solid.  
1H NMR (500 MHz, CDCl3): δ 8.47 (d, J= 4.5 Hz, 1H), 7.83-7.77 (m, 3H), 7.67 (dt, J= 7.5, 
1.5 Hz, 1H), 7.42-7.35 (m, 8H), 7.28 (t, J= 7.5 Hz, 2H), 7.22-7.18 (m, 1H), 7.12-7.09 (ddd, 
J= 7.5 Hz, 4 Hz, 1 Hz, 1H), 7.07-7.04 (m, 2H), 5.77 (s, 2H). 
13C NMR (125 MHz, CDCl3): δ 167.9, 163.9, 148.9, 144.0, 139.8, 136.7, 136.3, 130.2, 128.8, 
128.6, 128.4, 128.4, 128.0, 127.7, 127.5, 126.8, 122.0, 121.8, 71.9. 
HRMS (EI+): m/z calcd for C25H20N2: 347.1543, found [M+H]+: 347.1539 
 
45. N-(Diphenylmethylene)-1-phenyl-1-(o-tolyl)methanamine:21 
 
7.5% Ni loading. Yield 75%, 135 mg, brown solid . 
1H NMR (400 MHz, CDCl3): δ 7.77-7.74 (m, 2H), 7.71 (d, J= 7.6 Hz, 1H), 7.46-7.18 (m, 
13H), 7.09-7.06 (m, 3H), 5.76 (s, 1H), 1.97 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 166.8, 144.0, 142.7, 139.8, 137.0, 135.3, 130.3, 130.0, 128.7, 
128.5, 128.4, 128.2, 128.0, 127.6, 126.6, 126.5, 126.1, 66.7, 19.5. 
Analytical data matches previously reported characterisation. 
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46. Naphthalen-1-yl(phenyl)methanaminium chloride: 21 
 
7.5% Ni loading. Yield 61%, 71 mg (after hydrolisis), white solid. 
1H NMR (400 MHz, CDCl3): δ 8.01-7.94 (m, 3H), 7.72-7.63 (m, 2H), 7.56-7.37 (m, 7H), 
6.44 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ 138.8, 135.6, 131.4, 130.6, 130.3, 130.2, 130.1, 129.1, 128.5, 
128.0, 127.4, 126.2, 124.4, 124.2, 56.1. 
Analytical data matches previously reported characterisation. 
7.6 Experimental details for Chapter 6 
Typical procedure for the arylation of ketones with haloindoles. 
A vial containing a stirring bar was charged with (Pd(DtBPF)Cl2) 43 (2.0 mol%, 2.6 mg). 
haloindole (0.2 mmol, 1.0 equivalents) was added. The vial was then closed with a 
septum cap and the liquid ketone (0.8 mmol, 4.0 equivalents) was added. The vial was 
purged three times with Ar/vacuum cycles. A stock solution of NaOH in water was 
prepared (160 mg/mL, 4.0 M). Under an Ar atmosphere, dioxane (0.2 mL), the ketone 
and and the aqueous NaOH solution (4.0 equivalents, 0.2 mL) were added through the 
septum using a syringe. Finally, the vial was stirred at 60°C for 16 h. The solution was 
cooled to room temperature, then 0.5 mL water and 0.5 mL of ethyl acetate were added 
and mixed. The aqueous phase was then extracted with ethyl acetate (4 x 1 mL) and the 
organic phase was filtered through a short pad of MgSO4. The product was then 
purified via column chromatography (typically hexane : acetate = 9 : 1). 
Typical procedure for the arylation of ketones with other haloarenes. 
A vial containing a stirring bar was charged with (Pd(DtBPF)Cl2) 43 (2.0 mol%, 2.6 mg). 
All the solid coupling partners were added at this stage: solid haloarenes (0.2 mmol, 
1.0 equivalents) and/or solid ketones (0.4 mmol, 2.0 equivalents). The vial was then 
closed with a septum cap and purged three times with Ar/vacuum cycles. A stock 
solution of NaOH in water was prepared (100 mg/mL ). Under an Ar atmosphere, 
dioxane (0.2 mL), the liquid ketone and/or the liquid haloarene, and the aqueous 
NaOH solution (2.5 equivalents, 0.2 mL) were added through the septum using a 
syringe. Finally, the vial was stirred at 60°C for 16 h. The solution was cooled to room 
temperature, then 0.5 mL water and 0.5 mL of ethyl acetate were added and mixed. 
The aqueous phase was then extracted with ethyl acetate (4 x 1 mL) and the organic 
phase was filtered through a short pad of MgSO4. The product was then purified via 
column chromatography (typically hexane : acetate = 9 : 1). 
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Synthesis of Prochlorperazine derivative 75.  
Proclorperazine dimaleate (0.2 mmol, 121.2 mg) was suspended in 2 mL of ethyl 
acetate. To this suspension, 2 mL of 1.0 M aqueous Na2CO3 was added. After the 
organic phase became clear, the aqueous phase was separated and extracted again with 
ethyl acetate (4 x 2 mL). The combined organic extract was evaporated and the 
remaining oil was dissolved in dioxane and transferred to a vial. After evaporation of 
the solvent, (Pd(DTBPF)Cl2) (5 mol%, 6.5 mg) was weighted in the vial. The vial was 
then closed with a septum cap and purged three times with Ar/vacuum cycles. A stock 
solution of NaOH in water was prepared (160 mg/mL ). Under an Ar atmosphere, 
dioxane (0.2 mL), propiophenone (2.0 equivalents, 50 uL), and the aqueous NaOH 
solution (4.0 equivalents, 0.2 mL) were added through the septum using a syringe. 
Finally, the vial was stirred at 60°C during 16 h. The solution was cooled to r.t., then 0.5 
mL water and 0.5 mL of ethyl acetate were added and mixed. The aqueous phase was 
then extracted with ethyl acetate (4 x 1 mL) and the organic phase was filtered through 
a short pad of MgSO4 and evaporated. The resultant crude oil was suspended in ethyl 
ether (5 mL) and 0.1 M HCl (5 mL). The aqueous phase wash washed with ethyl ether 
(3 x 5 mL) and then the pH was adjusted to ca. 11 using a saturated solution of Na2CO3. 
This basic aqueous solution was then extracted with ethyl acetate (6 x 5mL), dried over 
MgSO4 and evaporated. The mixture was then purified by flash chromatography (97:3 
DCM/MeOH) over pre-treated, basified silica (2% triethylamine in DCM, overnight), 
affording 248 mg (86%) of the product 75 as a pale, yellow oil. 
Synthesis of N-Boc protected halotryptophans 78, 81, 83.23  
A suspension of S-7-Br-tryptophan (100 mg, 0.35 mmol, 1.0 eq) and di-t-butyl 
dicarbonate (92 mg, 0.42 mmol, 1.2 eq) in 1,4-dioxane-water (1:1, 3.0 mL) was cooled to 
0 °C. Aqueous KOH (1 M, 0.45 mL, 0.45 mmol, 1.25 eq) was added dropwise. The 
mixture was stirred overnight while warming to room temperature. The reaction was 
diluted with water (10 mL) and extracted with diethyl ether (2 x 10 mL). The aqueous 
layer was cooled in an ice-bath and the pH was adjusted to 2 using 1 M HCl. The 
resulting white suspension was extracted using ethyl acetate (5 x 10 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and the solvent was 
removed in vacuo to give S-N-Boc-7-Br-tryptophan 83 (120 mg, 89%) as a white, waxy 
solid that was used without further purification. Analogous procedures were used for 
the preparation of S-N-Boc-5-Br-tryptophan and 6-Cl-S-tryptophan. 
Coupling of N-Boc protected halotryptophans.  
S-N-Boc-5-Br-tryptophan (0.05 mmol, 19.2 mg) and [Pd(DtBPF)Cl2] 43 (10 mol%, 3.6 
mg) were weighted in a screw-cap vial equipped with a stirring bar. The vial was then 
purged with 3 cycles of vacuum/Ar. Dioxane (0.1 mL; previously filtered on basic 
alumina), propiophenone (5.0 equivalents, 30 µL) and an aqueous solution of NaOH 
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(0.1 mL of a 2M solution, 4.0 equivalents) were added in this order, and the reaction 
was stirred at 60°C for 16 h. After this time, the reaction was cooled to r.t., 2 mL of 
water was added and the dioxane was evaporated at the rotavapor. The resulting 
aqueous solution was extracted with ethyl ether (3 x 3 mL). The pH of the solution was 
then adjusted to ca. 2, and the resulting suspension was extracted with ethyl acetate (6 
x 3 mL). The ethyl acetate phases were combined and dried on Na2SO4, then filtered 
and concentrated under vacuum. The crude mixture was then purified either by 
column chromatography (DCM/Ethyl acetate/formic acid = 9:1:0.1) or by automated 
column chromatography on C18-functionalised reverse phase silica using a gradient of 
water and methanol (5-95%) to afford product 79 as a white solid. The same protocol 
was applied for the synthesis of compounds 81 and 83. 
Assessment of the enantiopurity of 83. 
Boc-deprotection of 83 using TFA 
6h (10 mg, 0.023 mmol) was dissolved in CH2Cl2 (1 mL) and transferred to a 
microwave vial. TFA (50 µL, ca. 2 mmol) was added and reaction vial was sealed with 
an aluminium crimp cap. Reaction mixture was heated in a microwave reactor at 60°C 
for 40 min. After cooling, solvent was evaporated under reduced pressure.  
 
Enantiopurity analysis of tryptophan derivatives by UPLC after derivatisation with 
Marfey’s reagent.24 
The enantiopurity of Boc-deprotected 83 was analysed using Marfey’s Reagent (1-
fluoro-2,4-dinitrophenyl-5-L-alanine amide, FDAA). 
A stock solution of 10.0 mM FDAA in acetone was prepared by dissolving 2.7 mg 
FDAA in 1 ml acetone. The sample was dissolved in 1 M sodium hydrogen carbonate 
(0.5 mg/mL). FDAA (50 µl) stock solution were added to 100 µl of sample solution, and 
the mixture incubated at 40 °C for 1h. The reaction was quenched with 100 µl of 1 M 
hydrochloric acid. The reaction mixture was diluted (10 ml in 190 ml water) and 
centrifuged (13,000 rpm, 5 min). Clear supernatant was analysed by UPLC: the analysis 
was performed on Waters Acquity UPLC BEH C18 (1.7um 2.1 x 50 mm) column 
eluting with 0.1% TFA in water (solvent A) and acetonitrile (solvent B). Following 
gradient was used: 0-0.2 min (20% B), 0.2-4.0 min (20% to 70% B), 4.0-4.2 (70% to 90% 
B), 4.2-5.2 min (90% B), 5.2-5.5 (90% to 20%B), 5.5-6.0 (20% B). The flow rate was set to 
600 µl min-1 and the column temperature was maintained at 50°C. Detection was by 
UV (PDA 200-400nm, UV 340 nm). A mixture of S-tryptophan to D-tryptophan was 
used as a standard to confirm the separation of enantimers. The FDAA derivative of 
Boc-deprotected 6h revealed only peak, indicating presence of single enantiomer. The 
stereocenter in the α-position of the ketone carbonyl moiety did not affect the analysis. 
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Characterisation data. 
78. S-N-Boc-5-Br-tryptophan:25 
 
Yield 87%, 123 mg. 
1H NMR (400MHz, CD3OD) : δ 7.71 (d, J = 1.6 Hz, 1H), 7.25 (d, J = 8.6 Hz, 1H), 7.17 (d, J 
= 8.6 Hz, 1H), 7.12 (s, 1H), 4.40 (dd, J = 7.4, 5.0 Hz, 1H), 3.27 (dd, J = 14.6, 4.8 Hz, 1H), 
3.09 (dd, J = 14.6, 7.7 Hz, 1H), 1.39 (s, 9H). 
13C NMR (101 MHz, CD3OD): δ 175.5, 157.7, 136.6, 130.8, 126.0, 125.0, 122.0, 113.9, 
113.0, 111.1, 80.6, 56.0, 29.4, 28.7. 
[α] 20D = -1.4 (c= 0.5, MeOH) 
Analytical data matches previously reported characterisation. 
 
80. S-N-Boc-6-Cl-tryptophan: 
 
Yield 88%, 119 mg,. 
1H NMR (400MHz, CD3OD) : δ 7.52 (d, J = 8.5 Hz, 1H), 7.33 (s, 1H), 7.10 (s, 1H), 6.98 
(dd, J = 8.4, 1.6 Hz, 1H), 4.39 (dd, J = 7.7, 5.2 Hz, 1H), 3.31-3.24 (m, 1H, partly covered 
by the solvent signal), 3.09 (dd, J = 14.6, 7.9 Hz, 1H), 1.38 (s, 9H). 
13C NMR (101 MHz, CD3OD) : δ 175.7, 157.8, 138.3, 128.2, 127.6, 125.4, 120.5, 120.2, 
112.0, 111.6, 80.5, 55.8, 28.7, 28.6. 
[α] 20D = +5.4 (c= 0.5, MeOH) 
HRMS (EI+): m/z calcd for C16H2035ClN2O4: 339.1111, found [M+H]+: 339.1113 
 
82. S-N-Boc-7-Br-tryptophan:26 
 
Yield 91%, 127 mg. 
1H NMR (300MHz, CD3OD) : δ 10.55 (bs, 1H), 7.56 (dd, J = 7.9, 0.7 Hz, 1H), 7.26 (d, J = 
7.5 Hz, 1H), 7.17 (s, 1H), 6.94 (d, J = 7.7 Hz, 1H), 4.43 (dd, J = 7.7, 5.2 Hz, 1H), 3.31 (dd, J 
= 14.9, 4.5 Hz, 2H), 3.11 (dd, J = 14.6, 7.8 Hz, 1H), 1.37 (s, 9H). 
13C NMR (101 MHz, CD3OD): δ 174.3, 156.3, 129.1, 124.3, 124.2, 123.5, 119.6, 117.5, 
111.2, 111.2, 104.1, 79.2, 54.4, 27.4, 27.3. 
[α] 20D = +15.2 (c= 0.5, MeOH) 
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57. 2-(1H-Indol-5-yl)-1-phenylpropan-1-one: 
 
Yield 84%, 126 mg. X=Br, brown solid. 
1H NMR (400MHz, CDCl3) : δ 8.19 (bs, 1H), 8.04-7.99 (m, 2H), 7.56 (d, J=1.2 Hz, 1H), 
7.46-7.40 (m, 1H), 7.38-7.29 (m, 3H), 7.17-7.14 (m, 1H), 7.13 (dd, J = 8.4, 1.7 Hz, 1H), 6.49 
(ddd, J = 3.0, 2.0, 0.9 Hz, 1H), 4.79 (q, J = 6.8 Hz, 1H), 1.59 (d, J = 6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3) : δ 201.0, 136.7, 134.8, 132.9, 132.5, 128.9, 128.3, 124.7, 121.9, 
119.7, 111.6, 102.47, 48.0, 20.0. One aromatic carbon was not detected. 
HRMS (EI+): m/z calcd for C17H17NO: 250.1226, found [M+H]+: 250.1224. 
 
58. 2-(1H-Indol-6-yl)-1-phenylpropan-1-one: 
 
Yield 82%, 123 mg. X=Br, brown solid. 
1H NMR (400 MHz, CDCl3) : δ 8.24 (bs, 1H), 8.00 (dt, J = 8.5, 1.7 Hz, 2H), 7.59 (d, J = 8.1 
Hz, 1H), 7.48-7.40 (m, 1H), 7.35 (ddt, J = 8.2, 6.8, 1.2 Hz, 2H), 7.27 (s, 1H), 7.13 (m, 1H), 
7.10 (dd, J = 8.2, 1.5 Hz, 1H), 6.49 (ddd, J = 3.0, 2.0, 0.9 Hz, 2H), 4.79 (q, J = 6.8 Hz, 1H), 
1.59 (d, J = 6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3) : δ 200.8, 136.6, 136.2, 135.4, 132.6, 128.8, 128.4, 126.7, 124.4, 
121.2, 120.3, 109.8, 102.4, 77.0, 48.1, 19.9. 
HRMS (EI+): m/z calcd for C17H17NO: 250.1226, found [M+H]+: 250.1226. 
 
59. 2-(1H-Indol-6-yl)-1-phenylpropan-1-one: 
 
Yield 90%, 135 mg. X=Br, brown solid. 
Yield 85%, 128 mg. X=I. 
Yield 81%, 122 mg. X=Cl (Pd 5 mol%). 
1H NMR (400MHz, CDCl3) : δ 9.13 (s, 1H), 8.10 (d, J = 7.5 Hz, 2H), 7.58 (d, J = 7.9 Hz, 
1H), 7.49 (t, J = 7.4 Hz, 1H), 7.40 (t, J = 7.6 Hz, 2H), 7.23 (dd, J = 5.0, 1.9 Hz, 2H), 7.14 (t, J 
= 7.5 Hz, 1H), 6.54 (ddd, J = 3.0, 2.0, 0.9 Hz, 1H), 5.04 (q, J = 7.0 Hz, 1H), 1.72 (d, J = 7.0 
Hz, 7H). 
13C NMR (101 MHz, CDCl3) : δ 201.8, 136.3, 133.9, 133.3, 129.1, 128.9, 128.5, 124.7, 122.9, 
122.5, 120.2, 120.1, 102.3, 47.2, 16.8. 
HRMS (EI+): m/z calcd for C17H17NO: 250.1226, found [M+H]+: 250.1224. 
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60. 2-(1H-Indol-7-yl)-1-(o-tolyl)-ethan-1-one: 
 
Yield 69%, 103 mg. X=Br, brown solid. 
1H NMR (400 MHz, CDCl3): δ 9.21 (s, 1H), 8.00 – 7.87 (m, 1H), 7.56 (dd, J = 6.6, 2.1 Hz, 
1H), 7.35 (td, J = 7.5, 1.2 Hz, 1H), 7.29 – 7.23 (m, 2H), 7.20 (d, J = 7.6 Hz, 1H), 7.12 – 6.97 
(m, 2H), 6.59 – 6.51 (m, 1H), 4.43 (s, 2H), 2.40 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 201.9, 139.2, 136.9, 135.6, 132.1, 131.8, 129.5, 128.4, 125.64, 
124.8, 123.3, 120.0, 117.0, 102.6, 46.7, 21.4. One aromatic carbon was not detected. 
HRMS (EI+): m/z calcd for C17H17NO: 250.1226, found [M+H]+: 250.1225. 
 
60’. 2,2-di(1H-Indol-7-yl)-1-(o-tolyl)-ethan-1-one: 
 
20 mg, 9% yield of this product were isolated from the reaction for 60, brown solid. 
1H NMR (400 MHz, CDCl3): δ 8.28 (s, 2H), 7.89 (d, J = 7.4 Hz, 1H), 7.63 (d, J = 7.8 Hz, 
2H), 7.40 (td, J = 7.5, 1.2 Hz, 1H), 7.32 – 7.23 (m, 2H), 7.20 (d, J = 7.2 Hz, 2H), 7.12 (t, J = 
7.6 Hz, 2H), 7.01 (t, J = 2.8 Hz, 2H), 6.48 (dd, J = 3.1, 2.1 Hz, 2H), 6.42 (s, 1H), 2.32 (s, 
3H). 
13C NMR (101 MHz, CDCl3): δ 202.2, 139.1, 138.3, 134.8, 132.1, 131.9, 129.1, 128.7, 125.87, 
124.8, 122.5, 120.8, 120.3, 120.0, 102.4, 58.4, 21.0. 
HRMS (EI+): m/z calcd for C25H21N2O: 365.1648, found [M+H]+: 365.1651. 
 
61. 2-(1H-Indol-5-yl)-pentan-3-one: 
 
Yield 45%, 54 mg. X=Br, brown oil. 
1H NMR (400 MHz, CDCl3): δ 8.40 (s, 1H), 7.52 (s, 1H), 7.34 (d, J = 8.4 Hz, 1H), 7.22 – 
7.18 (m, 1H), 7.04 (d, J = 8.4 Hz, 1H), 6.53 (s, 1H), 3.88 (q, J = 6.9 Hz, 1H), 2.70 – 2.14 (m, 
2H), 1.48 (d, J = 8.1 Hz, 3H), 0.98 (t, J = 7.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 212.9, 134.9, 132.2, 128.2, 124.9, 121.7, 119.7, 111.5, 102.2, 
52.7, 34.0, 17.9, 8.0. 
HRMS (EI+): m/z calcd for C13H16NO: 202.1226, found [M+H]+: 202.1225. 
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62. 2-(4-(Methylsulfonyl)phenyl)-1-phenylpropan-1-one: 
 
Yield 92%, 159 mg. X=Cl. 
For characterisation, see entry 46, Chapter 2. 
 
63. 2-(4-(Dimethylamino)phenyl)-1-phenylpropan-1-one:27 
 
Yield 92%, 140 mg. X=Br, pale yellow solid. 
H NMR (400MHz, CDCl3) : δ 7.97 (m, 2H), 7.46 (m, 1H), 7.37 (m, 2H), 7.16 (m, 2H), 6.67 
(m, 2H), 4.60 (q, J = 6.8 Hz, 1H), 2.90 (s, 6H), 1.51 (d, J = 6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 200.7, 149.3, 136.7, 132.5, 129.1, 128.7, 128.4, 128.4, 113.04, 
46.8, 19.4. 
Analytical data matches previously reported characterisation. 
 
64. 2-(4-(Methylsulfonyl)phenyl)-1-(4-(trifluoromethyl)phenyl)propan-1-one: 
 
Yield 88%, 188 mg. X=Cl, brown solid. 
1H NMR (400 MHz, CDCl3) δ 8.00 (d, J = 8.1 Hz, 2H), 7.84 (d, J = 8.0 Hz, 2H), 7.62 (d, J = 
8.0 Hz, 2H), 7.46 (d, J = 8.3 Hz, 2H), 4.79 (q, J = 6.9 Hz, 1H), 2.99 (s, 3H), 1.52 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 198.3, 146.7, 139.3, 138.5, 134.7, 134.4, 134.2 (q, J = 32.8 
Hz), 134.0, 133.7, 128.9, 128.7, 128.0, 127.4, 127.4, 127.3, 127.3, 125.6, 125.6 (d, J = 3.5 Hz), 
125.6, 124.6, 123.3 (q, J = 272.8 Hz), 121.9, 119.2, 119.2, 47.7, 44.1, 19.1. 
19F NMR (377 MHz, CDCl3) δ -63.18. 
HRMS (EI+):  (m/z): [M+H]+ calcd for C17H16F3O3S, 357.0775; found, 357.0775 
 
65. 2-(4-(Dimethylamino)phenyl)-1-(4-methoxyphenyl)propan-1-one: 
 
Yield 95%, 162 mg. X=Br, yellow solid. 
1H NMR (400 MHz, CDCl3) δ 8.03 – 7.92 (m, 2H), 7.17 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.9 
Hz, 2H), 6.67 (d, J = 8.7 Hz, 2H), 4.57 (q, J = 6.8 Hz, 1H), 3.79 (s, 3H), 2.89 (s, 6H), 1.51 (s, 
3H). 
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13C NMR (101 MHz, CDCl3) δ 199.2, 162.9, 149.3, 130.9, 129.5, 129.5, 128.2, 113.4, 112.87, 
55.2, 46.4, 40.4, 19.4. 
HRMS (EI+): m/z calcd for C18H22NO2: 284.1645, found [M+H]+: 284.1641. 
 
66. 6-methoxy-2-(4-(Methylsulfonyl)phenyl)-3,4-dihydronaphthalen-1(2H)-one:28 
 
Yield 63%, 124 mg. X=Cl, brown solid. 
1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 8.8 Hz, 1H), 7.91 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 
8.4 Hz, 2H), 6.87 (dd, J = 8.8, 2.5 Hz, 1H), 6.74 (d, J = 2.4 Hz, 1H), 3.88 (s, 3H), 3.87-3.83 
(m, 1H), 3.19-3.08 (m, 1H), 3.05 (s, 3H) 3.04-2.96 (m, 1H), 2.41 (td, J = 9.2, 7.9, 4.4 Hz, 
2H). 
13C NMR (101 MHz, CDCl3) δ 195.7, 163.9, 146.6, 146.3, 138.9, 130.3, 129.6, 127.5, 125.95, 
113.5, 112.6, 77.3, 55.5, 54.2, 44.6, 31.2, 29.3. 
Analytical data matches previously reported characterisation. 
 
67. 2-(1-Benzyl-1H-indol-5-yl)-1-phenylpropan-1-one: 
 
Yield 83%, 177 mg. X=Br, brown solid. 
1H NMR (400 MHz, CDCl3) δ 8.01 (m, 2H), 7.56 (d, J = 1.5 Hz, 1H), 7.47 – 7.39 (m, 1H), 
7.38 – 7.33 (m, 2H), 7.32 – 7.26 (m, 3H), 7.26 – 7.20 (m, 1H), 7.15 – 7.05 (m, 4H), 6.49 (dd, 
J = 3.1, 0.7 Hz, 1H), 5.26 (s, 2H), 4.78 (q, J = 6.8 Hz, 1H), 1.58 (d, J = 6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 200.8, 137.3, 136.7, 135.4, 132.6, 132.5, 129.1, 128.8, 128.72, 
128.7, 128.3, 127.6, 126.9, 121.7, 119.9, 110.2, 101.5, 50.1, 47.9, 19.9. 
HRMS (EI+): m/z calcd for C24H22NO: 340.1696, found [M+H]+: 340.1695. 
 
68. 1-Phenyl-2-(quinolin-6-yl)propan-1-one: 
 
Yield 83%, 130 mg. X=Cl, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 8.85 (d, J = 2.8 Hz, 1H), 8.13 – 7.99 (m, 2H), 8.01 – 7.94 (m, 
2H), 7.69 (m, 2H), 7.51 – 7.42 (m, 1H), 7.41 – 7.31 (m, 3H), 4.89 (q, J = 6.9 Hz, 1H), 1.62 
(d, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 199.9, 150.2, 147.2, 139.8, 136.2, 135.9, 133.0, 130.1, 129.76, 
128.7, 128.5, 128.4, 126.1, 121.3, 47.6, 19.5. 
HRMS (EI+): m/z calcd for C18H16NO: 262.1226, found [M+H]+: 262.1226. 
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69. 1,2-Diphenyl-2-(quinolin-6-yl)ethan-1-one:29 
 
Yield 65%, 126 mg. X=Cl, brown solid. 
1H NMR (400 MHz, CDCl3) δ 8.88 (dd, J = 4.2, 1.5 Hz, 1H), 8.12 – 8.00 (m, 4H), 7.71 – 
7.64 (m, 2H), 7.52 (t, J = 7.3 Hz, 1H), 7.41 (t, J = 7.7 Hz, 2H), 7.37 – 7.32 (m, 5H), 7.28 (dd, 
J = 10.3, 6.0 Hz, 1H), 6.25 (s, 1H). 
13C NMR (101 MHz, CDCl3) δ 197.9, 150.3, 147.3, 138.4, 137.6, 136.5, 136.0, 135.1, 133.19, 
131.0, 129.7, 129.1, 128.9, 128.9, 128.6, 128.1, 127.5, 127.4, 126.4, 121.8, 121.2, 59.1. 
Analytical data matches previously reported characterisation. 
 
70. 1-Phenyl-2-(quinolin-5-yl)propan-1-one: 
 
Yield 95%, 149 mg. X=Cl, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 9.28 (d, J = 0.7 Hz, 1H), 8.65 (d, J = 6.1 Hz, 1H), 7.97 (d, J = 
6.4 Hz, 1H), 7.90-7.81 (m, 3H), 7.55-7.39 (m, 3H), 7.36-7.26 (m, 2H), 5.33 (q, J = 6.8 Hz, 
1H), 1.64 (d, J = 6.9 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ 200.1, 153.7, 143.9, 137.2, 136.0, 133.4, 133.0, 129.3, 129.2, 
128.6, 128.5, 127.2, 127.1, 115.6, 43.0, 18.5. 
HRMS (EI+): m/z calcd for C18H16NO: 262.1226, found [M+H]+: 262.1225. 
 
71. 1-Phenyl-2-(6-(trifluoromethyl)176yridine-2-yl)propan-1-one: 
 
Yield 74%, 125 mg. X=Cl, yellow solid. 
1H NMR (400 MHz, CDCl3) δ 8.06 (dd, J = 8.4, 1.2 Hz, 2H), 7.78 (t, J = 7.8 Hz, 1H), 7.55 
– 7.36 (m, 5H), 5.08 (q, J = 7.0 Hz, 1H), 1.62 (d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 199.2, 161.6, 138.1, 136.0, 133.3, 129.0, 128.6, 124.7, 118.58 
(q, J= 2.7 Hz), 50.4, 18.0. Trifluoromethyl carbon was not detected.j 
19F NMR (377 MHz, CDCl3) δ -68.04. 
HRMS (EI+): m/z calcd for C15H13 F3NO: 280.0939, found [M+H]+: 280.0944. 
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72. 2-(4-Nitrophenyl)-1-phenylpropan-1-one:30 
 
Yield 58%, 89 mg. X=Cl, yellow oil. 
1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 8.7 Hz, 2H), 7.93 (dt, J = 8.5, 1.6 Hz, 2H), 7.57 – 
7.45 (m, 3H), 7.41 (t, J = 7.7 Hz, 2H), 4.84 (q, J = 6.9 Hz, 1H), 1.58 (d, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 199.1, 148.6, 146.9, 135.8, 133.3, 128.7, 124.1, 47.3, 46.6, 
44.5, 21.2, 20.3, 19.3, 19.0. 
Analytical data matches previously reported characterisation. 
 
73. 4-(1-Oxo-1-phenylpropan-2-yl)benzonitrile:31 
 
Yield 19%, 27 mg. X=Cl, yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.95 – 7.88 (m, 1H), 7.62 – 7.56 (m, 1H), 7.56 – 7.50 (m, 
0H), 7.45 – 7.38 (m, 2H), 4.77 (q, J = 6.9 Hz, 0H), 1.55 (d, J = 6.9 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 199.2, 146.6, 135.9, 133.3, 132.7, 128.7, 128.6, 118.6, 110.93, 
47.6, 19.3. 
Analytical data matches previously reported characterisation. 
 
75. 2-(10-(3-(4-Methylpiperazin-1-yl)propyl)-10H-phenothiazin-2-yl)-1-
phenylpropan-1-one: 
 
Yield 86%, 248 mg. X=Cl, brown oil. 
1H NMR (400 MHz, CDCl3) δ 7.96-7.90 (m, 2H), 7.50 -7.44 (m, 1H), 7.40-7.34 (m, 2H), 
7.14-7.06 (m, 2H), 7.03 (d, J = 7.8 Hz, 1H), 6.90-6.83 (m, 3H), 6.72 (d, J = 1.6 Hz, 1H), 4.61 
(q, J = 6.8 Hz, 2H), 2.58-2.15 (m, 13 H), 3.86 (t, J = 6.9 Hz, 2H), 1.85 (p, J = 7.0 Hz, 1H), 
1.50 (d, J = 6.8 Hz, 3H)  
13C NMR (101 MHz, CDCl3) δ 200.1, 145.7, 145.0, 140.7, 136.3, 132.9, 128.7, 128.5, 127.71, 
127.3, 127.2, 124.9, 123.7, 122.4, 122.0, 115.6, 114.5, 55.4, 55.1, 53.1, 47.6, 46.0, 45.2, 24.2, 
19.5. 
HRMS (EI+): m/z calcd for C29H34N3OS: 472.2417, found [M+H]+: 472.2408. 
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79. (S)-2-[(t-Butoxycarbonyl)amino]-3-(5-(1-oxo-1-phenylpropan-2-yl)-1H-indol-3-
yl)propanoic acid: 
 
Yield 87%, 56 mg. X=Br, brown solid. 
1H NMR (400 MHz, CD3OD) δ 10.28 (s, 1H), 8.00 (d, J = 7.4 Hz, 2H), 7.55-7.49 (m, 1H), 
7.45 (t, J = 7.3 Hz, 1H), 7.37 (t, J = 7.5 Hz, 2H), 7.24 (d, J = 8.3 Hz, 1H), 7.06 (s, 1H), 6.97 (t, 
J = 7.7 Hz, 1H), 4.86-4.83 (m, partly covered by the signal of water, 1H), 4.41 (td, J = 8.0, 
5.2 Hz, 1H), 3.26 (dd, J = 14.5, 5.4 Hz, 1H), 3.10 (dd, J = 15.4, 7.3 Hz, 1H), 1.53 (d, J = 6.7 
Hz, 3H), 1.39 (d, J = 1.9 Hz, 9H). 
13C NMR (101 MHz, CD3OD) 203.2, 176.0, 157.8, 138.1, 133.7, 133.3, 129.9, 129.4, 129.4, 
125.2, 122.2, 118.7, 112.8, 111.1, 80.5, 55.9, 49.3, 48.4, 28.7, 23.7, 20.3. One aromatic 
carbon was not detected. 
[α] 20D = -30.2 (c= 0.5, MeOH) 
HRMS (EI+): m/z calcd for C25H29N2O5: 437.2071, found [M+H]+: 437.2071. 
 
81. (S)-2-[(t-Butoxycarbonyl)amino]-3-(6-(1-oxo-1-phenylpropan-2-yl)-1H-indol-3-
yl)propanoic acid: 
 
Yield 70%, 45 mg. X=Cl, brown solid. 
1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 7.4 Hz, 2H), 7.55-7.41 (m, 2H), 7.36 (t, J = 7.6 
Hz, 2H), 7.22 (s, 1H), 7.03 (s, 1H), 6.96 (d, J = 8.3 Hz, 1H), 4.86-4.83 (m, partly covered 
by the signal of water, 1H), 4.41-4.32 (m, 1H), 3.29-3.20 (m, 1H), 3.07 (dd, J = 14.6, 7.9 
Hz, 1H), 1.50 (d, J = 6.8 Hz, 3H), 1.32 (d, J = 4.3 Hz, 9H). 
13C NMR (101 MHz, CDCl3) δ 203.0, 176.0, 157.7, 138.4, 138.1, 136.1, 133.7, 129.9, 129.44, 
128.0, 124.8, 120.0, 119.9, 111.3, 111.1, 80.4, 56.0, 49.3, 28.7, 28.6, 20.1. 
[α] 20D = -2.2 (c= 0.5, MeOH) 
HRMS (EI+): m/z calcd for C25H29N2O5: 437.2071, found [M+H]+: 437.2071. 
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83. (S)-2-[(t-Butoxycarbonyl)amino]-3-(6-(1-oxo-1-phenylpropan-2-yl)-1H-indol-3-
yl)propanoic acid: 
 
Yield 94%, 60 mg. X=Br, yellow solid. 
1H NMR (400 MHz, CDCl3) δ 10.57 (s, 1H), 7.92 (d, J = 7.8 Hz, 2H), 7.44 (dd, J = 7.5, 5.1 
Hz, 2H), 7.31 (t, J = 7.7 Hz, 2H), 7.19 (s, 1H), 6.91 (t, J = 7.6 Hz, 1H), 6.79 (d, J = 7.3 Hz, 
1H), 5.15 (q, J = 6.7 Hz, 1H), 4.47-4.34 (m, 1H), 3.29-3.28 (m, partly covered by the signal 
of deuterated methanol, 1H), 3.11 (dd, J = 14.7, 8.0 Hz, 1H), 1.53 (dd, J = 6.7, 1.3 Hz, 3H), 
1.36 (d, J = 6.5 Hz, 9H). 
13C NMR (101 MHz, CDCl3) δ 202.2, 175.8, 157.8, 137.8, 134.0, 130.0, 129.5, 129.5, 125.8, 
125.0, 124.8, 121.0, 120.5, 118.5, 112.2, 80.5, 55.9, 49.3, 44.7, 28.8, 28.7, 18.2. One aromatic 
carbon was not detected. 
[α] 20D = +23.4 (c= 0.5, MeOH) 
HRMS (EI+): m/z calcd for C25H29N2O5: 437.2071, found [M+H]+: 437.2071.
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